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AbSTrACT
A total of 4,563 adult patients underwent cardiac surgical procedures at Vaasa Cen-
tral Hospital from January 1994 to June 2008. A substantial amount of data from 
all the patients was prospectively collected in an institutional database, including 
both cardiac examinations and surgical care. This material was later retrospec-
tively analysed in five studies. The main focus of these studies was on recognizing 
specific risk factors related to various cardiac surgical procedures.
The first two studies evaluated the risk predicting value of preoperative spirom-
etry. In the first one we showed that impaired left ventricular function (EF<50%) 
is strongly associated with preoperative low percentages of forced vital capacity 
(FVC<80%) in a material of 453 patients undergoing aortic valve reconstruction 
(AVR).  The same association was not found with forced expiratory volume in 1 
second (FEV1). Preoperatively lowered FVC (FVC<80%) had a better prognostic 
value for postoperative death in AVR patients than preoperatively lowered FEV1 
(FEV1<75%). Also, the lowered FVC had a clear predictive value for adverse neuro-
logic events and prolonged postoperative stay in the intensive care unit (ICU). The 
second study ascertained the prognostic value of preoperative spirometry among 
1,848 patients undergoing coronary bypass surgery (CABG). The percentages of 
predicted FVC and of predicted FEV1 were associated with in-hospital death, 
combined adverse end-point, need for postoperative de novo dialysis, neuropsy-
chological disturbances, atrial fibrillation as well as length of stay in the intensive 
care unit ≥ 5 days. Only percentage of predicted FVC < 70% along with pulmonary 
disease but not percentage of predicted FEV1 < 70%, were independent predictors 
of late overall mortality.
The prevalence of people aged 80 years or over is steadily increasing. The third 
study included a consecutive series of 247 patients aged 80 years or over who 
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underwent isolated CABG. They belonged to a series of 3,474 patients who under-
went isolated CABG during the same study period. Of them 40% were women 
(24% among the younger age group). A special focus was on the long-term sur-
vival (5 years) of these patients and on risk factors contributing to it. Both uni-
variate analysis and regression analysis showed that diabetes, extracardiac arterio-
sclerotic disease, neurologic dysfunction, recent myocardial infarction and critical 
preoperative status were associated with poorer long-term outcome. The 30-day 
in-hospital mortality in this material was 4.7% compared to 1.3% in the younger 
age group. The 5-year survival rate was 77% and the 10-year survival 35% (com-
pared to 90% and 76% in the younger group). A propensity score analysis between 
matched pairs of patients aged 80 years or over  and under 80 years showed parallel 
survival curves between these two groups up to five years after the greater initial 
30-day mortality of  older patients.
There is longstanding evidence confirming that a long aortic cross-clamp time 
(XCT) and a long cardiopulmonary bypass time (CPBT) are strong risk factors 
connected to heart surgery. In our fourth study both XCT and CPBT were cut 
in cohorts of 30-minute intervals. Both XCT and CPBT were included separately 
into a statistical regression model in proportion to changes in mortality rate. The 
best cutoff values of increasing risk were 150 min for XCT and 240 min for CPBT 
(adjusted for additive EuroSCORE and complexity of the operation). It is worth 
noting that  these cutoff values, despite having a high accuracy (over 90%), have a 
very low sensitivity (34% for XCT and 28% for CPBT).  Thus long XCT and CPBT 
do not automatically indicate a dismal prognosis. XCT and CPBT have, however, a 
marked impact on postoperative morbidity. The strong association between post-
operative stroke and XCT as well as CPBT is of particular interest. In this series, 
CPBT was a much stronger predictor of 30-day mortality than XCT.
EuroSCORE, established in 1999, is the most popular and widely validated 
risk-scoring system in Europe. It is known that EuroSCORE tends to overestimate 
mortality in low-risk patient groups and to underestimate the risk in very high-
risk patient groups. In the original EuroSCORE, non-CABG surgery was calcu-
lated as a risk. Thus a simple AVR carries greater risk than a CABG with several 
bypasses. On the other hand, the complexity of the operation and the severity of 
Determinants of outcome in aDult carDiac surgery 11
the non-cardiac illnesses of the patient are not fully evaluated. In the fifth study we 
created a new model for risk evaluation (Modified EuroSCORE). More attention 
was paid to preoperatively impaired renal function by estimating the glomerular 
filtration rate. Also, the complexity of the operation was taken into consideration. 
Not surprisingly, this model fitted our material well in Vaasa. The model was tested 
and validated in Tampere University Hospital  (study VI), with an adult cardiac 
surgery material of 4,014 people, operated from January 2004 to December 2008. 
Here, the predicted mortality rates with the Modified EuroSCORE were rather 
similar to those observed. This was not the case for EuroSCORE. Interestingly, the 
accuracy of the modified score was particularly evident in high risk patients.
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TIIvISTElmä 
Abstract in Finnish
Vaasan keskussairaalassa leikattiin kaikkiaan 4563 aikuissydänkirurgista poti-
lasta tammikuun 1994 ja kesäkuun 2008 välisenä aikana. Huomattava määrä 
sekä kardiologisiin tutkimuksiin että kirurgiseen hoitoon liittyvää tietoa kerättiin 
prospektiivisesti kaikista potilaista sairaalan sisäiseen rekisteriin. Tätä rekisteri-
materiaalia käytettiin myöhemmin retrospektiivisiin analyyseihin viidessä eri tut-
kimuksessa. Yksi tarkastelun päänäkökulmista oli leikkaukseen liittyvien määrät-
tyjen riskitekijöiden parempi tunnistaminen. Kahdessa ensimmäisessä työssä 
tutkittiin preoperatiivisen spirometrian leikkausriskiä ennustavaa arvoa. Ensim-
mäisessä tutkimuksessa todettiin 453 aortaläppäleikkauksen läpikäyneen potilaan 
materiaalissa alentuneen vasemman kammion funktion (EF< 50%) assosioituvan 
spirometriassa mitattuun alentuneeseen vitaalikapasiteettiin (FVC< 80%). Samaa 
yhteytä ei havaittu mitatun sekuntikapasiteetin (FEV1) suhteen. Ennen leikkausta 
mitatulla alentuneella vitaalikapasitettiarvolla (FVC< 80%) oli parempi aortaläppä-
leikkaukseen liittyvä ennustearvo kuin alentuneella sekuntikapasiteettiarvolla 
(FEV1< 75%). Samoin alentuneella FVC:llä oli selvä ennustearvo aivotapahtu mien 
ja pitkittyneen leikkauksen jälkeisen tehohoidon suhteen. Toisessa tutkimuksessa 
selvitettiin ennen leikkausta mitattujen spirometria-arvojen ennusteellista merki-
tystä 1848 sepelvaltimo-ohistuspotilaan (CABG) joukossa. Sekä alentunut sekun-
tikapasiteetti että vitaalikapasiteetti ennustivat sairaalakuolemaa, haitallisia yhdis-
tettyjä päätetapahtumia, leikkauksen jälkeisen munuaiskorvaushoidon tarvetta, 
neuropsykologisia häiriöitä, eteisvärinää ja pitkittynyttä tehohoitoa (>5 vrk). 
Kuitenkin vain alentuneella vitaalikapasiteettiarvolla (<70%) oli keuhkojen laajen-
tumataudin (COPD) ohella merkitystä pitkäaikaisennusteen (10 v.) kan nalta.
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Koska yli 80 v. täyttäneiden vanhusten osuus sydänleikkausmateriaaleissa on 
jatkuvasti kasvamassa (15% tässä materiaalissa), haluttiin kolmannessa työssä 
selvittää tämän potilaskohortin riskiä. Tutkimukseen otettiin 274 peräkkäistä yli 
80-vuotista sepelvaltimo-ohitusleikkaukseen tulevaa potilasta.  He olivat osa 3474 
potilaan ryhmää, jolle samana tarkasteluaikana tehtiin puhdas sepelvaltimoiden 
ohitusleikkaus. 40 % tämän ikäluokan potilaista oli naisia (24% tätä nuorempien 
joukossa). Erityisesti haluttiin selvittää tämän potilasmateriaalin pitkäaikais-
ennustetta (5v.) ja siihen vaikuttavia riskitekijöitä. Sekä yksimuuttuja-analysissa 
että regressioanalyysissa todettiin sokeritaudin, sydämen ulkopuolisen valtimo-
kovettumataudin, neurologisen häiriön, tuoreen sydäninfarktin ja kriittisen 
leikkausta edeltävän tilanteen ennustavan myöhäiskuolleisuutta. 30 vuorokauden 
sairaalakuolleisuus oli tässä materiaalissa 4,7 %, kun se nuoremmassa ikäryhmässä 
oli 1,3 %. Viiden vuoden kuluttua oli leikatuista potilaista elossa 77 % ja kymmenen 
vuoden kuluttua 35% (verrattuna 90% ja 76%:iin nuoremman potilasjoukon koh-
dalla). Kun näitä potilaita verrattiin kohdennettuun nuorempaan potilasmate-
riaaliin, todettiin vanhusryhmässä korkeampi sairaalakuolleisuus (4,7%/1,3%), 
mutta sen jälkeen eloonjäämiskäyrät olivat varsin yhdensuuntaiset.
Tiedetään, että pitkä aortan sulkuaika sekä pitkä perfuusioaika ovat sydän-
leikkaukseen liittyviä riskitekijöitä. Neljännessä työssä etsittiin molempiin liittyvät 
riskirajat. Molemmat pilkottiin 30 minuutin aikaväleihin ja tutkittiin leikkauk-
seen liittyvän kuolleisuuden muutosta sulkuajan ja perfuusioajan kasvaessa. Tässä 
materiaalissa riskin todettiin oleellisesti lisääntyvän, kun aortan sulkuaika ylittää 
150 min. ja perfuusioaika 240 min. (suhteutettuna additiiviseen EuroSCOREen 
ja leikkauksen kompleksisuuteen). On kuitenkin huomattava, että pitkä aortan 
sulkuaika ja pitkä perfuusioaika eivät automaattisesti merkitse huonoa ennustetta. 
Selkeä yhteys postoperatiiviseen sairastuvuuteen on kuitenkin olemassa. Erityisen 
mielenkiintoista on, että pitkä sulkuaika ja perfuusioaika lisäävät haitallisten aivo-
tapahtumien riskiä. Tässä materiaalissa perfuusioajan pituus oli aortan sulkuaikaa 
vahvempi kuolleisuuden ennustaja.
Euroopassa sydänleikkauksen riskiä arvioidaan tavallisesti v. 1999 luodun 
EuroSCORE-luokituksen avulla. EuroSCOREn ongelmaksi tiedetään riskin yliar-
vioiminen matalan riskiryhmän potilaille ja toisaalta riskin aliarvioiminen hyvin 
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korkean riskin potilailla. Alkuperäisessä EuroSCORE-mittarissa muu kuin CABG-
toimenpide arvioitiin riskiksi. Siten esim. yksinkertainen aortaläppäleikkaus saa 
enemmän riskiarvoa kuin useamman suonen ohitusleikkaus. Myöskään moni-
mutkainen useaa sydämen aluetta käsittelevä leikkaus tai potilaan sydämen 
ulkopuoliset sairaudet eivät saa niille kuuluvaa riskiarvoa. Työssä V mallinnet-
tiin tilastollisen analyysin avulla Vaasan materiaalista uusi mukailtu EuroSCORE 
(Modified EuroSCORE), joka ennen kaikkea otti paremmin huomioon alentuneen 
munuaisfunktion vaikutuksen (preoperatiivisen laskennallisen glomerulusfiltraa-
tion avulla) ja toisaalta toimenpiteen kompleksisuuden aiheuttaman riskilisäyksen. 
Työssä VI tämä malli testattiin ja validoitiin Tampereen yliopistosairaalassa tam-
mikuun 2004 ja joulukuun 2008 välisenä aikana leikatun 4014 sydänkirurgisen 
aikuispotilaan avulla. Mallin todettiin ennustavan toteutunutta kuolleisuutta 
tarkemmin kuin alkuperäisen EuroSCORE-mittarin. Erityisen mielenkiintoista 
oli, että malli ennusti kuolleisuutta tarkasti korkean riskin potilaille.
16 Determinants of outcome in aDult carDiac surgery
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AbbrEvIATIONS
ABI Ankle-brachial index
ACC American College of Cardiology
ACS Acute coronary syndrome
AF Atrial fibrillation
AHA American Heart Association
AKI Acute kidney injury
AMI Acute myocardial infarction
ANOVA Analysis of variance
AP Angina pectoris
APACHE Acute physiology, age, chronic health evaluation
ARF Acute renal failure
ASO Arteriosclerosis obliterans
AUC Area under the receiver operating characteristics curve
AVR Aortic valve reconstruction
BCP Blood cardioplegia
BSA Body surface area
CAD Coronary artery disease
CAB(G) Coronary artery bypass (grafting)
CHD Coronary heart disease
CHF Congestive heart failure
CI Confidence interval
C-CPB Conventional cardiopulmonary bypass
CCP Crystalloid cardioplegia
CCS Canadian Cardiovascular Society
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CF Calibration factor
CHD Coronary heart disease
CK Creatine kinase
CK-Mb Creatine kinase MB isoenzyme
COPD Chronic obstructive pulmonary disease
CPB  Cardiopulmonary bypass
CPBT Cardiopulmonary bypass time
CRP C-reactive protein
CVD Cerebral vascular disease
DW-MRI Diffusion-weighted magnetic resonance imaging
DM Diabetes mellitus
ECC Extracorporeal circulation
ECG Electrocardiogram
EF Ejection fraction
EuroSCORE European system for cardiac operative risk evaluation
FEV1 Forced expiratory volume in 1 second
FVC Forced vital capacity
GFR Glomerular filtration rate
GOLD Global Strategy for the Diagnosis, Management and 
 Prevention of COPD
HRQoL Health-related quality of life
IABP Intra-aortic balloon pump
ICU Intensive care unit
IMA Internal mammary artery
IMT Intima-media thickness
ITA Internal thoracic artery
LOS Low output syndrome
LV Left ventricle
LVEF Left ventricular ejection fraction
Mini-CPB Miniaturized cardiopulmonary bypass
MRI Magnetic resonance imaging
NYHA New York Heart Association
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MACE Major adverse cardiovascular event
MACCE Major adverse cardiovascular or cerebral vascular event
MI Myocardial infarction
NE Neurologic event
NSTE-ACS Non ST-segment elevation acute coronary syndrome
NSTEMI Non ST-segment elevation myocardial infarction
OPCAB Off-pump coronary artery bypass
OR Odds ratio
PAD  Peripheral artery disease
PCI Percutaneous coronary intervention
PVD Peripheral vascular disease
ROC Receiver operating characteristic
SIRS Systemic inflammatory response syndrome
SPSS Statistical Package for the Social Sciences
SRI Simplified renal index
STEMI ST-segment elevation myocardial infarction
STS  Society of Thoracic Surgeons
STS NCD National adult cardiac surgery database
TAAD Thoracic aortic aneurysm dissection
TIA Transient ischemic attack
TIMI Thrombolysis in myocardial infarction
TORCH Towards a Revolution in COPD Health
UAP/USA Unstable angina pectoris
XCT Aortic cross clamp time
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1 INTRODUCTION
However delicate and sophisticated a cardiac operation is, it still carries a basic 
risk. This risk depends on the magnitude and complexity of the operation, the 
characteristics of the patient and the institution the patient is referred to.
Estimating the risk of severe complications associated with a cardiac opera-
tion is a fundamental aspect of patient evaluation. More rigorous expectations for 
obtaining consent and a more enquiring patient population have made risk assess-
ment even more important. Risk evaluation and especially control of risks have 
important economic and operational implications. Considering the risks to the 
patient is a meaningful way to plan the operation and the resources required.
Indices and scoring systems designed to estimate risk have been developed 
over decades. These form the basis for discussions with individual patients when 
the forthcoming procedures or complications are enumerated. Based on large 
population studies these scores are usually very accurate in predicting statistical 
odds for adverse events. – Individually the prognosis of a patient is anyway more 
uncertain and cannot be determined by a scoring system alone.
Patient populations may differ significantly between institutions and geo-
graphic areas. Cardiac surgery is also now performed in an increasingly high-risk 
population. Aging, co-morbidities, failing ventricles and expanding demands for 
urgent operations make patient care even more demanding. Crude estimation of 
mortality rates has only a limited value without knowledge of the patient’s risk pro-
file as a whole. Various risk stratification models have been developed to correct 
for differences between populations and to allow comparison of actual outcome 
with the predicted outcome. Those models, however, are not all-inclusive and tend 
to either underestimate or overestimate the individual risk. This is a legacy of their 
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historical nature, generalized structure not being able to consider every meaning-
ful detail and fast development of surgical practice.
The estimate of average perioperative mortality is increasing, since older, sicker 
and more acute patients are referred to cardiac surgery. However, the hospital mor-
tality has remained unchanged or even slightly reduced because of improvements 
in medical care. Meanwhile, an increase of postoperative complications has led 
to an increase of surviving patients with prolonged intensive care unit (ICU) and 
hospital length of stay with increasing costs, individual suffering and consumption 
of medical resources. (Warner CD 1997).
Therefore, creating a detailed individual institutional risk profile is worthwhile 
for more reliable and accurate patient screening. Although this kind of profile 
merely reflects the results of the particular institution, its predictability and accu-
racy for individual assessment can be rewarding. Testing and validation of such a 
profile with materials of similar institutes eliminate any crude biases and are to be 
recommended.
The aim of the present study was to create a more precise tool for risk estima-
tion by analysing the adult cardiac surgical material operated in the Vaasa Central 
Hospital from 1994 through 2008. Updating of the EuroSCORE system - currently 
in the ascendant, at least in Europe – has been one special consideration. More 
weight was put to the complexity of the procedure, and effort was invested in out-
lining safety limits for more demanding operations. Particular attention was paid 
to the evaluation of preoperative pulmonary function, as well as the peri- and post-
operative outcome of older people – a growing part of the surgical population.
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2 REVIEW OF THE LITERATURE
2.1  The importance of identifying the predictors of outcome
Estimating the risks of serious complications associated with cardiac surgery is a 
fundamental aspect of both surgery and clinical anaesthesia. As a result of con-
tinually improving surgical strategy and the technology which supports it, cardiac 
surgery is now possible in an increasingly aging and increasingly high-risk popula-
tion (Warner et al. 1997). In a context of increased control of growing health-care 
expenditures it is important to assess cardiac surgical results as precisely as pos-
sible (Kolh 2006). Given fairly low operative mortality but an increasing number 
of disturbances from vital organs, more sensitive models predicting forthcoming 
problems are needed  (Warner et al. 1997). The target should be on comparing dif-
ferent methods of treatment and planning optimal sharing of limited resources. 
From the patient’s standpoint the main goals of preoperative risk assessment 
are quantification of the individual operative risk and the potential reduction of 
this risk by various interventions. These interventions may include modifying drug 
therapy, intensified physical training, individually planned operative procedure, 
more intensive intraoperative monitoring, anaesthetic and surgical techniques 
and postoperative care (Kurki 1997). Applying catheter-based techniques for high 
risk aortic valve operations or giving preoperative levosimendan-infusion to an 
uncompensated patient with severe heart failure are some examples of attempts to 
improve the patients’ outcome (Eriksson et al 2009). For the patient and his/her 
relatives, knowledge of the exact calculated risk associated with a certain operation 
is also of major importance. It must be underlined that risk stratification models 
score the risks of the patient, but not the quality of care ( Kolh,P. 2006).
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From a global perspective the interpretation and comparison of published 
materials requires a uniformly accepted and validated scoring system, according 
to which presented patients are adjusted.
2.2 Preoperative risk factors
Outcomes of interest in cardiac surgery include mortality, morbidity, major adverse 
events (i.e. perioperative myocardial infarction, stroke, acute kidney injury), 
resource utilization, functional postoperative status and patient satisfaction. Inde-
pendent predictable variables affecting outcome can be categorized as preopera-
tive patient characteristics, type and severity of the cardiac disease, preoperative 
measurement of physiologic parameters and type and extent of the surgical pro-
cedure. Unpredictable variables include intraoperative events with a fundamental 
impact on postoperative outcome.
2.2.1    Patient characteristics
Patient characteristics are related to individual patients’ personal features.
Age
Age is an elementary determinant of outcome, although the relationship between 
advanced age and poor outcome is neither linear nor consistent from patient to 
patient (Higgins 1998). Traditionally, the age of 65 years has been used as a cutoff 
value differentiating between elderly and younger patients. With the improvement 
in the general health of the population and in medical care, no particular cutoff 
age may any longer be valid as an exclusion criterion.  However, mortality rises 
steadily after the age of 60 years (Higgins et al. 1992c, Roques et al. 1999).  Figure 1 
shows the influence of age on mortality according to logistic EuroSCORE. Patients 
are divided into cohorts at intervals of five years. According to the logistic Euro-
SCORE, mortality below age 60 is calculated to be 0.88 %. At age 60 it is 0.93 % and 
rises progressively to be almost tenfold at the age of 95.
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Sex
Many studies quote female sex as a risk factor for both mortality and morbidity 
(O’Connor et al. 1993b) and this variable is included in most cardiac surgery risk 
scoring methods (Parsonnet et al. 1989, Edwards et al. 1994b, Roques et al. 1999). 
Tan et al. in their review show that the higher prevalence of hypertension, dia-
betes and obesity in older women portends a greater risk in women than in men 
(Tan et al. 2010). Although cardiovascular mortality for men has been declining, 
the number of women dying from cardiovascular disease has slightly increased 
(Tremmel and Yeung 2007). Female patients referred to CABG are often older and 
have several co-morbidities (Koch et al. 1996) such as higher age, hypertension, 
diabetes or metabolic syndrome, heart failure, renal disease, peripheral vascular 
disease, and worse lipid profile (Dullum and Dullum 2008). Additionally, risk fac-
tors like smoking, hypertriglyseridemia and low high-density lipoprotein choles-
terol levels have greater impact in women than in men (Tan et al. 2010). Hogue 
also showed that women undergoing cardiac surgery have a higher incidence of 
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Figure 1.  Influence of age on mortality according to the logistic EuroSCORE.
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periprocedural morbid events, such as stroke and bleeding, compared with men 
(Hogue et al. 2001).
Some studies have examined both sex and body size in the same population 
and noted that it is  rather small body size and not sex that increases risk in female 
gender. (Fisher et al. 1982, Parsonnet et al. 1989, Higgins et al. 1992b, O’Connor et 
al. 1993b). The clinical picture of women’s heart disease is variable, possibly result-
ing in delays in diagnosis and treatment. In comparison to men women also more 
often have unstable angina, as well as severe angina and congestive heart failure 
(Jacobs 2003). Congestive heart failure has been shown to account for excess mor-
tality in women undergoing coronary artery bypass grafting (CABG) (O’Connor 
et al. 1993a).
 Increased mortality of women in CABG surgery may also be due to refer-
ral bias. Women are referred for coronary bypass surgery later in the course of 
their disease than men, hence being older than men, having a higher percentage 
of unstable angina pectoris, postmyocardial infarction angina, congestive heart 
failure, and New York Heart Association class IV symptoms (Khan et al. 1990). 
There has been general acceptance that women undergoing bypass surgery 
have a mortality double that of their male peers and mortality rates as high as 4 
times that of men have been reported in women following CABG (Hogue, C.W.,Jr 
2001, Vaccarino et al. 2002). Recent sex-based analysis has suggested that diabetes 
and urgency or emergency presentation accounts for this manifold mortality risk 
(Wenger 2003). This is especially true in younger age groups. In a National Car-
diovascular Network database survey from 1993 to 1999 the odds ratio for post-
CABG in-hospital mortality for patients <50 years of age was 2.23 for women com-
pared with men. This difference decreased with age, and disappeared for patients 
>80 years of age (Vaccarino et al. 2002).  
Some recent studies by Blankstein and Tan confirm that female gender is an 
independent predictor of perioperative mortality, even after accounting for all 
comorbidities, and including low body surface area, BSA (Women 4.24% ver-
sus men 2.23%) (Blankstein et al. 2005). However, after discharge from hospital, 
adjusted survival at 5 years after CABG seems to be similar in women and men 
(Herlitz et al. 2000).
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Body size
Obese people carry a higher statistical risk of death (Manson et al. 1995, Solomon 
and Manson 1997, Gelber et al. 2007).  At least three studies have confirmed the 
risk of morbid obesity in patients undergoing cardiac surgery. Paiement in the 
Montreal Heart Classification found body mass index over 0.30 to be an independ-
ent risk factor (Paiement,B. 1983). Parsonnet in his risk model defined morbid 
obesity as at least 1.5 times normal weight. The logistic coefficient for overweight 
was -0.271 with a p-value of 0.027 (Parsonnet et al. 1989). Prasad et al.found no dif-
ference in perioperative mortality, but respiratory problems (p< 0.01); leg wound 
infections (p< 0.001); myocardial infarction (p< 0.02); arrhythmias (p< 0.02); and 
sternal wound dehiscence (p< 0.02) were more common in obese patients (Prasad 
et al. 1991).  At a mean follow-up time of 36.9 months obese patients exhibited a 
greater incidence of significant recurrent angina (p < 0.01), which was associated 
with further weight gain (mean 12.2 kg; linear correlation: p< 0.001, r = 0.891). 
Higgins in the Cleveland Clinic model found a bodyweight < 65 kg to be a risk 
factor (Higgins 1998). Newer risk models used nowadays (EuroSCORE and STS) 
have not found overweight to be an independent risk factor.
Heredity  
Clinicians tend to consider family history of CHD when evaluating CHD risk. 
However, quantitative methods taking into account family history of CHD are 
not readily available. Nor does any risk model identify heredity as a measured 
variable. The genetic background of some cardiovascular disorders, however, is 
well known. For example, thoracic aortic aneurysms leading to type A dissections 
(TAAD) may occur in isolation or in association with genetic syndromes, such 
as Marfan syndrome or Loeys-Dietz syndrome. Familial TAAD is inherited in an 
autosomal dominant manner with decreased penetrance (especially in women) 
and variable expression and exhibits significant clinical and genetic heterogeneity 
(Collod-Beroud et al. 1997, Pearson GD. Devereux R. Loeys B. Maslen C. Milewicz 
D. Pyeritz R. Ramirez F. Rifkin D. Sakai L. Svensson L. Wessels A. Van Eyk J. Dietz 
HC. National Heart, Lung and Blood Institute and National Marfan Foundation 
Working Group 2008).  Bicuspid aortic valve (BAV) with its co-morbidities also 
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seems to be highly heritable. In a study by Cripe, where a total of 309 probands and 
relatives participated in an investigaton of the heritability of BAV and BAV and/
or other cardiovascular malformations, the heritability figures were 89% and 75% 
respectively (Cripe et al. 2004).
2.2.2 Comorbidities
Chronic pulmonary disease
Pulmonary disease defined according to EuroSCORE criteria provides long term 
use of bronchodilators or steroids for lung disease. Severity of COPD is classified 
according to the Global Strategy for the Diagnosis, Management and Prevention 
of COPD  (GOLD) (Rabe et al. 2007)
Table 1.  GOLD Staging System for COPD Severity
Stage Description Findings (based on postbronchodilator FEV1)
0 At risk Risk factors and chronic symptoms but normal spirometry
I Mild FEV1/FVC ratio less than 70 percent 
  FEV1 at least 80 percent of predicted value 
  may have symptoms
II Moderate FEV1/FVC ratio less than 70 percent 
  FEV1 50 percent to less than 80 percent of predicted value 
  may have chronic symptoms
III Severe FEV1/FVC ratio less than 70 percent 
  FEV1 30 percent to less than 50 percent of predicted value 
  may have chronic symptoms
IV Very severe FEV1/FVC ratio less than 70 percent 
  FEV1 less than 30 percent of predicted value 
    or 
  FEV1 less than 50 percent of predicted value plus severe chronic symptoms
GOLD = Global Initiative for Chronic Obstructive Lung Disease; COPD = chronic obstructive pulmonary disease; FEV1 = forced 
expiratory volume in one second; FVC = forced vital capacity. 
review of the literature 31
Patients with severe chronic obstructive pulmonary disease (COPD) are known to 
be at increased risk of mortality and morbidity (Ranieri et al. 2008). This is par-
ticularly true when they undergo major surgery (Kroenke et al. 1992). A few risk 
scoring methods include pulmonary disease as a major determinant of mortality 
after adult cardiac surgery (Higgins et al. 1992a,  Magovern et al. 1996,  Roques et 
al. 1999). On the other hand, the adverse role of this condition has not been recog-
nized in several other major risk scoring methods (Parsonnet et al. 1989, Grover et 
al. 1993, Ivanov et al. 1999, Huijskes et al. 2003).  COPD has earlier been shown to 
predict the immediate outcome after coronary artery bypass surgery (Samuels et 
al. 1998a, Fuster et al. 2006) and after aortic valve reconstruction (AVR) , although 
a recent review by Tjang failed to identify pulmonary disease as a risk factor for 
early mortality of AVR (Tjang et al. 2007).  Angouras et al. found similar results in 
their study, where 3,760 CABG patients were followed up for 7.6 years (mean).  Of 
these 14.6% had COPD. COPD-patients were older and sicker. When compared to 
propensity-matched patients without COPD, no difference was noted in terms of 
hospital mortality or major morbidity. By contrast, COPD-patients had increased 
long-term mortality with a hazard ratio of 1.28 (95% confidence intervals, 1.11 to 
1.47; p = 0.001) (Angouras,D.C. 2010).
Extracardiac arteriopathy
The extent and severity of atherosclerotic lesions in major and peripheral arteries 
correlate with the extent and severity of coronary artery disease (Amanullah et al. 
2002, Sukhija et al. 2003, Rohani et al. 2005, Lekakis et al. 2005). Among patients 
undergoing major surgery for peripheral artery disease (PAD), the prevalence of 
CAD ranges from 25% to 78%, and myocardial infarction is the main cause of 
perioperative death (Monaco et al. 2009). In Hertzer’s study, severe correctable 
CAD was identified in 25% of the entire series of 1,000 patients under considera-
tion for elective peripheral vascular reconstruction  (Hertzer et al. 1984). 
The European system for cardiac operative risk evaluation (EuroSCORE) 
considers extracardiac arteriopathy as a risk factor for early mortality. In a recent 
study from Netherlands and Belgium 10,626 patients underwent isolated coronary 
artery bypass operation in a 10-year period. Out of these patients 1,222 (11.6%) 
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had peripheral vascular disease (PVD). The PVD was identified as an independent 
risk factor for late mortality (death at any time after hospital discharge), but not 
for early mortality (death within 30 days or before discharge). Patients without 
PVD had a better survival than patients with PVD: 2.3%/3.6% early mortality and 
10,1%/19.1% late mortality (p<0.0001), respectively (van Straten et al. 2010).
Symptomatic carotid disease increases the risk of stroke, and the management 
of patients with both symptomatic coronary and carotid artery diseases demands 
careful consideration (Wong 1991).  In St.Louis, 1,087 patients 65 years of age 
and older undergoing cardiac surgical procedures (91% had coronary artery dis-
ease) were evaluated before operation with carotid duplex ultrasonography. The 
prevalence of disease was 17.0% for 50% or greater stenosis and 5.9% for 80% 
or greater stenosis (Berens,E.S. 1992). Hill in 2000 stated that asymptomatic uni-
lateral carotid stenosis of 80–90% appears to be independently associated with 
ipsilateral hemispheric stroke following cardiac surgery and increases the risk of 
stroke 5.2 fold  (Hill,A.B. 2000).  Ascher 2001 recommended carotid screening for 
patients under 60 years only in the presence of two of the following risk factors: 
hypertension, diabetes or smoking. However, carotid screening is recommended 
for all patients undergoing open heart operations who are more than 60 years old 
(Ascher et al. 2001). On the other hand Archbold et al. recommended screening 
for all patients with a history of stroke or TIA, all patients with a carotid bruit, 
and all patients aged > 65 years (Archbold,R.A. 2001). It is suggested that pro-
phylactic carotid endarterectomy could neutralize the risk in those with at least 
80% carotid stenosis (Gott,J.P. 1999). In a preoperative MRI-study by Goto on 421 
elderly people, it was observed that 30% of patients had small brain infarctions 
and 20% had multiple infarctions (Goto et al. 2001). These findings of the extent of 
cerebrovascular disease were correlated with the occurrence of both postoperative 
stroke (1.4%/5.6%/8.4%) and cognitive change (7%/13%/20%) in control/ small 
infarct/ multiple infarct groups consecutively. In another Japanese study including 
a combination of MRI and magnetic resonance angiography, an even higher prev-
alence of cerebrovascular disease was found preoperatively in 39 CABG patients. 
Existing cerebral infarction was found in 97%, internal carotid artery disease in 
25%, periventricular hyperintensities in 87% and external carotid artery disease in 
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41% (Nakamura et al. 2004). Thus it may be important to consider investigating 
the carotid arteries before a cardiac operation. On the other hand, meta-analyses 
questioned the value of carotid revascularization in patients undergoing CABG  as 
the combined approach is associated with rather high risk of stroke/death (Borger 
and Fremes 2001, Naylor et al. 2009).
Neurological dysfunction
Stroke remains a devastating complication after cardiac surgical procedures. In 
addition to several known risk factors for postoperative neurologic events (NE), 
a history of preoperative NEs has also been reported to be associated with an 
increased risk of postoperative NEs (Rorick and Furlan 1990, Tuman et al. 1992, 
Mickleborough et al. 1996, Redmond et al. 1996, Halkos et al. 2008). In the study 
by Halkos a total of 14,278 patients prospectively registered were retrospectively 
analysed, 1,478 patients (10.4 %) having a history of preoperative NEs. Postopera-
tive neurological events occurred in 1.9% (274 patients).  In a propensity score 
matched analysis it was found that patients with preoperative NEs had three times 
more postoperative NEs than a matched cohort (4.6% vs. 1.6%; p<0.0001). Patients 
with preoperative NEs also had longer duration of postoperative ventilation and 
longer hospital stays. 
In other studies, evaluating the effect of preoperative NEs in patients operated 
using cardiopulmonary bypass, Redmond et al. documented a 44% stroke incidence 
and Rorick and Furlan reported a 13% stroke incidence postoperatively (Rorick 
and Furlan 1990, Redmond et al. 1996). In a large study by Bucerius (n=16,184), 
a previous history of cerebrovascular disease was a significant risk (OR 3.55) for 
postoperative stroke (Bucerius et al. 2003a). This and other studies (Anyanwu et 
al. 2007) also showed that those patients with stroke had 6-fold higher mortality 
(32.8% versus 4.9%, p<0.0001). Dacey et al. in the Northern New England Car-
diovascular Disease Study Group showed that those patients postoperatively diag-
nosed with stroke had a three-fold greater risk of death during  10-year follow-up 
(Dacey et al. 2005). Other authors also observed that a prior neurological event 
was an independent predictor for both early and late postoperative stroke (Hogue 
et al. 1999, Anyanwu et al. 2007).
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Postoperative neurologic disturbances
It seems likely that patients with postoperative coma, stroke and encephalopathy 
represent a continuum of conditions with similar underlying mechanisms: show-
ers of embolic material to the brain, whether they then are gaseous or particular 
(Gootjes et al. 2005). Encephalopathy is a diffuse brain injury with clinical mani-
festations including confusion, delirium, seizures, comatose state of consciousness, 
prolonged state of mental alteration, aggressiveness and agitation. Its reported 
incidence varies widely from 8.4% to 32% depending on difficulties in getting 
this condition formally diagnosed (McKhann et al. 2006). Like stroke, encepha-
lopathy is also associated with increased length of stay in the hospital, and with 3 
times higher mortality than in patients without this complication. The factors that 
appeared important were history of previous stroke, hypertension, diabetes, pres-
ence of carotid bruit, and age.
Patients operated off-pump were likely to have a reduced risk of postopera-
tive NEs compared to patients operated on-pump (Wijeysundera, D.N. 2005, 
Biancari,F. 2007). However, OPCAB does not confer additional risk reduction in 
patients with preoperative neurological events.  Friday in a prospective diffusion-
weighted magnetic resonance imaging (DW-MRI) found that ischaemic lesions 
at DW-MRI are seen after off-pump CABG at a rate similar to that reported for 
CABG with cardiopulmonary bypass (Friday,G. 2005). Lund in his prospective 
randomized study found a reduction in the number of microemboli measured 
by transcranial doppler during off-pump compared with on-pump surgery (16.3 
[range 0 to 131] versus 90.0 [range 15 to 274], p < 0.0001). However, no significant 
difference was found with regard to the incidence of neuropsychologic perform-
ance (decline in 29% off-pump, 35% on-pump) or neuroradiologic findings at 3 
months, and there was no association between the number of cerebral microem-
boli and cognitive outcome (Lund,C. 2003).
The incidence of stroke is much higher in the setting of combined cardiac pro-
cedures (> 2) and in more technically challenging operations, such as aortic aneu-
rysm repairs with the use of hypothermic circulatory arrest or in conjunction with 
extended perfusion times (Anyanwu et al. 2007).
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Renal failure
Renal dysfunction following cardiac surgery is well recognised as being mainly 
of ischaemic origin, but its precise pathogenesis is complex and multifactorial. 
It likely involves at least six major injury pathways: exogenous and endogenous 
toxins, metabolic factors, ischaemia and reperfusion, neurohormonal activation, 
inflammation and oxidative stress (Bellomo et al. 2004). The spectrum varies from 
subclinical injury to established renal failure requiring renal replacement therapy. 
Depending on definitions, acute kidney injury (AKI) after cardiac surgery gener-
ally occurs in 1–10% of patients (Mehta 2005) but may occur in up to 30% of post-
cardiac surgery patients (Vaschetto and Groeneveld 2007). Dialysis is required in 
approximately 1%–2% of all patients (Ostermann, M.E. 2000. Rosner and Okusa 
2006).  Mortality rates associated with perioperative acute renal failure range from 
60% to 90% (Sheinbaum et al. 2003). Even small decreases in kidney function are 
associated with poorer outcome. The risk of death associated with AKI after car-
diothoracic surgery remains high for 10 years regardless of other risk factors, even 
for those patients with complete renal recovery (an increased adjusted hazard ratio 
for death of 1.28 ) (Hobson et al. 2009). Several clinical studies have identified 
risk factors that can be used to effectively determine the risk for AKI in patients 
undergoing cardiac surgery. The Consensus Conference of the Acute Dialysis 
Quality Initiative in 2004 suggested a consensus definition named RIFLE (Risk of 
renal dysfunction; Injury to the kidney; Failure of kidney function; Loss of kidney 
function; and End-stage kidney disease) attempting to get uniform and generally 
accepted criteria for acute renal failure (ARF). However, its impact on surgical 
practice seems to be of minor importance. Wijeysundera et al. in 2007 derived and 
validated the Simplified Renal Index (SRI) for estimating the risk of renal replace-
ment therapy after cardiac surgery (Wijeysundera et al. 2007).
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Table 2.  The Simplified Renal Index (SRI) risk factors.
Variables Points
Estimated GFR 31–60 ml/min 1
Estimated GFR <30 ml/min  2
Diabetes mellitus requiring medication 1 
Left ventricular ejection fraction <40% 1 
Previous cardiac surgery 1
Procedures other than CABG or atrial septal repair 1
Nonelective procedure 1
Preoperative intra-aortic balloon pump 1  
GFR, glomerular filtration rate, derived from Cockroft and Gault, 1976
Eight predictors of the need for replacement therapy were identified. A minority 
of patients (6%) had high risk scores (> 4) translating into a 10% risk of requiring 
replacement therapy (Wijeysundera et al. 2007). As can be seen, most risk factors 
included in SRI are also included in usual cardiac surgery risk models. There is no 
uniform consensus on what level of renal function should be labelled as evidence 
of pre-existing renal insufficiency. 
In a recent German study 2,522 consecutive patients (men age 69+12 years, 
68% male) underwent cardiac surgery between years 2007–2009. Renal failure 
requiring dialysis occurred in 3.9% (n=98) of patients. Hospital mortality among 
them was 37.8% compared to a mortality rate of 1.3% in patients without this 
complication. Multivariate analysis revealed pulmonary hypertension (OR=8.1), 
preoperative renal dysfunction (creatinine >2.0 mg/dl)(OR=4.6), cardiopulmo-
nary bypass time >120 min. (OR=3.9), peripheral vascular disease (OR=3.1), pre-
vious myocardial infarction (OR=3.0), atrial fibrillation (OR=2.8), age >75 years 
(OR=2.6), New York Heart Association class IV (OR=2.5) and diabetes (OR=2.0) 
as independent predictors for postoperative AKI (Rahmanian 2010).
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The only parameter incorporated into the cardiac surgery models of today is 
serum creatinine, in spite of the fact that neither serum creatinine nor creatinine 
clearance will accurately reflect the GFR in the non-steady-state condition of acute 
renal failure. Nonetheless, the degree to which serum creatinine changes from 
baseline also reflects the change in GFR (Bellomo et al. 2004). The superiority of 
estimated glomerular filtration rate (eGFR) over serum creatinine as a measure of 
renal function has recently been claimed (Stevens et al. 2006). EGFR has a major 
impact as a predictive tool of subclinical degrees of renal failure on the immedi-
ate and late outcome of patients undergoing CABG (Kangasniemi et al. 2008). 
Comparing eGFR to serum creatinine (eGFR <60 ml/min/1.73m2 vs. serum cre-
atinine >150 mg/dl or >200 mg/dl), eGFR was the only significant predictor of 
30-day postoperative mortality. In this study, poor late overall survival during a 
10-year follow-up was also particularly evident among patients with eGFR <60ml/
min/1.73m2. 
In a meta-analysis of randomized and observational studies on off-pump 
CABG and AKI Nigwekar et al. stated that a significant reduction in overall AKI 
and renal replacement therapy was achieved in the OPCAB group compared with 
the CABG group (Nigwekar et al. 2009).
Current strategies to provide perioperative renal protection include maintain-
ing adequate renal O2 delivery, suppressing renovascular vasoconstriction, main-
taining renovascular vasodilatation and tubular flow, decreasing renal cellular O2 
consumption, and attenuating reperfusion injury (Sheinbaum et al. 2003). Palom-
baet al. in 2007 published the Acute Kidney Injury after Cardiac Surgery (AKICS) 
score based on a single Brazilian centre cohort of patients who underwent elective 
cardiac surgery. Both pre- intra- and postoperative variables were incorporated in 
the risk model developing AKI not requiring dialysis after cardiac surgery. Here 
cardiopulmonary bypass time of more than 120 min and a postoperative central 
venous pressure of higher than 14 cmH2O were found to be significant risk factors 
for AKI after cardiac surgery.
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Diabetes mellitus
The importance of diabetes mellitus (DM) as a cause of mortality and morbidity is 
well known (Feskens and Kromhout 1992, Gol et al. 1998). DM type II is preceded 
by longstanding asymptomatic hyperglycaemia, which accounts for the develop-
ment of long-term diabetic complications. The connection was demonstrated in 
a prospective study on elderly Finnish people, whose risk of fatal and nonfatal 
cardiovascular events after 3.5 years was greater than 4-fold in the presence of 
diabetes than in its absence (Kuusisto et al. 1994).
Diabetes mellitus is as much a vascular disease as it is a metabolic disorder. 
The main macrovascular complications, for which diabetes has been a well estab-
lished risk factor throughout the cardiovascular system, are: coronary artery dis-
ease (CAD), peripheral vascular disease (PVD), increased intima-media thickness 
(IMT) and stroke. Diabetics have a 2 to 4-fold increased risk of CAD (Feskens and 
Kromhout 1992). Cardiovascular disease (CVD) is the cause of death in 65 % of 
patients with diabetes, whereas only 35 % of deaths in non-diabetic persons can 
be attributed to CVD (Yosefy 2008). Using coronary angiography as the diagnostic 
tool multivessel disease was found to be more common in diabetics than in con-
trols, with three-vessel disease being the most common (Fallow and Singh 2004). 
Diabetic patients were also more likely to have more segments diseased in one ves-
sel. Systolic function was impaired in the diabetic group with lower mean ejection 
fraction (p<0.05). This study corroborates the evidence that diabetic patients have 
more extensive coronary artery disease than non-diabetics and a poorer progno-
sis. This is also demonstrated by the OASIS and GUSTO II trials, where diabetic 
patients with acute coronary syndrome are still at substantial risk of increased 
mortality and morbidity (Malmberg et al. 2000, McGuire et al. 2000).
Impaired renal function as a result of nephropathy and neuropathy, particu-
larly that involving the autonomic nervous system are other ramifications of DM, 
impairing the likelihood of a diabetic patient  withstanding major surgery. Moreo-
ver, diabetes is a well-established independent risk factor for stroke.
Hyperglycaemia is a normal response to stress. Normally, insulin release is 
stimulated by elevated levels of glucose. When glucose levels fall, the counter-reg-
ulatory hormones (adrenaline,glucagon, growth hormone, and cortisol) facilitate 
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glycolysis, releasing glucose from hepatic stores and promoting gluconeogenesis 
in peripheral tissues. During times of stress, such as surgery, there is an increase 
in the levels of counter-regulatory hormones and inflammatory cytokines, such as 
tumor necrosis factor and interleukins, which results in increased hepatic glucose 
production, impaired peripheral glucose utilization, relative insulin deficiency, 
and hyperglycaemia (Shine et al. 2007). In a critically ill patient or during surgery, 
hyperglycaemia may be detrimental. Treating hyperglycaemia in the operating 
theatre or ICU is complicated by the fact that many cardiac surgical patients have 
insulin resistance (Macheda et al. 2005).
Considering the cardiovascular surgery, DM is associated with an increased 
rate of early and late complications following cardiac surgery (Yosefy 2008). In 
2005, Gandhi et al. at the Mayo clinic reported on 409 patients undergoing cardiac 
surgery and found that intraoperative hyperglycaemia was associated with postop-
erative mortality and morbidity. When the blood glucose concentration was >5.55 
mmol/l (100 mg/dl), a 1.11 mmol/l (20 mg/dl) increase in glucose concentration 
was associated with a 34% increase in the number of postoperative adverse events 
(Gandhi et al. 2005).  Surgical site infections (SSI) are among the most feared com-
plications among all cardiac surgery patients. Several studies have shown diabetes 
and postoperative hyperglycaemia to be important causative risk factors for post-
operative SSI (Gol et al. 1998, Latham et al. 2001). Individuals with type 2 DM are 
at higher risk for postoperative infections due to a muted immune response, the 
effects of hyperglycaemia on neutrophil function and pathogen proliferation, and 
the negative effects of impaired tissue perfusion. Hyperglycaemia resulting from 
insulin resistance is common in critically ill patients, including those who have not 
previously been diagnosed with diabetes. Factors contributing to postoperative 
hyperglycaemia include increased levels of catecholamines, growth hormone, and 
corticosteroids. Higher glucose levels may also result from pharmacologic agents 
commonly used during and following surgery, such as heparin and beta-blockers 
(Patel 2008). Up to 6 % of patients with no prior history of diabetes may have evi-
dence of undiagnosed diabetes. Their infection rate seems to be comparable to that 
of known diabetics (Latham et al. 2001). 
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Liver cirrhosis
Cardiac surgery is seldom performed on patients with liver cirrhosis and its out-
come has been reported only in small series (Klemperer MD et al. 1998, Bizouarn 
et al. 1999, Kaplan et al. 2002, Hayashida et al. 2004). Cardiac operations may 
be performed with good results for patients suffering from liver disease of mild 
severity (Child A), but cardiac interventions that include CPB in conjunction with 
advanced hepatic pathologies are associated with high mortality and morbidity 
(Kaplan et al. 2002). Cirrhosis is not included in usual risk scoring systems.
Other emerging risk factors
Traditional risk factors do not explain all of the risk for incidental heart disease. 
Various new or emerging risk factors may have the potential to improve global risk 
assessment for heart disease, especially for coronary heart disease (CHD). Helfand 
in his survey summarized 9 systematic reviews of novel risk factors to evaluate their 
clinical usefulness (Helfand et al. 2009). Risk factors analysed were C-reactive pro-
tein (CRP), calcium content of the coronary arteries (CAC-score), lipoprotein(a), 
homocystein, leukocyte count, fasting glucose concentration, periodontal disease, 
ankle-brachial index (ABI) and carotid intima and media thickness (IMT). Of the 
9 markers evaluated, only CRP showed strength of evidence, shown also earlier by 
Biancari et al. (Biancari et al. 2003). High CRP level may identify a high-risk sub-
set of patients with a Framingham risk score between 15% and 20%. On the other 
hand CRP count is very nonspecific and manoeuvres like weight loss, smoking 
cessation, statins and fibrates reduce serum CRP levels. However, none of these 
effects has yet been linked to a reduced risk for major CHD events.
Low preoperative hematocrit (Higgins et al. 1992b) and albumin levels (Hig-
gins et al. 1997) have also been identified as risk factors, often reflecting chronic 
illness.
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2.2.3   Severity of the cardiac disease
Acute coronary syndromes (ACS)
The term acute coronary syndrome refers to any group of clinical symptoms com-
patible with acute myocardial ischaemia and includes unstable angina (UAP), 
non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment 
elevation myocardial infarction (STEMI) (Iqbal,M.B. 2008). These conditions are 
associated with high morbidity and mortality. They constitute the most frequent 
cause of hospital admission related to cardiac disease (Wenaweser and Windecker 
2008). Certain patient types require very limited consideration in terms of stratify-
ing their risks; these include those with cardiogenic shock, severe LV dysfunction, 
persistent severe ischaemia, or malignant arrhythmias, despite maximal medical 
management.
Figure 2.  Acute coronary syndromes. (USA: Unstable angina)
Modified from Iqbal et al.
Acute coronary syndrome
Significant troponin release?
Persistent ST segment elevation?
STEMI
NSTEMIUSA
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Among patients with unstable angina or non-Q-wave myocardial infarction, there 
is an increased risk of death within 6 weeks in those with elevated troponin levels 
and the risk of death continues to increase as the troponin level increases. Revers-
ible ST-segment depression is associated with an increase by a factor of 3–6 in the 
likelihood of death, myocardial infarction, ischaemia at rest, or provocable ischae-
mia during a test to stratify risk. Early diagnosis and risk stratification are essential 
for urgent initiation of optimal medical and invasive treatment.
Risk Stratification Methods 
The TIMI (Thrombolysis in Myocardial Infarction) risk score
Table 3.  TIMI Risk Score variables 
Characteristics Point
History
 Age >65 years 1
 Presence of at least 3 risk factors for CHD 1
 Prior coronary stenosis  equal or greater than 50%    1
 Use of aspirin in prior seven days  1
Presentation
 At least two anginal episodes in previous 24 hours    1
 Presence of ST segment elevation on admission ECG    1
 Elevated serum markers  1
  Risk total score (0–7)
TIMI scoring was set up to predict 30-day mortality at patient presentation of 
patients with either STEMI or NSTEMI/UAP (Morrow 2000, Elliott 2000). TIMI 
scoring uses the seven variables seen in Table 3. The variables are independently 
predictive for adverse outcome in patients with UAP or NSTEMI (Antman et al. 
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2000). The TIMI-score may be useful not only for identifying those patients at risk 
for ischemic complications but also in guiding to specific interventions for ACS.
The baseline ECG
New or reversible ST segment depression greater than 0.5 mm, transient ST eleva-
tion or new left bundle branch block are important prognostic signs revealing ACS 
(Cannon et al. 1997). Although specific for identifying ACS patients, ECG is less 
sensitive and has poor predictive value; thus a negative ECG does not offer reas-
surance.
Serum troponins
Serum troponins are now considered the ‘gold standard’ for the diagnosis of car-
diac injury and are useful for quantitative risk stratification in ACS. The troponins 
are highly cardiac specific, and more sensitive than previously used cardiac mark-
ers, such as serum creatine kinase MB-isoenzyme (CK-MB) (Ohman et al. 1996). 
Because detectable levels of troponin are not present in the blood of patients with 
NSTEMI until 4–6 hours after myocardial injury, serial blood testing is essential in 
patients with non-diagnostic ECG but high suspicion of ACS.
Mechanism of ACS
Disruption of vulnerable or high-risk plaques is the common pathophysiological 
mechanism of acute coronary syndromes with or without ST-elevation (Ross 1999). 
The great majority of these lesions have proved to be previously angiographically 
nonsevere with the culprit lesion in up to 80% of patients being less than 70% in 
severity (Roe et al. 2000). The reflection of the same pathophysiological mecha-
nism differs in non-ST-elevation acute coronary syndromes and ST-elevation 
myocardial infarction (STEMI) in terms of clinical presentation, prognosis and 
therapeutic approaches.
Clinical evaluation
For the patient with suspected or proven ACS, the goals for the clinician are to 
establish a diagnosis, stratify risk and choose optimal therapeutic interventions. 
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To achieve the goals of risk assessment, several tools are available, including his-
tory, physical examination, ECG, serum troponin and various protocols for risk 
stratification. For high-risk ACS patients with high TIMI-scores, ST-segment 
depression on ECG, or elevated serum troponins, the urgency is to move toward 
revascularization procedures in a timely fashion. Standard medical therapies are 
indicated according to the valid recommendations. For low-risk patients with low 
TIMI score, negative troponins and no ST depression on ECG, the optimal thera-
peutic protocol includes optimal medical therapies, stabilization of the patient and 
noninvasive stress testing before discharge, if recurrent ischaemia does not occur.
It is anticipated that contemporary antiplatelet (aspirin, clopidogrel, prasug-
rel, ticagrelor, GP IIb/IIIa receptor inhibitors) and anticoagulant therapy lower 
the risk of peri-interventional ischaemic complications and thereafter an invasive 
strategy is advised within 24–72 hours of admission  in case of ACS (Anderson JL. 
et al. ACC/AHA Task Force on Practice Guidelines for the Management of Patients 
With Unstable Angina/Non ST-Elevation Myocardial Infarction. American Col-
lege of Emergency Physicians. Society for Cardiovascular Angiography and Inter-
ventions. Society of Thoracic Surgeons. American Association of Cardiovascular 
and Pulmonary Rehabilitation. Society for Academic Emergency Medicine 2007). 
The greatest benefit (<50% relative risk reduction) of an early invasive strategy 
is observed in moderate  to high-risk patients, notably patients with ST segment 
depression and/or positive troponin test (Wenaweser and Windecker 2008). The 
current practice guidelines therefore recommend an early invasive strategy consist-
ing of coronary angiography followed by appropriate revascularization by either 
PCI or CABG as routine management in intermediate to high-risk NSTE-ACS 
patients. In addition, an urgent invasive strategy should be entertained in patients 
with severe, ongoing chest pain, dynamic ST segment changes, severe arrhytmias, 
and haemodynamic instability (Braunwald et al. 2002, ESC guidelines 2010).
However, bleeding is a common complication resulting from administration 
of these adjunctive powerful drugs and is a serious threat during an urgent opera-
tion. The importance of bleeding as a major independent predictor of recurrent 
myocardial infarction, stroke, and death has been recognized recently in patients 
with acute coronary syndromes (Eikelboom et al. 2006). Bleeding is likely in 
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patients with high levels of co-morbidity, such as elderly patients or those with 
chronic kidney disease, who already inherently carry a higher risk. Bleeding may 
also induce a prothrombotic state as a result of increased concentrations of circu-
lating erythropoietin (Smith et al. 2003). Moreover, blood transfusions can induce 
a proinflammatory and prothrombotic state (Reeves and Murphy 2008, Budaj et al. 
2009,). One could anticipate that reduction in early bleeding can lead to substan-
tial improvements in major adverse clinical events in patients with ACS.
Although the conditions of the majority of patients with low-risk unstable 
angina will stabilize with effective anti-ischaemic medications, approximately 
50–60% of such patients will require coronary angiography and revascularization 
because of the “failure” of medical therapy. High-risk patients are those who have 
had angina at rest, prolonged angina, or persistent angina with dynamic ST seg-
ment changes or hemodynamic instability (Auer et al. 2001).
Features of high risk according to ACC/AHA guidelines (USA) and European 
Society of Cardiology Task Force Report (EU), respectively, are seen in Table 4 
(Hamm et al. 2001).
Table 4.  Features of high risk in connection with acute coronary syndromes in ACC/AHA 
guidelines (USA) and European Society of Cardiology Task Force Report (EU).
Increased troponin concentrations EU/USA
Recurrent ischaemia (ST depression, transient ST elevation) EU/USA
Haemodynamic instability EU/USA
Major arrhythmias (ventricular tachycardia/ fibrillation) EU/USA
Early post-infarction angina EU
High-risk finding on non-invasive stress testing USA
Depressed left ventricular function (EF <40%) USA
PCI within 6 months USA
Previous CAbG USA
(Hamm et al. 2001).
46 Determinants of outcome in aDult carDiac surgery
Significant coronary artery lesions are present in 80–90% of patients with ACS. 
Data from the TACTICS-TIMI 18 trial revealed narrowing of the left main coro-
nary artery in 9%, single vessel disease in 26%, and three-vessel disease in 34% of 
patients (Weintraub et al. 1999).
Left ventricular function
The available evidence suggests that patients with moderate to severe left ventricu-
lar systolic dysfunction and concomitant limiting angina have improved survival 
with CABG (Alderman et al. 1983). However, both low ejection fraction and clini-
cal heart failure are predictive of higher operative mortality rates with CABG. In 
early reports including the CASS study, the mortality rate ranged from 18% to 33% 
(Baker et al.). Still in 1982, left ventricular ejection fraction was considered the 
most important predictor of perioperative mortality for CABG. By 1986, improved 
perioperative and surgical techniques had reduced this to the fourth most impor-
tant predictor, after repeat CABG, urgent surgery, and age (Christakis et al. 1989). 
In 1993 Elefteriades et al. published a series of patients with a left ventricular ejec-
tion fraction < 30% who underwent isolated coronary artery bypass grafting. The 
hospital mortality rate was 8.4% (Elefteriades et al. 1993). In her article concerning 
influence of left ventricular function on survival after coronary artery bypass graft-
ing Elisabeth Ståhle, in a material of 6,514 patients, showed that reduced LV func-
tion (moderate LV dysfunction, OR 1.4 ; severe LV dysfunction, OR 2.1) was inde-
pendently related to early mortality  giving a 6.6% operative mortality in patients 
with an EF<35% in contrast to 2.6% in those with an EF>50% (Stahle et al. 1997).
In a prospective study of 426 consecutive patients undergoing cardiac surgery, 
Atoui et al. observed  that EF <40%, high Parsonnet risk score, history of renal 
failure and emergency surgery were independent risk factors for prolonged ICU 
stay (> 2days) (Atoui et al. 2008). Other authors also noted that one of the most 
important factors associated with early disharge from ICU was preoperative ejec-
tion fraction (Xu et al. 2006, Ranucci et al. 2007).
Patients with depressed preoperative left ventricular function also have 
increased long-term mortality. A Canadian study consisting of 7,841 patients hav-
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ing isolated CABG showed that compared to patients with normal EF, patients 
having low (<30%) or moderately low (30%–50%) preoperative EF have both 
higher operative mortality (4.6%–3.4%–1.9%)  and poorer long term prognosis at 
5 years (77.7%–85.5%–91.2%) than patients with normal EF (Appoo et al. 2004). 
In a review considering aortic valve replacement and long term (> 5 years) prog-
nosis, age at surgery, NYHA functional class at time of surgery, left ventricular 
ejection fraction, atrial fibrillation, and type of valvular lesion were independent 
prognostic factors of adverse outcome (Naslafkih et al. 2006). Loef in 2009 showed 
that preoperative EF <50% increased the mortality risk during 13-year follow-up 
by 1.71 (Loef et al. 2009). If preoperative left ventricular dysfunction was associ-
ated with postoperative renal dysfunction, the hazard ratio for late mortality was 
3.23. 
2.3 Intraoperative risk factors
2.3.1 Cardiopulmonary bypass
At the present time, there is considerable controversy surrounding the appropri-
ate management of physiologic variables during cardiopulmonary bypass (CPB). 
Low-risk patients tolerate mean arterial blood pressures of 50–60 mm Hg without 
apparent complications, although limited data suggest that higher-risk patients 
may benefit from mean arterial blood pressures >70 mmHg (Charlson et al. 1995, 
Gold et al. 1995, Charlson et al. 2007). The optimal haematocrit on CPB has not 
been defined, with large data-based investigations demonstrating that both severe 
haemodilution (DeFoe et al. 2001, Habib et al. 2003, Karkouti et al. 2005b, Kark-
outi et al. 2005a, Hare 2006) and transfusion of packed  red blood cells increase the 
risk of adverse postoperative outcomes (Karkouti et al. 2004). 
Oxygen delivery is determined by the pump flow rate and the arterial oxy-
gen content. Organ injury may be prevented during more severe haemodilutional 
anaemia by modifying the CPB technique or by simply increasing pump flow 
rates (Ranucci et al. 2005, Liebold et al. 2006). Furthermore, the optimal tempera-
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ture during CPB likely varies with physiologic goals, and recent data suggest that 
aggressive rewarming practices may contribute to neurologic injury (Cook et al. 
1996, Grocott HP. Mackensen GB. Grigore AM. Mathew J. Reves JG. Phillips-Bute 
B. Smith PK. Newman MF. Neurologic Outcome Research Group (NORG). Cardi-
othoracic Anesthesiology Research Endeavors (CARE) Investigators’ of the Duke 
Heart Center 2002, Kaukuntla et al. 2004). The design of components of the CPB 
circuit may also influence tissue perfusion and outcomes. Although there are theo-
retical advantages to centrifugal blood pumps over roller pumps, it has been dif-
ficult to demonstrate that the use of centrifugal pumps improves clinical outcomes 
(Steinbrueckner et al. 1995, Baufreton et al. 1999). 
CPB is associated with an acute phase reaction of protease cascades, leuko-
cyte, and platelet activation inducing a systemic inflammatory reaction (SIRS) and 
resulting in tissue injury (Edmunds 1998). This is largely manifested as subclinical 
organ dysfunction that produces a clinical effect in those patients who generate an 
excessive inflammatory response or those with limited functional reserve (Khabar 
et al. 1997, Whitten et al. 1998) increasing morbidity and mortality after cardiac 
surgery (Kang et al. 2004, Salis et al. 2008). Heparin coating of the CPB circuit may 
attenuate inflammatory and coagulation pathways, but has not been clearly dem-
onstrated to reduce major morbidity and mortality. Similarly, no distinct clinical 
benefits have been observed when open venous reservoirs have been compared to 
closed systems. In conclusion, there are currently limited data upon which to con-
fidently make strong recommendations regarding how to conduct optimal CPB. 
(Shann et al. 2006, Murphy et al. 2009).
Hence, it is still clear that cardiopulmonary bypass techniques are not perfect. 
Indeed, it is fair to say that the period of bypass still contributes to significant 
morbidity in most patients (Khabar et al. 1997, Hogue et al. 1999, Murphy and 
Angelini 2004). In particular, cerebral injury is a significant problem for patients 
and their caregivers and for funding of health-care systems. Incidence rates for 
stroke are around 2% to 3% (Taylor 1998), with increased risk in elderly patients 
and other high-risk groups (Sotaniemi 1995).
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2.3.2 Off-pump vs. on-pump vs. mini-extracorporeal circulation
The introduction of extracorporeal circulation in the late 1950s revolutionised the 
practice of modern cardiac surgery. While the use of CPB still remains essential 
in most cardiac operations, it sill has several disadvantages. First its use is associ-
ated with a systemic inflammatory response syndrome (SIRS) due to activation 
of a myriad of cellular and humoral inflammatory mediators as blood circulates 
through the extracorporeal circuit and blood cells make contact with the synthetic 
components (Hall et al. 1997). Second, cardiopulmonary bypass has been regarded 
as an important aetiologic factor in the generation of both particulate and gase-
ous microemboli which can further contribute to the development of end organ 
damage (Roach et al. 1996, Murkin and Stump 2000). In an attempt to ameliorate 
the potential deleterious effects of cardiopulmonary bypass, techniques have been 
created to either totally avoid bypass or build up an at least theoretically less harm-
ful miniperfusion facility (Fromes et al. 2002, Wiesenack et al. 2004, Mulholland 
et al. 2007).
Kolessov was the first to report his experience with coronary artery surgery 
on the beating heart in 1967 (Kolessov 1967). The technique, however, was soon 
abandoned with the increasing availability of cardiopulmonary bypass. Later on, 
off-pump surgery has experienced a revival, beginning in the early 1990s with the 
work of Benetti and colleagues (Benetti et al. 1991) and Buffolo and colleagues 
(Buffolo et al. 1996). Hypothetically, off-pump surgery would be expected to result 
in a reduction in systemic inflammation, emboli production (at least if the aorta is 
not touched) and subsequent end organ dysfunction as well as avoidance of myo-
cardial ischaemia. 
So far, several meta-analyses have been conducted comparing the outcomes 
of revascularization with and without cardiopulmonary bypass, including both 
observational data and randomized controlled trials (Cheng et al. 2005, Lim et 
al. 2006, Marasco et al. 2008, Moller et al. 2008, Sistino 2008, Takagi et al. 2007, 
Feng et al. 2009). Off-pump surgery tends to be associated with a reduction in 
the rate of atrial fibrillation, transfusion and inotrope requirements, respiratory 
infections, ventilation time, intensive care unit stay and hospital stay. No signifi-
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cant differences were found for 30-day mortality, myocardial infarction, stroke, 
renal dysfunction, intra-aortic balloon pump use, wound infection, re-explora-
tion, or re-intervention, but these studies may be biased by surgical technique and 
revascularization policy. It seems to be safe to conduct OPCAB procedure also 
on patients having poor left ventricular function. In a retrospective study of 177 
patients with EF <30% OPCAB patients tolerated the procedure well and accord-
ing to this study, cardiopulmonary bypass was the only predictor for all postopera-
tive complications (Arom et al. 2000). The randomized controlled trials to date 
have been conducted in relatively low-risk patients who are at least risk of the del-
eterious effects of cardiopulmonary bypass. Møller et al. conducted a prospective 
study between off  and on-pump in patients having >5 EuroSCORE points. Both 
off and on-pump coronary artery bypass grafting performed on high-risk patients 
with equal low short-term complications (Moller et al. 2010).
The early literature on off-pump CABG also suggested that off-pump surgery 
would reduce or eliminate the neuropsychological risks of putting a patient on a 
heart-lung bypass machine. However, the results of the 2203-patient, 18-centre 
Randomized On/Off Bypass (ROOBY) trial, showed no difference between the 
on-pump and off-pump approaches in neuropsychological outcomes ( Shroyer 
AL. Grover FL. Hattler B. Collins JF. McDonald GO. Kozora E. Lucke JC. Baltz 
JH. Novitzky D. Veterans Affairs Randomized On/Off Bypass (ROOBY) Study 
Group 2009). The proportion of patients with fewer grafts completed than origi-
nally planned was higher with off-pump CABG than with on-pump CABG (17.8% 
vs. 11.1%, P<0.001). The study also showed a consistent trend toward better overall 
outcomes after one-year postsurgery with the on-pump approach (death within 
one year on-pump vs. off-pump 2.9%/4.1% and composite end points at one year 
7.4%/9.9%, p0.04 respectively). Follow-up angiography in 1371 patients and a total 
of 4093 grafts showed that the on-pump group had a higher graft patency rate 
(87.8% vs 82.6%; p<0.001). Also, 36.5% of the off-pump group had at least one 
occluded graft compared with 28.7% of the on-pump group.
In terms of Health Related Quality of Life (HRQoL) neither traditional CABG 
using cardiopulmonary bypass nor the newer OPCAB technique is superior to 
other (Jokinen et al. 2010).The full benefits of off-pump surgery may be with those 
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elderly, high-risk patients with significant aortic atherosclerosis, where avoiding 
the manipulation of the aorta yields greatest benefit.
 Miniaturized CPB systems (Mini-CPB) have been introduced in clinical prac-
tice as an alternative to conventional cardiopulmonary bypass (C-CPB) and its 
use has been embraced with enthusiasm. Mini-CPB systems aim to minimize the 
blood-artificial surface contact as well as to reduce the priming volume and, thus, 
to maintain haematocrit over critical levels. A recent meta-analysis of randomized 
studies, despite the latter being of small size and including low-risk patients, 
suggested that Mini-CPB may be associated with a lower risk of postoperative 
stroke and blood losses and also with a somewhat decreased mortality (Biancari 
and Rimpilainen 2009). A recent study by Koivisto et al. showed that the use of 
Mini-CPB in high-risk patients undergoing isolated CABG can be associated with 
favourable outcome compared to C-CPB. Mini-CPB seems to be associated with a 
lower risk of in-hospital mortality, re-sternotomy for bleeding, use of intra-aortic 
balloon pump, combined adverse end-point and, most notably, stroke. The trend 
toward reduced risk of severe complications after using Mini-CPB is of particular 
interest. A consecutive series of 236 patients with additive EuroSCORE ≥6 were 
operated on employing either a conventional bypass circuit (C-CPB) or a mini-
mized bypass circuit (Mini-CPB). In-hospital mortality in the C-CPB group was 
only slightly higher than in the Mini-CPB group (4.8% vs.3.4%, p=0.75). Stroke 
rate was significantly higher among C-CPB patients (5.4% vs. 0% in Mini-CPB, 
p=0.026). Combined adverse end-point was experienced more frequently by 
C-CPB patients (20.4% vs. 13.5%, p=0.18) as well, but the difference failed to reach 
statistical significance (Koivisto et al. 2010). A meta-analysis comprising 13 studies 
and comparing miniaturised (Mini-CPB) versus conventional cardiopulmonary 
bypass (C-CPB) suggests that the use of Mini-CPB may be associated with lower 
risk of postoperative stroke and blood losses and with somewhat decreased mor-
tality. However, due to the wide heterogeneity of methods and the small number 
of studies and patients evaluated so far, larger and homogeneous studies should 
be performed to obtain more conclusive results on the safety and efficacy of Mini-
CPB (Biancari and Rimpilainen 2009).
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2.3.3 Myocardial protection
Cardioplegia is an important strategy to facilitate cardiac surgery in order to limit 
myocardial injury. Initially cardioplegia was introduced as an agent to allow for 
hypothermic hyperkalemic arrest (Tyers et al. 1977, Roe et al. 1977). Various 
additives were explored to try to optimize the myocardium during this time of 
ischaemia (Bretschneider et al. 1975).  Blood was then found to be the most logi-
cal vehicle for delivery of potassium cardioplegia (Follette et al. 1978, Buckberg 
1979). The optimal cardioplegic temperature, timing, and routes of delivery were 
further explored (Braimbridge et al. 1977, Poirier et al. 1975, Fremes et al. 2000, 
Buckberg 1987). Although cardioplegia is generally accepted as a mandatory tool 
for myocardial protection during on-pump cardiac surgery, there is still contro-
versy regarding various aspects including its composition, temperature, and mode 
of delivery. Blood as opposed to crystalloid cardioplegia (CCP) could potentially 
improve postoperative cardiac outcomes, because it more closely approximates 
normal physiology due in part to its oxygen carrying capacity and less associated 
haemodilution (Menasche et al. 1992, Menasche and Menasche 1994, Menasche 
1996). On the other hand,  blood cardioplegia (BCP) may impair visualization 
during the operation.
The largest prospective randomised controlled trial comparing blood vs. crys-
talloid cardioplegia was done by Øvrum et al. in 2004. Two surgeons performed 
1,440 CABG procedures randomised to either cold CCP or cold BCP. The clinical 
course, systemic temperature and delivery methods were unified for all patients 
and emergencies, redos and low EF patients were included. No differences were 
seen for perioperative myocardial infarction or mortality. However, the mean 
ischaemic time in this study was 33.5 (SD 10.0) and 34.1 (SD 9.1) min, and the 
duration of perfusion was 52.2 (SD 11.6) and 53.5 (SD 11.6) min for CCP and BCP 
patients respectively, which may limit its general applicability to more complex 
cardiac surgery (Ovrum et al. 2004). The other large trial was conducted by Mar-
tin et al. from 1990–1992. One thousand-and-one patients undergoing elective 
CABG were randomised to either (1) systemic hypothermia at 28° and intermit-
tent 25 mmol/l potassium cold crystalloid cardioplegia or (2) antegrade high potas-
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sium (20 mmol/l) warm blood cardioplegia followed by continuous retrograde low 
potassium (19 mmol/l) warm blood cardioplegia. There was an unexpectedly high 
rate of perioperative strokes, delayed strokes and total neurologic events in the 
warm blood cardioplegia arm, which caused the study to be discontinued prema-
turely. At this stage there were no differences in mortality, IABP use, inotrope use, 
or hospital stay (Martin et al. 1994). Both the equivalent myocardial outcomes and 
adverse neurological outcomes may be explained in terms of temperature rather 
than cardioplegic solution.
Fremes’ Toronto group in 2006 performed a meta-analysis of 34 randomised 
controlled trials comparing crystalloid to blood cardioplegia. Most of the studies 
were of small size, and there were only two with more than 1,000 patients in total 
and another three with more than 100 patients in the blood cardioplegia arm. In 
total there were 5,000 patients included in these studies (but of these, half were 
from two studies). They reported that the incidence of low output syndrome was 
significantly lower with BCP with an odds ratio of 0.54 (95% CI 0.34–0.84), and 
the CK-MB release was higher with CCP at 24 hours by a weighted mean differ-
ence of 5.7 U/l at 24 h (95% CI 1.6–10.2). There was no difference in the aggregated 
myocardial infarction or mortality rates. However, firm conclusions are difficult 
to draw from these findings as the authors were unable to obtain any data on low 
output syndrome or CK-MB from the two studies with more than 1,000 patients 
and thus the low output finding was based on only 10 of the 34 trials (879 patients), 
and the CK-MB findings came from only seven trials (Guru et al. 2006).
Jacob et al. expanded the series of randomised trials gathered by Fremes’ group 
with 15 additional studies. Of these, eight reported statistically significant clinical 
outcomes in favour of BCP and five reported statistically significant differences in 
enzyme release in favour of BCP. No studies reported findings in favour of CCP 
(Jacob et al. 2008).
Thus, the literature is far from conclusive. This is reflected in a survey of prac-
tice in the UK of 2004 which found that of the surgeons performing on-pump 
CABG, 56% used cold blood cardioplegia, 14% used warm blood cardioplegia, 
14% used crystalloid cardioplegia, 21% used retrograde infusion and 16% did 
not use any cardioplegia, preferring cross-clamp fibrillation (Karthik et al. 2004). 
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Scarci et al. conducted a meta-analysis of intermittent cross-clamping compared to 
either blood or crystalloid cardioplegia. They stated that intermittent cross-clamp 
fibrillation was a versatile and cost-effective method of myocardial protection in 
first-time CABG, with the immediate postoperative outcome comparable to cardi-
oplegic arrest. The duration of ischaemia associated with intermittent cross-clamp 
fibrillation is invariably shorter than that associated with cardioplegic arrest, and 
this may be one explanation for the comparable outcomes. There may also be an 
element of preconditioning protection during intermittent cross-clamp fibrilla-
tion, as has been shown experimentally (Fujii,Masahiro 2005,  Scarci et al. 2009).
2.3.4 Duration of aortic cross-clamp and perfusion
A long aortic cross-clamp time and hence at least suboptimal oxygenation of the 
heart are known to be major risk factors. Kirklin in a summary of a consensus on 
death and ischaemic events after coronary artery bypass grafting noted that aor-
tic cross-clamp time, among several other factors, was an incremental risk factor 
(Kirklin et al. 1989). A longer aortic cross clamp time was a risk factor for myocar-
dial infarction during coronary artery bypass graft surgery in a study by Oysel et 
al. (Oysel et al. 1989). In a recent study by Onorati et al. an additive EuroSCORE 
greater than 6, ongoing unstable angina, aortic cross-clamp time longer than 90 
minutes, cardiopulmonary bypass time longer than 180 minutes, incomplete 
revascularization, and intraoperative intraaortic balloon pump were independent 
predictors of myocardial damage  at multivariate analysis (Onorati et al. 2005).
Despite many years of clinical and experimental research, the contribution of 
cardiopulmonary bypass (CPB) and cardioplegic arrest to morbidity and mortality 
following cardiac surgery remains unclear. This is due, in part, to a lack of a suit-
able control group against which bypass and cardioplegic arrest can be compared. 
The recent success of beating heart coronary artery bypass grafting has, however, 
provided an opportunity to compare the same operation, in similar patient groups, 
with, or without CPB and cardioplegic arrest. CPB is associated with an acute 
phase reaction of protease cascades, leukocyte, and platelet activation that results 
in tissue injury. This is largely manifested as subclinical organ dysfunction that 
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produces a clinical effect in those patients who generate an excessive inflamma-
tory response or in those with limited functional reserve (Murphy and Angelini 
2004). This systemic inflammatory response syndrome (SIRS) is a complex array 
of clinical conditions including hypotension, coagulopathy, and increased capil-
lary permeability. At worst the situation can lead to multiple organ dysfunction 
syndrome (Khabar et al. 1997).
The detrimental effects of CPB have also been attributed to reinfusion of cardi-
otomy suction blood exposed to pericardial and mediastinal surfaces, the presence 
of microemboli (gaseous or particulate) and foreign material in the CPB circuit 
(Salis et al. 2008).  The contribution of myocardial ischaemia/reperfusion, second-
ary to aortic cross-clamping, and cardioplegic arrest, to the systemic inflammatory 
response and wider organ dysfunction is unknown, and requires further evalua-
tion in clinical trials (Murphy and Angelini 2004).
It is reasonable to assume that the longer the CPB duration, the worse its det-
rimental effects will be. Andersson et al. identified CPB longer than 150 minutes 
as one of the independent predictors of major GI complications (Andersson et al. 
2005). Perugini et al. similarly found that in patients who underwent CABG sur-
gery only, CPB time was significantly longer in patients with GI complications (166 
vs. 138 min, p=0.004) (Perugini et al. 1997). Some other studies were unable to 
confirm this finding, possibly because of the infrequent nature of GI complications 
(0.7%) (Salis et al. 2008). Salis et al. showed that CPB time is an independent risk 
factor for postoperative death (OR 1.57), pulmonary (OR 1.31), renal (OR 1.31), 
and neurologic complications (OR 1.28), multiorgan failure (OR 1.21), reopera-
tion for bleeding (OR 1.1) and multiple blood transfusions (OR 1.58) (Salis et al. 
2008). In a material from St. Louis, Hogue et al. found the incidence of strokes to 
be 1.6% among 2,972 patients undergoing cardiac surgery. They divided strokes 
into early, occurring immediately after surgery, and delayed (65% of all) after an 
initial uneventful neurological recovery. By multivariate analysis, prior neurologi-
cal event, aortic atherosclerosis, and duration of CPB were independently associ-
ated with early stroke, whereas CPB time was not connected to delayed neurologi-
cal events (Hogue et al. 1999). Bucerius, in a multivariate analysis of over 16,000 
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cardiac surgery patients found CPB time more than 2 hours to be independent 
predictor for stroke.
Ranucci et al. in 2007 observed that factors associated with late discharge from 
ICU were age, preoperative serum creatinine value, unstable angina, congestive 
heart failure, redo operation, combined operation, and cardiopulmonary bypass 
duration (Ranucci et al. 2007).
2.3.5 Perioperative versus ICU risk assessment
Morbidity and mortality are influenced by surgical, anaesthetic and perfusion 
techniques that include aortic crossclamp time, length of time on cardiopulmo-
nary bypass, completeness of revascularization, adequacy of myocardial protec-
tion, and haemodynamic management. Intraoperative events can both neutralize 
or amplify the risk calculated preoperatively.
The majority of scoring models rely solely on preoperative anamnesis and 
investigations. A methodology in order to more accurately predict hospital mor-
tality risk for critically ill hospitalized adults was developed 1978 by William A. 
Knaus. It is known as APACHE (Acute Physiology, Age, Chronic Health Evalua-
tion) and a third version is in current use. There are four components: age, major 
disease category (reason for ICU admission), acute (current) physiology, and prior 
site of healthcare (e.g., hospital floor, emergency room, etc.). The physiologic vari-
ables require scoring of the following vital signs and laboratory abnormalities: 
pulse rate, mean blood pressure, temperature, respiratory rate, PaO2/P(A-a)O2, 
haematocrit, white blood cell count, creatinine, urine output, blood urea nitrogen, 
serum sodium, albumin, bilirubin, glucose, acid-base status and neurologic status. 
Other models for evaluating physiologic reserve and  risk for intensive care unit 
patients are “the Mortality Probability Model” (MPM) developed by Lemeshow 
(Lemeshow et al.) and SAPS, presented by Le Gall (Le Gall et al. 1993), both based 
on the same principles as APACHE.
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2.4 Operative risk indices and their clinical use
The prediction of the risk of adverse peri- and postoperative outcome is of para-
mount importance in cardiac surgery as it may guide the decision-making process 
towards cardiac surgery or towards other currently available treatment methods. 
Risk prediction helps in planning resource utilisation, it is useful in compari-
son between different institutions and, especially, is an estimate of the individual 
patient’s risk. Compared to conservative treatment methods, surgical interven-
tions carry a higher degree of risk and the proposed benefit of an intervention 
must be weighed against a valid risk estimate. Growing concern among the medi-
cal profession induces the drastically changing landscape where cardiac surgery 
is nowadays performed and where (old) models for risk adjustment are proving 
imprecise. This evolution has been driven by a changing patient population but 
also by the expansion of interventional cardiology, catheter-based interventions, 
and minimally invasive cardiac procedures. 
Variations in results between institutions can also be significant making com-
parison between institutions problematic (Nashef 2009).
In recent decades, several risk-scoring methods have been derived and vali-
dated with varying success. (Nilsson et al. 2006). With all risks in mind there is 
a great desire for models to predict mortality and morbidity. Predicting the risk 
of mortality for an individual patient might seem like the most obvious reason to 
use a predictive model. However, this approach has its drawbacks. Not the least of 
which is that the models available are derived from a study of large populations 
including a great number of different variables not necessarily fitting the particular 
individual. A variety of factors are in play causing these models to be inaccurate. 
These are the skill and experience of the surgical team, institution-specific issues, 
comorbidities not included in the calculation of risk, magnitude of the cardiac 
procedure and the misinforming possibility of gathered risk profile when numer-
ous variables are included in an attempt to control or adjust the data (Granton and 
Cheng 2008, Ranucci et al. 2009).
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2.4.1 Comparison of some commonly used algorithms
Parsonnet Score
The Parsonnet score was developed in the United States in the 1980s (Parsonnet 
et al. 1989). The database used was 3,500 consecutive operations, and an additive 
model was constructed to predict 30-day mortality (Parsonnet,V. 1989). The Par-
sonnet score divides patients into 5 risk groups based on the score accumulated 
from 16 different preoperative variables. However, there was a major criticism of 
the model. Two of the variables (catastrophic states and other rare circumstances) 
were fairly arbitrary and could significantly influence the score (Gabrielle et al. 
1997). To help address this issue a modified Parsonnet’s score was developed. It is 
far more detailed than the original scoring system and includes a wide variety of 
what could be classified as catastrophic states and rare circumstances. However, 
the complexity of the modified score is far greater than the original, making it 
somewhat more difficult to use.
Since its publication in 1989, the Parsonnet score has received widespread 
acceptance and has been heavily studied and used. A criticism of the Parsonnet 
score is that it often overpredicts mortality (Geissler et al. 2000).  Possibly due 
to the age of the Parsonnet score the predictive accuracy has been diminished 
as a result of advances in surgical and medical techniques. One of the confusing 
aspects of comparing scoring systems is that it may be difficult to understand if the 
modified or initial Parsonnet score is being used while reading a report.
Cleveland Clinic Model 
In 1992, the Cleveland Clinic model for risk stratification in CABG surgery was 
published (Higgins et al. 1992c). It was developed from a retrospective analysis of 
5,051 patients undergoing CABG in the mid to late 1980s at the Cleveland Clinic. 
The model was also validated at the same centre. This model was developed not 
only to look at mortality but also morbidity in CABG patients. These aspects of 
morbidity included myocardial infarction, prolonged mechanical ventilation, renal 
failure, neurologic injury, serious infection, and the need for an intraaortic balloon 
pump. A variety of risk factors were identified and an additive score was developed 
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based on these risk factors. When compared to other risk stratification systems, 
the Cleveland Clinic risk score performs within an acceptable range (Nilsson et al. 
2006). However, as with many scoring systems, the Cleveland Clinic score is not 
perfect. It has been shown to underpredict mortality (Pinna-Pintor et al. 2002). 
Likely due to its original design, the Cleveland Clinic score does show a better 
performance in the prediction of morbidity when compared with the EuroSCORE, 
Parsonnet, and a variety of other scoring systems (Geissler et al. 2000).
Society of Thoracic Surgeons Score (STS Score)
The Society of Thoracic Surgeons (STS) initially developed the STS National Adult 
Cardiac Surgery Database (STS NCD) in the late 1980s. After many years of devel-
opment and improvement, it has become one of the largest clinical databases in the 
world. The STS began building risk models in 1994 (Edwards et al. 1994b). A series 
of additional models have been developed since then to keep the predictive models 
timely, accurate, and thus more reliable. Risk models now also include risk of death 
for isolated valve or valve concomitant with CABG operations as well as several 
morbidity risk models. The STS NCD has completely redeveloped its risk models 
approximately every 3 years. The latest models, the “2008 Models,” were developed 
using data collected from 2002 to 2006 (O’Brien et al. 2009, Shahian and Edwards 
2009, Shahian et al. 2009a, Shahian et al. 2009b) and comprise 27 models, includ-
ing nine endpoints for each of three cardiac procedure groups:
Procedures:
1  Isolated CABG 
2  Isolated valve procedure (aortic valve replacement; mitral valve 
 replacement or repair)
3  Isolated valve procedure plus CABG
Endpoints:
1  Operative mortality 
2  Reoperation for any reason
3  Permanent stroke
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4  Renal failure
5  Deep sternal wound infection
6  Prolonged ventilation time (>24 hours)
7  Operative death or major morbidity (of the five types above)
8  Short postoperative length of stay (<6 days and discharged alive)
9  Long postoperative length of stay (>14 days)
From 1999 until now, the STS has released four versions of the STS NCD, and the 
built-in models were changed accordingly. Thus, patients with exactly the same 
preoperative risk factors could receive different predicted risk values if they under-
went surgery in different time periods. Moreover, the individual patient risk scores 
require calibration, using the STS-provided calibration factors (CF) before they 
can be used to compute observed (O)/expected (E) ratios or compare provider 
performance over time. Calibration factors are updated after every new data har-
vest, which has been done every 3 months in recent years. The reason for these 
frequent changes is that the STS uses all data available up to the point of harvest to 
recalculate the CFs for a given year. Thus, to calibrate the predicted STS risk, one 
must always find the latest report and use the most recent CFs.
Unfortunately, one of the most complete studies done to date, comparing 19 
scoring systems, does not include the STS risk stratification algorithm, because 
it was not considered an open source (Nilsson et al. 2006). In a single institution 
Swedish study, Nilsson et al. found that the EuroSCORE and the STS algorithm 
showed similar accuracy, but the EuroSCORE demonstrated greater discrimina-
tive capability for CABG (Nilsson et al. 2004b). In general, the predictive perform-
ance of the STS algorithm is comparable to the other scoring systems (Farrokhyar 
et al. 2007, Ad et al. 2007).
The web address for STS score calculator is: http://209.220.160.181/STSWe-
bRiskCalc261/
EuroSCORE
The EuroSCORE was initially published in 1999 (Nashef et al. 1999). It was devel-
oped from a large European database including 19,030 patients from 128 hospi-
review of the literature 61
tals. Information on 97 risk factors was collected pre-operatively in all the patients 
(Roques et al. 1999). The risk factors were then compared to patient outcomes 
(survival or death) leaving 17 risk factors related to the patient, cardiac status and 
operation and known to affect outcome (Table 5). This original additive model 
allocates an appropriate weight for each risk factor resulting in a score intended to 
predict mortality. However, it was felt that this model had some drawbacks. First, 
an overprediction of mortality may occur in low-risk cases (Roques et al. 1999, 
Gogbashian et al. 2004a, Bhatti et al. 2006). Second,  the additive model has con-
versely also been shown to be a poor predictor of mortality in high-risk patients 
(Roques et al. 2003b, Gogbashian et al. 2004a). There was therefore an incentive to 
develop a more accurate scoring system to cover a wider population of cardiac sur-
gery patients. By means of logistic regression calculations, those risk factors that 
were most robust in predicting mortality became part of the logistic EuroSCORE 
calculation. Thus two different scoring systems exist for the EuroSCORE. One is 
the additive model, which can be calculated by simple aritmetic. The other is the 
logistic model, which is more extensive and requires a computer to derive a score. 
In further subdivision of the high-risk group, the logistic EuroSCORE seems to 
predict mortality with acceptable accuracy (Michel et al. 2003b).
This scoring system is used extensively in Europe and is also popular in Can-
ada (Roques et al. 2003a, Kolh 2006). Several studies have been performed to eval-
uate the accuracy, calibration and (international) clinical performance of Euro-
SCORE. In a review of six articles, Gogbashian et al. confirmed that the additive 
EuroSCORE overestimates mortality at lower EuroSCOREs (EuroSCORE <6) and 
underestimates mortality at higher EuroSCOREs (EuroSCORE >13) (Gogbashian 
et al. 2004a). In an extensive comparison of 19 pre-operative risk stratification 
models in adult open heart surgery, Nilsson et al. studied their validity to predict 
both 30-day and 1-year mortalities after cardiac surgical procedures (Nilsson et 
al. 2006). Their study included 6,222 cardiac operations performed between 1996 
and 2001 at a single Swedish institution, with prospective data collection. They 
used receiver-operating characteristic (ROC) curves to describe the perform-
ance and accuracy of the risk-scoring algorithms. An area under the curve >70% 
is usually considered to be associated with a good predictive value. For overall 
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Table 5.  Patient- and cardiac-related factors contributing to the Additive EuroSCORE
Patient-related factors  Score
Age  (per 5 years or part thereof over 60 years) 1
Sex female  1
Chronic pulmonary disease longterm use of bronchodilators or steroids for lung disease 1
Extracardiac arteriopathy any one or more of the following: claudication, carotid occlusion 
 or >50% stenosis, previous or planned intervention on the 
 abdominal aorta,limb arteries or carotids 2
Neurological dysfunction severely affecting ambulation or day-to-day functioning 2 
disease
Previous cardiac surgery requiring opening of the pericardium  3
Serum creatinine >200m micromol/L preoperatively 2
Active endocarditis patient still under antibiotic treatment for endocarditis at the time 
 of surgery 3
Critical preoperative state any one or more of the following: ventricular tachycardia or 
 fibrillation or aborted sudden death, preoperative cardiac massage, 
 preoperative ventilation before arrival in the anaesthetic room, 
 preoperative inotropic support, intraaortic balloon counterpulsation 
 or preoperative acute renal failure (anuria or oliguria<10 ml/hour) 3
Cardiac-related factors  Score
Unstable angina rest angina requiring iv nitrates until arrival in the anaesthetic room  2
LV dysfunction moderate or LVEF30-50% 1
 poor or LVEF <30 3
Recent myocardial infarct  (<90 days) 2
Pulmonary hypertension Systolic PA pressure>60 mmHg 2
Operation-related factors  Score
Emergency carried out on referral before the beginning of the next working day 2
Other than isolated CABG major cardiac procedure other than or in addition to CABG 2
Surgery on thoracic aorta for disorder of ascending, arch or descending aorta 3
Postinfarct septal rupture  4
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open-heart surgery, Nilsson et al. report that discriminatory power for 30-day and 
1-year mortalities was highest for logistic (0.84 and 0.77) and additive (0.84 and 
0.77) EuroSCORE algorithms. The next highest was the Cleveland Clinic score 
(0.82 and 0.76). Furthermore, in coronary artery bypass grafting (CABG)-only 
surgery (4,351 procedures), Euro-SCORE had the highest discriminatory power 
both for 30-day and 1-year mortalities. The finding that EuroSCORE, probably the 
most commonly used scoring algorithm in Europe, can accurately predict opera-
tive mortality after open-heart surgery and after CABG-only procedures confirms 
the results of earlier studies (Nashef,S.A. 2000; 386 Asimakopoulos,G. 2003). Fur-
thermore, despite substantial geographic differences between Europe and North 
America, EuroSCORE performs very well in the Society of Thoracic Surgeons 
database (Asimakopoulos et al. 2003, Nashef et al. 2000). Therefore, it can be con-
sidered an adequate risk stratification system on both sides of the Atlantic (Nashef 
et al. 2000).
Long-term mortality, probably the most useful outcome, is rarely assessed, 
essentially because of the difficulty in following up patients over a long period of 
time. It certainly should be a priority for future research in risk modelling. In this 
regard, the findings by Nilsson et al. that some risk stratification models, such as 
EuroSCORE, can predict 1-year mortality is potentially important, but requires 
further validation. Also, in another long-term (mean 10.7 years) follow-up study 
Biancari et al. stated that both additive and logistic EuroSCORE are good predic-
tors of both short-term and long-term survival (Biancari et al. 2006).
EuroSCORE has also been shown to predict long-term health-related quality 
of life after CABG. Loponen et al. in 2008 in a prospective material of 302 patients 
conducted a three-year follow-up and found that both additive and logistic Euro-
SCORE correlated significantly with the 15D quality of life-score at 6, 18 and 36 
months (Loponen et al. 2008). The best cut-off value of the additive EuroSCORE 
for prediction of a clinically important improvement of the 15D score during 
3-year follow-up was 3, as 46.7% of patients with EuroSCORE 0-3 and 30.1% of 
patients with a score >3 (P=0.006) improved clinically.
The web address for EuroSCORE calculator is: http://www.euroscore.org/calc.
html
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3 AIMS OF THE STUDY
The aims of the present study were:
To estimate the accuracy of  preoperative pulmonary function testing 
(I–II).
To investigate short and long term results of cardiac surgery in older patients 
(III).
To investigate the safety limits of current cardiac surgery practice in terms 
of aortic cross-clamp time and perfusion time (IV).
To derive and validate a more precise risk scoring algorithm from the cur-
rent EuroSCORE (V–VI).
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5 MATERIALS AND METHODS
Studies I–V deal with a consecutive series of 4,563 patients who underwent adult 
cardiac surgery at Vaasa Central Hospital, Vaasa, Finland, from January 1994 to 
June 2008. Study VI deals with a series of 4,014 adult patients who underwent 
cardiac surgery at the Heart Center of  Tampere University Hospital, Tampere, 
Finland, from January 2004 to December 2008.
Clinical and operative data
Variables are categorized according to the EuroSCORE criteria (Roques 1999). 
Operative risk was estimated according to EuroSCORE (Roques 1999) and Cleve-
land risk score (Higgins 1992). The data of these patients were collected prospec-
tively into an institutional cardiac surgery database. Studies I–V were approved by 
the Ethics Committee of Vaasa Central Hospital and a waiver of the requirement 
of written informed consent was obtained for Study III.
Studies I and II
The characteristics and operative data of the patients included in Studies I–II are 
summarized in Table 1. Study I included a series of 453 patients who underwent 
spirometry immediately before AVR operation with or without CABG at Vaasa 
Central Hospital, Vaasa, Finland, from January 1996 to June 2008. Patients who 
underwent any other concomitant heart valve operation as well as surgery on the 
ascending aorta were excluded from this analysis. Study II included 1,848 patients 
who underwent isolated CABG during the same period. Pulmonary disease was 
classified as use of bronchodilators or steroids for COPD/asthma. Spirometry was 
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Table 6.  Preoperative and operative data on patients included in Studies I–II. 
 Study I  Study II 
Variables: No. (%)  No. (%) 
Age (years)  69±11 67.8±9.4
Females  186 (41) 453 (24.5)
Percentages of  predicted FEV1 88±17 83.9±17.6
Percentages of  predicted FVC 82±18 89.5±16.6
History of smoking 115 (23) 734 (39.7)
Pulmonary disease 61 (14) 225 (12.2)
Diabetes  70 (16) 409 (22.1)
Serum creatinine  90±41 93.3±45.3
Neurological dysfunction  3 (1) 25 (1.4)
Myocardial infarction<3 months  17 (4) 275 (14.9)
Extracardiac arteriopathy  23 (5) 182 (9.8)
Previous cardiac surgery  18 (4) 78 (4.2)
Unstable angina pectoris 6 (1) 72 (3.9)
Critical preoperative status 6 (1) 5 (0.3)
Active endocarditis 7 (2) -
Systolic pulmonary a. pressure >60 mmHg  14 (3) 10 (0.5)
Emergency operation 3 (1) 16 (0.9)
Indication for surgery:  
    Aortic valve stenosis 281 (62) -
    Aortic valve regurgitation 64 (14) -
    Combined aortic valve disease 98 (22) -
    Others 10 (2) -
Additive EuroSCORE 6±3 3.8±2.5
Logistic EuroSCORE (%) 7±8 3.9±4.1
a: Definition criteria for preoperative variables are according to EuroSCORE; 
b: classified as use of bronchodilators or steroids for COPD/asthma; 
LVEF: left ventricular ejection fraction; Continuous variable are reported as the mean ± standard deviation; 
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Table 7.  Clinical and operative data of patients aged ≥80 years and <80 years and who 
underwent isolated coronary artery bypass surgery (Study III).
 Overall series  Propensity score matched pairs
 Octo- Younger p-value Octo- Younger p-value
 genarians  patients  genarians patients
 274 3200  273 273
 patients  patients  patients patients
 (%) (%)  (%) (%)  
 
Age (years)  82.5±1.9 66.6±8.8 <0.0001 82.5±1.9 70.5±6.8 <0.0001
Females  110 (40.1) 761 (23.8) <0.0001 109 (39.9) 109 (39.9) 1.00
Pulmonary disease  24 (8.8) 356 (11.1) 0.23 24 (8.8) 37 (13.6) 0.08
Diabetes  63 (23.0) 618 (19.3) 0.14 63 (23.1) 69 (25.3) 0.55
Renal failure  3 (1.1) 28 (0.9) 0.73 3 (1.1) 4 (1.5) 0.73
Cerebrovascular disease  42 (15.3) 373 (11.7) 0.07 41 (15.0) 43 (15.8) 0.81
Neurological dysfunction  5 (1.8) 34 (1.1) 0.25 5 (1.8) 3 (1.1) 0.73
Myocardial infarction<3 months  106 (38.7) 628 (19.6) <0.0001 105 (38.5) 105 (38.5) 1.00
Extracardiac arteriopathy  30 (10.9) 270 (8.4) 0.16 30 (11.0) 26 (9.5) 0.57
Previous cardiac surgery  0 (0) 126 (3.9) <0.0001 0 (0) 17 (6.2) <0.0001
LVEF≤50% 89 (32.5) 10 (34.2) 0.56 89 (32.6) 98 (35.9) 0.42
Unstable angina pectoris 53 (19.3) 417 (13.0) 0.003 53 (19.4) 58 (21.2) 0.60
Critical preoperative status 6 (2.2) 33 (1.0) 0.08 6 (2.2) 11 (4.0) 0.22
Systolic pulmonary artery 
pressure>60 mmHg  2 (0.7) 18 (0.6) 0.67 2 (0.7) 3 (1.1) 0.69
Emergency operation 21 (7.7) 180 (5.6) 0.17 21 (7.7) 29 (10.6) 0.24
Additive EuroSCORE 7.6±2.4  3.9±2.7 <0.0001 7.6±2.4 5.6±3.0 <0.0001
Logistic EuroSCORE (%) 10.6±9.3 4.3±5.6 <0.0001 10.6±9.6 7.0±8.2 <0.0001
Cleveland score 3.8±2.2 2.4±2.4 <0.0001 3.8±2.2 3.5±2.8 0.002
At least one mammary artery graft 220 (80.3) 2986 (93.3) <0.0001 219 (80.2) 219 (80.2) 1.00
Bilateral mammary artery graft 3 (1.1) 515 (16.1) <0.0001 2 (0.2) 2 (0.2) 1.00
No. of distal anastomoses 4.1±1.1 4.1±1.3 0.61 4.1±1.1 3.9±1.2 0.13
Beating heart surgery 54 (19.7) 288 (9.0) <0.0001 53 (19.4) 53 (19.4) 1.00
Aortic cross-clamping time (min) 71±30 80±28 <0.0001 71±30 73±31 0.50
Cardiopulmonary bypass time (min) 101±24 103±31 0.44 101±24 105±34 0.45
*: Definition criteria for preoperative variables are according to EuroSCORE; 
LVEF: left ventricular ejection fraction; 
Continuous variables are reported as mean±standard deviation. Values in parentheses are percentages.
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performed preoperatively in all these patients. Percentages of the predicted forced 
vital capacity (FVC) and percentages of the predicted forced expiratory volume 
in one second (FEV1) were calculated according to normal values of the Finnish 
population as reported by Viljanen and colleagues (Viljanen 1982). These values 
were estimated without bronchodilator test. Severity of pulmonary disease was 
graded in Study II according to the GOLD classification: Stage I FEV1≥80% of 
predicted; Stage II 50%≤FEV1<80% of predicted; Stage III 30%≤FEV1<50% of 
predicted; and Stage IV FEV1<30% (Rabe et al. 2007).
Study III
Study III included a consecutive series of 274 patients aged ≥ 80 years (only one 
patient was 90 years old) who underwent isolated CABG from 1994 to 2008 at 
Vaasa Central Hospital, Vaasa, Finland. These patients belong to a series of 3,474 
patients who underwent isolated CABG during the study period. No attempt was 
made to replace missing values. Data on these patients are summarized in Table 7. 
Study IV
Study IV included a series of 3,280 patients who underwent any adult cardiac sur-
gery. The aim of this study was to evaluate the impact of aortic cross clamp time 
(XCT) and cardiopulmonary bypass time (CPBT) on immediate outcome after 
adult cardiac surgery performed using cardiopulmonary bypass. In order to esti-
mate the impact of complex surgery on the immediate and late outcome, we cat-
egorized major cardiac procedures as isolated, double or a combination of three 
to four procedures. This may reflect a longer XCT and CPBT and, likely, more 
technically demanding procedures. Herein, we refer to isolated or multiple proce-
dures according to the number of procedures on each major anatomical structure 
(coronary arteries, heart valves, ascending aorta/aortic arch, atrial or ventricular 
septum). Surgery for cardiac tumours was considered  a major cardiac procedure. 
Preoperative data on these patients are summarized in Table 8, and data on surgery 
and perfusion are seen in Table 9. 
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Table 8.  Preoperative clinical characteristics and their impact on 30-day mortality 
according to univariate analysis and logistic regression in a series of 3,280 patients who 
underwent adult cardiac surgery using cardiopulmonary bypass (Study IV).
Clinical variables No. (%) Univariate Logistic regression
  analysis
   O.R,  95%C.I.
  p-value 
Age (years)  67.4±10.4 <0.0001 <0.0001, 1.076, 1.037–1.116
Females  944 (28.8) 0.001 
Pulmonary disease  352 (10.7) <0.0001 0.001,      2.711, 1.485–4.948
Diabetes  618 (18.8) 0.001 
Cerebrovascular disease 348 (10.6) 0.001 
Neurological dysfunction 41 (1.3) 0.08 0.021,      4.631, 1.266–16.938
Extracardiac arteriopathy  251 (7.7) 0.005 
Serum creatinine (mmol/L) 94.0±49.4 <0.0001 
Renal failure  35 (1.1) 0.002 
Estimated glomerular filtration rate ml/min/1.73 m2 74.5±19.5 <0.0001 0.003,      1.798, 1.044–3.096
Chronic kidney disease classification  <0.0001 
Classes 1–2 2573 (78.4)  
Class 3 668 (20.4)  
Classes 4–5 39 (1.2)  
Active endocarditis  19 (0.6) 0.001 
Myocardial infarction<3 months  626 (19.1) <0.0001 
Previous cardiac surgery  120 (3.7) <0.0001 
LVEF>50% 2180 (66.5) <0.0001 
           30–50% 967 (29.5)  0.34,       1.798, 1.044–3.096
           <30% 133 (4.1)  0.071,     2.437, 0.927–6.407
Nitrates infusion at OR arrival 359 (10.9) <0.0001 
Critical preoperative status 62 (1.9) <0.0001 <0.0001, 8.274, 3.971–17.240
Systolic pulmonary a. pressure>60 mmHg  82 (2.5) <0.0001 
Emergency operation 171 (5.2) <0.0001 
Postinfarct ventricular septal rupture 9 (0.3) <0.0001 
Additive EuroSCORE 4.8±3.1 <0.0001 
Logistic EuroSCORE (%) 5.9±8.7 <0.0001 
Continuous variables are reported as the mean±standard deviation; 
LVEF: left ventricular ejection fraction; 
OR: operating room. 
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Table 9.  Operative and perfusion data and their impact on 30-day mortality according 
to univariate and multivariate analysis in a series of 3280 patients who underwent adult 
cardiac surgery using cardiopulmonary bypass (Study IV).
Operative/perfusion variables No. (%) Univariate  Logistic regression
  analysis
   p-value, O.R, 95%C.I.
  p-value 
Type of operation   
Isolated CABG 2422 (73.8)  
CABG + ventriculoplasty 15 (0.5)  
CABG + AVR 245 (7.5)  
CABG + MV surgery 72 (2.2)  
CABG + double valve surgery 20 (0.6)  
CABG + triple valve surgery 3 (0.1)  
CABG + other major cardiac procedures 9 (0.3)  
CABG + other non cardiac procedures 11 (0.3)  
Isolated AVR 236 (7.2)  
Isolated MV surgery ± ASD closure 124 (3.8)  
Double valve surgery 24 (0.7)  
Triple valve surgery 7 (0.2)  
Bentall-DeBono procedure ± CABG 50 (1.5)  
Other aortic procedures 2 (0.1)  
Tricuspid valve surgery + other procedures 3 (0.1)  
Isolated ASD closure 20 (0.6)  
Isolated VSD closure 4 (0.1)  
Other major cardiac procedures 13 (0.4)  
No. major cardiac procedures*  <0.0001 0.001,  2.43, 1.41–4.19
1 2820 (86.0)  
2 404 (12.3)  
3–4 56 (1.7)  
Surgery on the thoracic aorta 56 (1.7) <0.0001 
Procedures other than isolated CABG 854 (26.0) <0.0001 
Aortic cross-clamping time (min) 91±36 <0.0001 <0.0001, 0.97, 0.96–0.99**
Cardiopulmonary bypass (CPB) duration (min) 117±48 <0.0001 <0.0001, 1.03, 1.02–1.04
Total potassium/magnesium administered through 
cardioplegia (ml); K+ 1mmol/ml, Mg2+ 0.25mmol/ml 40.2±21.2 0.067 
Lowest cardioplegia temperature (°C) 28.3±2.1 0.18 
Maintenance cardioplegia temperature (°C) 28.9±1.9 0.19 
Crystalloid component of cardioplegia (ml) 493±253 0.006 
Lowest systemic temperature during CPB (°C) 32.9±1.5 <0.0001 
Highest plasma level of K+ during CPB (mmol/l) 5.7±0.8 0.31 
Lowest haematocrit during CPB (%) 22±0.0 <0.0001  0.03,  0.92, 0.85–0.99
Continuous variables are reported as the mean±standard deviation; CABG: coronary artery bypass grafting; AVR: aortic valve 
replacement; MV: mitral valve; ASD: atrial septal defect; VSD: ventricular septal defect: *: We refer to isolated or multiple procedure 
according to the number of procedures on each major anatomical structure (coronary arteries, heart valves, ascending aorta/aortic arch, 
atrial or ventricular septum); **: Both cardiopulmonary bypass time and aortic cross-clamping time entered the regression model and 
correlation matrix showed their strong and negative correlation. For a separate analysis refer to the results section.
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Study V
This study included a series of 3,613 patients undergoing any major adult cardiac 
surgery. These patients belong to a series of 4,563 patients undergoing cardiac sur-
gery during the study period. The only exclusion criterion was  lack of preopera-
tive data on serum creatinine and left ventricular ejection fraction. Patients under-
going  isolated minor procedures such as pericardiectomy or for arrhythmias were 
also excluded. No attempt was made to replace missing values. 
Preoperative glomerular filtration rate was estimated according to the modi-
fied Modification of Diet in Renal Disease study equation (Levey 2000, Levey 
2003)(Levey et al. 2003): eGFR (ml/min/1.73 m2) = 186 x (serum creatinine (mg/
dl))-1.154 x (age)-0.203 x 0.742 (if the subject is female) x 1.212 (if the subject 
is black). Severity of renal failure was classified according to the chronic kidney 
disease (CKD) classification (Levey et al. 2003): class 1 (normal): eGFR > 90 ml/
min/1.73 m2; class 2 (mild): eGFR 60–89 ml/min/1.73 m2; class 3 (moderate): 
eGFR 30–59 ml/min/1.73 m2; class 4 (severe); eGFR 15–29 ml/min/1.73 m2, class 
5 (kidney failure): eGFR < 15 ml/min/1.73 m2. Into the regression analysis we 
entered three groups of patients: classes 1–2, class 3 and classes 4–5. 
We classified patients’ age into four classes (<60 years, 60–69.9 years, 70–79.9 
years, and ≥80 years) as this classification was associated with a more evident 
increase in operative risk than the additive EuroSCORE age classes. Indeed, octo-
genarians and nonagenarians represent a relatively small number of high risk 
patients whose age-related risk can be represented in only one class.
In the original EuroSCORE, non-coronary surgery was considered a predictor 
of adverse outcome, despite the fact that patients with few or no comorbidities may 
undergo any other isolated major cardiac procedure without significantly higher 
mortality risk. In order to better estimate the impact of complex surgery on the 
immediate outcome, we categorized major cardiac procedure as isolated, double 
or a combination of three or more procedures. This may reflect a longer CPB dura-
tion and, not infrequently, more technically demanding procedures. Herein we 
refer to isolated or multiple procedure according to the number of procedures for 
each major area (coronary arteries, heart valves, ascending aorta/aortic arch, atrial 
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Table 10.  Clinical characteristics and operative data of patients included in Study V.
 No. (%)
Age (years)  67.7±10.3
Age≥70 years  1705 (47.2)
Females  1028 (28.5)
Pulmonary disease  404 (11.2)
Diabetes  695 (19.2)
Cerebrovascular disease 396 (11.0)
Extracardiac arteriopathy  304 (8.4)
Serum creatinine (mmol/L) 94.8±49.4
Renal failure  41 (4.4)
Estimated glomerular filtration rate ml/min/1.73 m2 74.3±19.7
Chronic kidney disease classification: 
     Classes 1–2 2815 (77.9)
     Class 3 753 (20.8)
     Classes 4–5 45 (1.2)
Active endocarditis  19 (0.5)
Neurological dysfunction  47 (1.3)
Myocardial infarction<3 months  698 (19.3)
Previous cardiac surgery  158 (4.4)
LVEF>50% 2430  (67.3)
           30–50% 1043 (28.9)
           <30% 140 (3.9)
Nitrates infusion at OR arrival 397 (11.0)
Critical preoperative status 65 (1.8)
Systolic pulmonary a. pressure>60 mmHg  83 (2.3)
Emergency operation 186 (5.1)
Postinfarct ventricular septal rupture 9 (0.2)
Surgery on the thoracic aorta 56 (1.5)
Additive EuroSCORE 4.8±3.1
Logistic EuroSCORE (%) 5.9±8.4
Type of operation: 
    Isolated CABG 2750 (76.1)
    CABG + ventriculoplasty 15 (0.4)
    CABG + AVR 245 (6.8)
    CABG + MV surgery 72 (2.0)
    CABG + double valve surgery 20 (0.6)
    CABG + triple valve surgery 3 (0.1)
    CABG + other major cardiac procedures 9 (0.2)
    CABG + other non cardiac procedures 13 (0.4)
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and ventricular septal defect). Surgery for cardiac tumours was considered as one 
type of major cardiac procedure. However, operations for arrhythmias or pericar-
dial diseases were not classified as major cardiac procedures.
Study VI
This study included a series of 4,014 adult patients undergoing cardiac surgery at 
the Heart Center of Tampere University Hospital, Tampere, Finland, from Janu-
ary 2004 to December 2008. The aim of this study was to validate the modified 
EuroSCORE developed in Study V. Patients undergoing isolated minor procedures 
such as pericardiectomy or for arrhythmias were likewise excluded. No attempt 
was made to replace missing values. Clinical characteristics and operative data on 
these patients are summarized in Table 11.
Variables were classified according to EuroSCORE criteria (Roques et al. 1999) 
and other criteria defined in Study V. Patients were considered at high operative 
risk if their logistic score was within the 90th percentile of each risk algorithm as 
proposed by Dewey et al.(Dewey et al. 2008). 
 No. (%)
    Isolated AVR 235 (6.5)
    Isolated MV surgery ± ASD closure 127 (3.5)
    Double valve surgery 24 (0.7)
    Triple valve surgery 7 (0.2)
    Bentall-DeBono procedure ± CABG 50 (1.4)
    Other aortic procedures 2 (0.1)
    Tricuspid valve surgery + other procedures 3 (0.1)
    Isolated ASD closure 20 (0.6)
    Isolated VSD closure 4 (0.2)
    Other major cardiac procedures 8 (0.2)
    Isolated major cardiac procedures 3152 (87.2)
    Procedures other than isolated CABG 850 (23.5)
Continuous variables are reported as the mean±standard deviation; CABG: coronary artery bypass grafting; AVR: aortic valve 
replacement; MV: mitral valve; ASD: atrial septal defect; VSD: ventricular septal defect.
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Table 11.  Clinical characteristics of patients undergoing adult cardiac surgery from 2004 to 
2008 at the Heart Center, Tampere University Hospital, Finland.
 No. (%)
Age (years)  66.0±10.6
Females  1041 (25.9)
Pulmonary disease  312 (7.8)
Extracardiac arteriopathy  518 (12.9)
Serum creatinine>200 micromol/l 64 (1.6)
Active endocarditis  69 (1.7)
Neurological dysfunction  165 (4.1)
Myocardial infarction<3 months  1159 (28.9)
Previous cardiac surgery  178 (4.4)
LVEF>50% 3023 (75.3)
           30–50% 869 (21.6)
           <30% 122 (3.0)
Nitrates infusion at OR arrival 533 (13.3)
Critical preoperative status 244 (6.1)
Systolic pulmonary a. pressure>60 mmHg  255 (6.4)
Emergency operation 667 (16.6)
Postinfarct ventricular septal rupture 7 (0.2)
Surgery on the thoracic aorta 183 (4.6)
Additive EuroSCORE 5.5±3.6
Logistic EuroSCORE (%) 8.0±11.5
Additive modified score 3.5±1.7
Logistic modified score (%) 2.2±6.1
Type of operation: 
    Isolated CABG 2829 (70.5)
    Isolated AVR 345 (8.6)
    Isolated MV surgery 243 (6.1)
    CABG + AVR 208 (5.2)
   CABG + MV surgery 77 (1.9)
   Any operation on the ascending aorta with any associated procedure 123 (3.1)
   Triple valve surgery 2 (0.0)
   Other major cardiac procedures 187 (4.7)
Continuous variables are reported as the mean±standard deviation; CABG: coronary artery bypass grafting; AVR: aortic valve 
replacement; MV: mitral valve; ASD: atrial septal defect; VSD: ventricular septal defect.
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Anaesthesia method
The anaesthesia method consisted of combined general anaesthesia. Thoracic epi-
dural anaesthesia was used in Studies I–IV at the discretion of the anaesthesiologist 
for patients with anticipated pulmonary or other significant risk. Fentanyl 3–3.5 
ug/kg, and propofol 0.8–2 mg/kg were administered intravenously for anaesthesia 
induction, followed by continuous infusion of propofol 1–2 mg/kg/h. Pancuro-
nium 0.10 mg/kg was administered for muscle relaxation. Clonidine 1.5–2ug/kg 
was administered as a slow intravenous bolus dose at induction of anaesthesia to 
patients without thoracic epidural anesthesia. Patients were ventilated with oxygen 
in air, FiO2 0.4–0.5, supplemented with isoflurane or sevoflurane.
Cardiopulmonary bypass techniques
For CPB we used a membrane oxygenator (Dideco Compactflo; Dideco S.p.A., 
Mirandola, Italy) with a nonpulsatile pump flow by means of a Stöckert roller 
pump (CAPS or SIII, Stöckert GMBH, Munich, Germany) and a systemic temper-
ature drift down to 32–34 oC. A 40µm arterial line filter (D734, Dideco S.p.A.) was 
included in the CPB circuit. From 1996 to 2002 we used conventional non-coated 
PVC-tubings, but from 2002 we routinely used a phosphorylcholine-coated bypass 
circuit (Ph.I.S.I.O., Dideco S.p.A.). A blood cardioplegia technique was employed 
for cardiac protection in all cases. Cardiac arrest was initiated with a bolus dose of 
K/Mg-cardioplegia concentrate solution given in a 35 to 37 oC warm mixture of a 
moderately hyperkalemic 5% glucose solution and oxygenated blood infused into 
the aortic root in a ratio of 1:8. The mixture was cooled to about 30 oC after cardiac 
arrest and thereafter given as a continuous ante/retrograde infusion directly into 
the coronary ostia and/or through the coronary sinus, and into the venous grafts. 
Before declamping of the aorta the blood cardioplegia was warmed to 35 to 37 oC 
and infused for 4 to 5 minutes. The target activated clotting time was ≥ 600 sec due 
to use of a moderate dose of aprotinin (2.5–4 million units/patient).
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Surgical techniques
Surgery was undertaken via full median sternotomy. In Study I all procedures 
were prosthetic valve implantations. Valve type was chosen in consensus with the 
patient, the usual dividing point between mechanical and biological valve being 
70 years. In Study II, 1,604 patients were operated on with conventional CABG 
technique, whereas 274 (14.4%) were operated on with beating heart surgery tech-
nique.
Epiaortic ultrasound was performed in most of patients undergoing CABG. 
The decision to avoid aortic cross- or side-clamping was based on intraoperative 
findings of diseased ascending aorta and individual operative risk. A Heartstring 
anastomosis seal device (Guidant Corporation, San Jose, CA, USA) was used 
whenever a severely calcified ascending aorta prevented its safe cross- and side-
clamping.
Statistical analysis
Statistical analysis was performed using SPSS statistical software (SPSS v. 14.0.1, 
SPSS Inc., Chicago, Ill., USA). No attempt was made to replace missing values. 
Continuous variables are reported as mean±standard deviations. Pearson’s test, 
Fisher’s exact test with or without the Monte Carlo method, the Mann-Whitney 
test and Kruskall-Wallis’ test were used for univariate analysis. Receiver operating 
characteristics (ROC) curve was used to estimate the predictive value of continu-
ous variables. The best cutoff values were chosen according to the best sensitivity, 
specificity, accuracy as well as unadjusted odds ratio. Spearman’s test was used 
to estimate the correlation of continuous variables. Logistic regression and Cox 
regression analysis with the help of backward selection were used for multivariate 
analysis. Variables with  p<0.05 in univariate analysis were included in the regres-
sion model. A value of  p<0.05 was considered statistically significant.
In Study III, since patients aged  ≥ 80 years had an operative risk markedly 
higher  than that of younger patients – as indicated by EuroSCORE and Higgins 
score - which can be only partly explained by the age factor, we calculated a pro-
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pensity score to obtain one-to-one match pairs with similar clinical and operative 
characteristics (other than age). Indeed, elderly patients were operated on employ-
ing less frequently one or two bilateral mammary artery grafts. Logistic regression 
with backward selection was performed to calculate the propensity score. All vari-
ables but age, EuroSCORE and Higgins score listed in Table 2 with a p<0.20 were 
included in the regression model. ROC curve analysis was used to estimate the area 
under the curve of the calculated propensity score. The latter was employed for 
one-to-one matching according to the difference in the propensity score <0.005.
In Study V additive and logistic scoring systems were then developed, the 
former having been calculated by adding rounded odds ratios. The predictive 
value of these risk scoring methods was evaluated in Study VI.
Long-term outcome was assessed by Kaplan-Meier’s test and Cox regression 
analysis. Only variables with  p<0.20 were included in the regression models for 
prediction of late outcome. A value of p<0.05 was considered statistically signifi-
cant.
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6 RESULTS
Study I
Spirometry parameters
Patients undergoing AVR with CABG had similar spirometry parameters to 
patients undergoing isolated AVR. The percentage of the predicted FVC (rho: 
0.125, p=0.009) and the percentage of the predicted FEV1 (rho: 0.113, p=0.012) 
correlated with the preoperative left ventricular ejection fraction. Similarly, these 
parameters were associated with EuroSCORE left ventricular ejection fraction 
classes (p=0.005 and p=0.05 respectively). Interestingly, left ventricular ejection 
fraction <50% was significantly associated with the percentage of the predicted 
FVC<80% (30.6% vs. 15.5%, p<0.0001), but not the percentage of the predicted 
FVE1<75% (24.7% vs. 18.1%, p=0.11). 
As expected, the percentages of the predicted FEV1, but not the percentages 
of the predicted FVC (p=0.11, and p=0.097 respectively), were significantly lower 
among patients with history of smoking (74.7±16.8% vs. 84.3±18.1%, p<0.0001) 
and current smokers (69.9±13.6% vs. 82.8±18.3%, p<0.0001).
Percentages of the predicted FVC and FEV1 did not correlate with CPB time. 
Pulmonary disease and in–hospital mortality
Table 12 summarizes the immediate outcome endpoints. When all variables listed 
in Table 1 with a p<0.05 in the univariate analysis were included in the regression 
analysis, the percentages of the predicted FVC (O.R. 0.952, 95%C.I. 0.914–0.990, 
p=0.019), unstable angina pectoris (O.R. 12.981, 95%C.I. 1.618–104.126, p=0.016) 
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and CPB duration (O.R. 1.010, 95%CI 1.004–1.102, p=0.001) were independent pre-
dictors of in-hospital mortality. These variables remained independent predictors 
even when logistic EuroSCORE was included in the logistic regression analysis. 
The percentage of the predicted FVC (AUC 0.749, 95%C.I. 0.632–0.866, 
p=0.002) and the percentage of the predicted FEV1 (AUC 0.723, 95%C.I. 0.591–
0.854, p=0.003) had satisfactory areas under the ROC curve. The best cutoff value 
for the percentage of the predicted FVC was 80% (in-hospital mortality 6.3% vs. 
1.3%, p=0.005, O.R. 5.100, 95%C.I. 1.544–16.849, specificity 69%, sensitivity 69%) 
and for the percentage of the predicted FEV1 was 75% (in-hospital mortality 5.2% 
vs. 1.7%, p=0.04, O.R. 3.233, 95%C.I. 1.039–10.056, specificity 67%, sensitivity 
62%). History of pulmonary disease was also associated with increased risk of 
Table 12.  Postoperative outcome after aortic valve replacement surgery.
Clinical endpoints No. (%)
In-hospital mortality 13 (3)
30-day mortality 12 (3)
Resternotomy 48 (10)
Mediastinitis 3 (1)
Stroke 16 (4)
Stroke or TIA 20 (4)
Intra-aortic balloon pump 7 (2)
Acute renal failure requiring dialysis 2 (1)
Delirium 47 (10)
Atrial fibrillation 245 (54)
Extubation time (hours) 8±17
Reintubation 21 (5)
Pneumonia 35 (8)
Intensive care unit stay (days) 2±3
Intensive care unit stay ≥5 days 28 (6)
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Figure 3.  Observed in-hospital mortality rates after aortic valve replacement according to 
quartiles of percentages of the predicted FVC and of the predicted FEV1.
 
in-hospital mortality (9.7% vs. 1.8%, O.R. 5.893, 95%C.I. 1.911–18.167, p=0.004). 
However, even when the percentage of the predicted FVC<80% and the percent-
age of the predicted FEV1<75% were included in the regression analysis, again 
only the percentage of the predicted FVC was an independent predictor of adverse 
outcome. The mortality rates of different quartiles of percentages of the predicted 
FVC and FVE1 are shown in Figure 3.
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Impact of pulmonary disease on the other outcome end-points
The percentage of the predicted FVC was significantly associated with postopera-
tive stroke (p=0.008), but neither the percentage of the predicted FEV1 (p=0.21) 
nor history of pulmonary disease (p=0.25) were associated with this complication. 
When adjusted for cerebrovascular disease, neurological dysfunction, redo-sur-
gery, CPB time and aortic cross-clamping time, which were significantly associ-
ated with postoperative stroke at univariate analysis, only the percentage of the 
predicted FVC, however, was found to be an independent predictor of stroke (O.R. 
0.956, 95%C.I. 0.923–0.989, p=0.009). A percentage of the predicted FVC<80% 
was associated with a risk of postoperative stroke of 6.9% versus 1.9% among 
those patients with better FVC values (O.R. 3.769, 95%1.342–10.581, p=0.012). 
Stroke rates for increasing quartiles of the percentage of the predicted FVC were 
1.6%, 1.7%. 3.9% and 7.1% (p=0.10) respectively. Similarly, the percentage of the 
predicted FVC was significantly associated with stroke and/or transient ischae-
mic attacks (Mann-Whitney test: p=0.008; for 80% cut-off value: 8.3% vs. 2.6%, 
p=0.006, O.R. 3.420, 95%C.I. 1.366–8.536, p=0.006).
Interestingly, the percentage of the predicted FVC, the percentage of the pre-
dicted FEV1 and history of pulmonary disease were not associated with postop-
erative pneumonia, which was otherwise significantly associated with extracar-
diac arteriopathy (p=0.025), CPB time (p=0.004) and aortic cross-clamping time 
(<0.0001). 
The percentage of the predicted FVC (rho: -0.139, p=0.003) and the percentage 
of the predicted FEV1 (rho: -0.093, p=0.050) were negatively correlated with extu-
bation time, but the correlation coefficients were rather small. Only the percentage 
of the predicted FVC correlated with length of stay in the intensive care unit (rho: 
-0.127, p=0.007). The percentage of the predicted FVC<80% (10.4% vs. 4.2%, O.R. 
2.648, 95%C.I. 1.225–5.724, p=0.011) and history of pulmonary disease (13.1% vs. 
5.1%, O.R. 2.808, 95%C.I. 1.117–6.694, p=0.016) were significantly associated with 
higher risk of intensive care unit stay ≥5days.
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Study II
Pulmonary disease and immediate postoperative outcome after isolated CABG
The in-hospital mortality after isolated CABG was 1.6 % (29/1848). The percentage 
of the predicted FVC (AUC 0.660, 95%C.I. 0.563–0.757, p=0.003) and the percent-
age of the predicted FEV1 (AUC 0.636, 95%C.I. 0.527–0.745, p=0.012) were asso-
ciated with in-hospital death. The lowest quintiles of percentages of the predicted 
FVC were associated with increased in-hospital mortality rates (2.4%, 2.8%, 1.5%, 
0.3%, 0.8%  respectively, p=0.036). Similarly, the lowest quintiles of percentages of 
the predicted FEV1 were also associated with increased in-hospital mortality rates 
(3.1%. 1.4%, 1.7%, 0.8%, 0.9% respectively, p=0.11), but the differences failed to 
reach statistical significance. 
GOLD classes of percentages of the predicted FEV1 were associated with 
increased in-hospital mortality rates (I: 1.2%, II: 1.8%, III: 6.5%, and IV: 0% respec-
tively, p=0.010). GOLD classes of percentages of the predicted FEV1 were associ-
ated with increased risk of combined adverse event endpoint (3.9%, 9.8%, 17.7% 
and 16.7%  respectively, p<0.0001), stroke (1.7%, 3.4%, 3.2% and 0%  respectively, 
p=0.059), need for intra-aortic balloon pump (0.4%, 1.1%, 3.2% and 0%  respec-
tively, p=0.097), need for postoperative de novo dialysis (0.4%, 1.7%, 1.6%, 0% 
respectively, p=0.016), neuropsychological disturbances (7.6%, 13.1%, 11.3% and 
0%  respectively, p=0.002), atrial fibrillation (36.8%, 44.4%, 46.7% and 50.0% 
respectively, p=0.008) as well as length of stay in the intensive care unit ≥ 5 days 
(1.8%, 6.0%, 9.7% and 16.7% respectively, p<0.0001).
The percentages of the predicted FVC < 70% were associated with higher rates 
of in-hospital mortality (2.8%  vs. 1.2%, p=0.11), combined adverse endpoint 
(13.3% vs. 5.6%, p<0.0001), need for intra-aortic balloon pump (2.4% vs. 0.5%, 
p=0.016), need for postoperative de novo dialysis (2.8% vs. 0.6%, p=0.006), neu-
ropsychological disturbances (12.4% vs. 9.3%, p=0.15), atrial fibrillation (47.1% vs. 
39.0%, p=0.026), pneumonia (11.4% vs. 4.6%, p<0.0001) as well as length of stay in 
the intensive care unit ≥ 5 days (8.6% vs. 2.9%, p<0.0001).
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The percentages of the predicted FEV1 < 70% were associated with increased 
risk of in-hospital mortality (3.1% vs. 1.2%, p=0.011), combined adverse endpoint 
(12.0% vs. 5.2%, p<0.0001), need for intra-aortic balloon pump (1.9% vs. 0.5%, 
p=0.004), need for postoperative de novo dialysis (2.2% vs. 0.5%, p=0.006), neu-
ropsychological disturbances (13.7% vs. 8.7%, p=0.004), atrial fibrillation (48.0% 
vs. 37.9%, p=0.001), pneumonia (9.2% vs. 4.4%, p<0.0001) as well as length of stay 
in the intensive care unit ≥ 5 days (7.8% vs. 2.6%, p<0.0001).
Pulmonary disease defined according to EuroSCORE criteria was also asso-
ciated with higher rates of in-hospital postoperative mortality (3.6% vs. 1.3%, 
p=0.011), combined adverse endpoint (11.6% vs. 5.8%, p=0.001), need for intra-
aortic balloon pump (2.2% vs. 0.6%, p=0.007), as well as length of stay in the 
intensive care unit ≥ 5 days (7.6% vs. 3.2%, p=0.001). Similar trends were seen for 
postoperative de novo dialysis (1.3% vs. 0.8%, p=0.43), neuropsychological distur-
bances (11.2% vs. 9.4%, p=0.40), and atrial fibrillation (43.3% vs. 39.4%, p=0.28). 
ROC curve analysis showed that FEV1 (AUC 0.626, 95%C.I. 0.517–0.734, 
p=0.047) and FVC (AUC 0.642, 95%C.I. 0.533–0.751, p=0.025) were significantly 
associated with the risk of postoperative mediastinitis. 
Logistic regression showed that the percentage of predicted FVC was an inde-
pendent predictor of in-hospital mortality along with estimated glomerular filtra-
tion rate, age and extracardiac arteriopathy.
Pulmonary disease and late mortality
Ten-year overall survival in this series was 72.9% (119 patients entering the inter-
val, S.E. 0.02).
Cox regression analysis showed that pulmonary disease defined according to 
EuroSCORE criteria and percentages of predicted FVC were among the independ-
ent predictors of late overall mortality. The percentage of predicted FEV1 was not 
an independent predictor of late mortality. 
Since we observed that the risk of late mortality increased markedly when per-
centages of predicted FEV1 and FVC were lower than 70% (Figure 4), these cutoff 
values were included in the Cox regression model instead of their continuous val-
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Figure 4. Kaplan Meier’s estimates of overall survival rates according to different 
percentages of predicted FVC (A) and percentages of predicted FEV1 (B).
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ues. Again, the percentage of predicted FVC < 70% (at 10 years: 63.8% vs. 74.3%, 
p=0.014, RR 1.50, 95%C.I. 1.08–2.08) along with pulmonary disease (at 10 years: 
58.0% vs. 76.0%, p<0.0001, RR 1.75, 95%C.I. 1.29–2.39), but not percentage of 
predicted FEV1 < 70% were independent predictors of late overall mortality.
Study III
Th e prevalence of octogenarians in the cardiac surgery population has signifi cantly 
increased over the years (p<0.0001, Figure 5), reaching a rate of about 15% during 
the last years of our experience. Th e increasing prevalence of octogenarians was 
also associated with a trend for increased 30-day mortality (1994–1998: 0% 0/23 
Figure 5.  Increasing prevalence across the study period of patients aged 80 years or more 
who underwent isolated coronary artery bypass surgery at Vaasa Central Hospital, Finland 
(Fisher exact test, Monte Carlo method: p<0.0001).
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patients; 1999–2003: 4.5%, 4/88 patients; 2004–2008: 5.5%, 9/163, p=0.75). How-
ever, this was likely due to a certain increase in the operative risk observed during 
the last decade (mean logistic EuroSCORE: 8.0%, 10.8% and 10.9% respectively, 
Kruskall-Wallis test: p=0.48) as well as a more confi dent and aggressive revascu-
larization policy in this patient population.
Table 13 summarizes the postoperative complications as well as immediate 
and long-term outcome. Octogenarians have a signifi cantly poorer immediate and 
long-term outcome than younger patients. However, when compared with pooled 
survival estimates according to the study by McKellar and colleagues (McKellar 
2008), the overall survival of octogenarians in the present series was much better 
than estimated (Figure 6). Th is comparison could anyway, be aff ected by the inclu-
sion in this systematic review of patients operated on their eighties. 
Figure 6.  Overall survival rates of patients aged 80 years or more who underwent isolated 
coronary artery bypass surgery in the present series (black circles) and according to 
pooled estimates (grey circles) reported by McKellar and colleagues (McKellar 2008).
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Predictors of immediate and late mortality among octogenarians
Univariate analysis showed that diabetes (9.5% vs. 3.3%, p=0.04) and critical pre-
operative status (50.0% vs. 3.7%, p=0.002) were the only preoperative variables 
predicting 30-day postoperative mortality. Logistic regression analysis showed 
that only critical preoperative status was independently associated with 30-day 
postoperative mortality (p<0.0001, OR 26.03, 95%CI 4.38–154.65).
Univariate analysis showed that diabetes (p<0.0001), extracardiac arteriopa-
thy (p=0.006), neurological dysfunction (p=0.005), renal failure (p=0.02), criti-
cal preoperative status (p<0.0001), unstable angina pectoris (p=.004), and recent 
myocardial infarction (p=0.001) were associated with poorer long-term outcome.
Cox regression analysis showed that recent myocardial infarction (p=0.04, RR 
1.70,  95%CI 1.04–2.79), extracardiac arteriopathy (p=0.001, RR 2.78, 95%CI 1.50–
5.15), neurological dysfunction (p=0.03, RR 3.83, 95%CI 1.15–12.68), diabetes 
(p<0.0001, RR 2.63, 95%CI 1.61–4.30), and critical preoperative status (p<0.0001, 
RR 11.78, 95%CI 4.30–32.21) were independent predictors of late mortality.
Propensity score analysis
Propensity score analysis provided a model with a Hosmer-Lemeshow’s p=0.32 
and showed that the prevalence of female gender, recent myocardial infarction, at 
least one internal mammary artery graft used, bilateral mammary artery grafting 
and beating heart surgery significantly differed between patients aged  ≥80 years 
and younger patients. The propensity score obtained had an area under the ROC 
curve of 0.71 (95%CI 0.69–0.75, p<0.0001). This propensity score provided 273 
matched pairs with similar risk factors other than age.
The immediate outcome of propensity score matched pairs is summarised in 
Table 13. These findings demonstrate that, despite the evident negative prognostic 
impact of increased age, the immediate outcome of octogenarians does not signifi-
cantly differ from that of younger patients with otherwise similar baseline risk fac-
tors and operated on with the same technical approach, i.e. beating heart surgery 
and use of internal mammary artery grafts. Figure 7 also shows the 5-year overall 
survival which, despite the statistical significance, is not remarkably lower than 
that of propensity matched patients aged  < 80 years (77.0% vs. 81.3%, p=0.009). 
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Th e decrease in the survival of octogenarians seems to be evident during the fi rst 
few months aft er surgery, but not later on (Fig. 7). Ten-year survival, given the 
fi nite nature of life, was in any case rather poor  (Table 13).
Propensity score analysis, despite a rather good matching of patients, has not 
eliminated those patients who had prior cardiac surgery. When the latter were 
excluded, 5-year overall survival rates were 77.0% among octogenarians vs. 80.5% 
among patients aging < 80 years (p=0.019).
  
Figure 7.  Overall survival rates of 273 propensity score-matched pairs of patients aged 
80 years or more and less than 80 years who underwent isolated coronary artery bypass 
surgery (log-rank: p= 0.009).
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Table 13.  Immediate and late outcome after isolated coronary artery bypass surgery in 
octogenarians and younger patients.
 Overall series  Propensity score matched pairs
 Octo- Younger p-value Octo- Younger p-value
 genarians  patients  genarians patients
 274 3200  273 273
 patients  patients  patients patients
 (%) (%)  (%) (%)  
 
Immediate postoperative outcome:      
30-day mortality 13 (4.7) 40 (1.3) <0.0001 13 (4.8) 7 (2.6) 0.17
Reoperation 18 (6.6) 161 (5.0) 0.27 18 (6.6) 20 (7.3) 0.74
Reoperation for bleeding 9 (3.3) 106 (3.3) 0.99 9 (3.3) 16 (5.9) 0.22
Stroke 7 (2.4) 7 (2.6) 0.88 7 (2.6) 6 (2.2) 0.78
Intra-aortic balloon pump 6 (2.2) 26 (0.8) 0.02 6 (2.2) 5 (1.8) 0.76
Acute renal failure requiring dialysis 7 (2.6) 28 (0.9) 0.008 7 (2.6) 3 (1.1) 0.34
ICU-stay (days) 2.0±2.7 1.6±3.5 <0.0001 2.0±2.7 1.9±3.2 0.21
ICU-stay≥5 days 24 (8.8) 121 (3.8) <0.0001 24 (8.8) 19 (7.0) 0.43
Delirium 52 (19.0) 254 (8.0) <0.0001 52 (19.1) 30 (11.1) 0.009
Pneumonia 21 (7.7) 177 (5.5) 0.14 21 (7.7) 18 (6.6) 0.62
Atrial fibrillation 143 (55.4) 1142 (36.5) <0.0001 142 (55.3) 113 (43.6) 0.008
Combined adverse end-points 36 (13.1) 211 (6.6) <0.0001 36 (13.2) 29 (10.6) 0.36
      
Late postoperative outcome:   <0.0001   0.009
   1-year overall survival 90.8% 97.3%  90.8% 96.7% 
   3-year overall survival 86.3% 93.9%  86.7% 90.5% 
   5-year overall survival 76.6% 90.4%  77.0% 81.3% 
   10-year overall survival 34.9% 76.1%  35.0% 55.3% 
a: In-hospital mortality, stroke, length of stay in ICU ≥5 days, acute renal failure requiring dialysis; 
ICU: Intensive care unit. Values in parentheses are percentages; 
Late survival has been estimated by the Kaplan-Meier’s method with the log-rank test.
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Figure 8.  Aortic cross-clamping time correlated strongly with cardiopulmonary bypass 
duration (rho: 0.941, p<0.0001). The correlation between aortic cross-clamping time and 
cardiopulmonary bypass duration with unclamped aorta was somewhat weaker (rho: 0.439, 
p<0.0001). Black circles indicate patients who died during 30-day postoperative period.
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Study IV
Aortic cross-clamping and cardiopulmonary bypass time 
XCT, as expected, correlated strongly with CPBT (rho: 0.94, p<0.0001). However, 
the correlation between XCT and CPBT with unclamped aorta was somewhat 
weaker (rho: 0.44, p<0.0001). Figure 8 shows a scattered correlation indicating 
that prolonged XCT was not necessarily associated with prolonged CPBT with 
unclamped aorta. 
Thirty-day postoperative mortality
Thirty-day postoperative mortality rate was 2.5% (83/3280). Additive EuroSCORE 
(p<0.0001, area under the curve, AUC 0.837, 95%C.I. 0.791–0.882) and logistic 
EuroSCORE (p<0.0001, AUC 0.84, 95%C.I. 0.80–0.89) performed well in predict-
ing 30-day postoperative mortality. 
Thirty-day mortality rate was not significantly different after isolated coronary 
artery bypass surgery (1.6%), isolated aortic valve surgery (1.7%) and isolated 
mitral valve surgery (1.7%) (p=0.75). On the other hand, 30-day mortality rates 
after isolated procedure, double procedure and three to four procedures were 1.7% 
(47/2820), 5.4% (22/404) and 25% (14/56)  respectively (p<0.0001). Accordingly, 
the XCT (83±26 min, 134±36 min and 191±56 min respectively, p<0.0001) and 
CPBT (106±34 min, 173±52 min and 262±98 min respectively, p<0.0001) also cor-
related with the complexity of the operation.
ROC curve analysis showed that XCT (p<0.0001, AUC: 0.66, 95%C.I. 0.60–
0.73), CPBT (p<0.0001, AUC: 0.73, 95%C.I. 0.67–0.78), and CPBT with unclamped 
aorta (p<0.0001, AUC: 0.77, 95%C.I. 0.71–0.83) were associated with 30-day post-
operative mortality. The increasing risk of 30-day mortality along with increased 
XCT and CPBT is presented in Figure 9.
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Figure 9.  30-day mortality rates for increasing duration of aortic cross-clamping 
(p<0.0001, O.R. 1.41, 95%C.I. 1.23–1.62 when adjusted for additive EuroSCORE) and 
cardiopulmonary bypass (p<0.0001, O.R. 1.45, 95%C.I. 1.30–1.61 when adjusted for 
additive EuroSCORE).
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Figure 10.  Rates of postoperative complications for increasing duration of aortic cross-
clamping and cardiopulmonary bypass. P-values adjusted for additive EuroSCORE.
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Logistic regression showed that both XCT and CPBT were independent predictors 
of immediate postoperative death. It is worth noting that in the correlation matrix 
XCT and CPBT were negatively correlated. Thus, XCT and CPBT were included 
in the regression model separately and the results were similar. XCT of increasing 
30-minute intervals (p=0.04, O.R. 1.24, 95%C.I. 1.01–1.52, Hosmer-Lemeshow’s 
test: p=0.43, change in -2 Log likelihood: 4.45) and CPBT of increasing 30-minute 
intervals (p<0.0001, O.R. 1.47, 95%C.I. 1.270–1.71, Hosmer-Lemeshow’s test: 
p=0.49, change in -2 Log likelihood: 24.28) were independent predictors of 30-day 
postoperative mortality also when included separately in the regression model. 
The best cutoff value for XCT was 150 min (1.8% vs. 12.2%, p<0.0001, O.R. 
3.07, 95%C.I. 1.48–6.39 as adjusted for additive EuroSCORE and complexity of 
the operation; sensitivity 33.7%, specificity 93%, accuracy 91.5%) and for CPBT 
240 min (1.9% vs. 31.5%, p<0.0001, O.R. 8.78, 95%C.I. 4.64–16.61 as adjusted for 
additive EuroSCORE and complexity of the operation; sensitivity 27.8%, specifi-
city 97.8%, accuracy 96.0%).
Outcome prediction after isolated procedures
According to the logistic regression CPBT, but not XCT, was associated with 
30-day mortality among patients undergoing isolated procedures. However, the 
area under the ROC curve of CPBT was rather small (p=0.001, AUC: 0.64, 95%C.I. 
0.58–0.71) compared to that of the overall series and of patients undergoing com-
plex procedures. 
Outcome prediction after complex procedures
Four-hundred and twenty patients underwent two or more procedures on coro-
nary arteries, heart valves, ascending aorta/aortic arch, atrial or ventricular septum. 
ROC curve analysis showed that XCT (p<0.0001, AUC: 0.681, 95%C.I. 0.57–0.80), 
CPBT (p<0.0001, AUC: 0.74, 95%C.I. 0.64–0.85), and CPBT with unclamped aorta 
(p<0.0001, AUC: 0.79, 95%C.I. 0.70–0.88) were associated with 30-day postopera-
tive mortality.
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When adjusted for additive EuroSCORE, XCT (p<0.0001, O.R. 1.01, 95%C.I. 
1.01–1.02) and CPBT (p<0.0001, O.R. 1.01, 95%C.I. 1.01–1.02) were independent 
predictors of 30-day mortality among patients undergoing complex procedures. 
XCT >150 min (14.5% vs. 3.8%, p<0.0001, O.R. 4.24, 95%C.I. 2.03–8.85) and CPBT 
>240 min (p<0.0001, O.R. 9.10, 95%C.I. 4.40–18.81) were associated with greatly 
increased risk of 30-day mortality. When their best cutoff values were adjusted for 
additive EuroSCORE, XCT>150 min (p=0.001, O.R. 4.13, 95%C.I. 1.82–9.37) and 
CPBT>240 min (p<0.0001, O.R. 4.81, 95%C.I. 2.13–10.86) were also associated 
with 30-day mortality in this high risk group. The effect of combining the cutoff 
values of these two risk factors is shown in Figure 11 (p<0.0001 adjusted for addi-
tive EuroSCORE). 
Figure 11.  30-day mortality rates after complex cardiac surgery according to different 
combinations of cutoff values of aortic cross-clamping and cardiopulmonary bypass 
duration. P-value adjusted for additive EuroSCORE. XCT: aortic cross-clamping time. 
CPBT: cardiopulmonary bypass time.
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Severe postoperative complications
The rate of combined severe complications endpoint (30-day mortality, intensive 
care unit stay ≥ 5 days, stroke, postoperative use of IABP, and need for postopera-
tive dialysis) was 10.9% (357/3280 patients). ROC curve analysis showed that XCT 
(p<0.0001, AUC: 0.644, 95%C.I. 0.61–0.68), CPB duration (p<0.0001, AUC: 0.70, 
95%C.I. 0.67–0.73), and CPB duration with unclamped aorta (p<0.0001, AUC: 
0.74, 95%C.I. 0.71–0.77) were associated with combined severe complications 
endpoint. Figure 11 shows the rates of severe complications according to different 
XCTs and CPBTs adjusted for additive EuroSCORE.
XCT correlated significantly with the number of transfused red blood cell 
units (rho: 0.26, p<0.0001), the number of transfused homologous blood products 
(rho: 0.27, p<0.0001), time to extubation (rho: 0.136, p<0.0001) and length of stay 
in the intensive care unit (rho: 0.19, p<0.0001). Likewise, CPBT correlated signifi-
cantly with the number of transfused red blood cell units (rho: 0.31, p<0.0001), the 
number of transfused homologous blood products (rho: 0.32, p<0.0001), time to 
extubation (rho: 0.16, p<0.0001) and length of stay in the intensive care unit (rho: 
0.25, p<0.0001). 
Study v
Thirty-day postoperative mortality
The overall 30-day postoperative mortality rate was 2.5% (90/3613). Thirty-day 
postoperative mortality was not significantly different after isolated coronary 
artery bypass surgery (1.6%), isolated aortic valve surgery (1.7%) and isolated 
mitral valve surgery (2.5%) (p=0.75). On the other hand, 30-day mortality rates 
after isolated procedure, double procedure and three to four procedures were 1.7% 
(54/3152), 5.4% (22/405) and 25% (14/56)  respectively (p<0.0001). Accordingly 
the CPB duration correlated with the numbert of procedures (106±34 min, 172±52 
min and 262±98 min  respectively, p<0.0001).
The area under the ROC curve for predicting 30-day mortality was much larger 
for estimated preoperative glomerular filtration rate (0.716, 95%C.I. 0.656–0.776, 
p<0.0001) than for preoperative serum creatinine (0.660, 95%C.I. 0.594–0.727, 
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p<0.0001). Thirty-day mortality rate for CKD classes 1–2 was 1.3%, for class 3 
6.1%, and for classes 4–5  13.3%  respectively (p<0.0001), whereas it was respec-
tively 12.2% and 2.4% for patients with and without renal failure according to 
EuroSCORE criteria (p=0.003). Estimated glomerular filtration rate, but not pre-
operative creatinine, was an independent predictor of 30-day mortality.
Patients’ age in all regression models was an independent predictor of 30-day 
mortality. When we evaluated age according to additive EuroSCORE criteria, a 
marked difference in mortality was detected for patients aged 70 or more. How-
ever, a further increase was observed among octogenarians. Because of this, we 
divided patients’ ages into four classes (30-day mortality rates: <60 years, 0.6%; 
60–69.9 years, 1.8%; 70–79.9 years, 3.6%; ≥80 years, 4.6%, p<0.0001). 
Risk factors associated with 30-day postoperative mortality in the regression 
analysis are listed in Table 14. The Hosmer-Lemeshow chi-square of the final 
regression model was 4.952, p=0.763. 
ROC analysis showed that the modified score had a slightly larger area under 
the curve (additive: 0.867, 95%C.I. 0.830–0.904; logistic: 0.873, 95%C.I. 0.837–
0.909) than the EuroSCORE (additive: 0.835, 95%C.I. 0.790–0.879; logistic: 0.840, 
95%C.I. 0.796–0.883) (Figure 12) for prediction of 30-day postoperative mortality. 
Similar areas under the ROC curve were observed in predicting in-hospital mor-
tality (area under the ROC curve: additive modified score 0.867, 95%C.I. 0.832–
0.902; logistic modified score 0.872, 95%C.I. 0.838–0.907; additive EuroSCORE 
0.831, 95%C.I. 0.788–0.873; logistic EuroSCORE 0.836, 95%C.I. 0.794–0.878).
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Table 14.  Results of logistic regression in predicting 30-day postoperative mortality and 
additive score points as estimated in Study V.
 Beta- Standard p-value Odds 95% interval Additive 
 coefficient error  ratio confidence score 
      points
Patients’ age       
    <60 years   0.005   
    60–69 years 0.779 0.571 0.173 2.178 0.711–6.674     2
    70–79 years 1.371 0.550 0.013 3.940 1.340–11.588     4
    ≥80 years 1.853 0.606 0.002 6.377 1.944–20.923     6
Female 0.536 0.263 0.042 1.709 1.020–2.863     2
Pulmonary disease 1.080 0.280 0.000 2.945 1.700–5.101     3
Extracardiac arteriopathy  0.778 0.320 0.015 2.178 1.164–4.075     2
Neurological dysfunction 1.461 0.615 0.018 4.309 1.290–14.398     4
Redo surgery 1.049 0.385 0.006 2.855 1.343–6.070     3
Critical preoperative status 2.079 0.371 0.000 7.993 3.860–16.552     8
Left ventricular ejection fraction       
    >50%   0.001   
    30–50% 0.870 0.262 0.001 2.387 1.429–3.986     2
    <30% 1.102 0.461 0.017 3.010 1.218–7.436     3
Surgery of the thoracic aorta  2.115 0.549 0.000 8.287 2.825–24.305     8
Ventricular septal defect secondary to 
myocardial infarction 2.219 0.777 0.004 9.197 2.005–42.192     9
Chronic kidney disease classification       
    Classes 1–2   0.000   
    Class 3 0.995 0.263 0.000 2.704 1.615–4.527     3
    Classes 4–5 1.858 0.586 0.002 6.413 2.035–20.211     6
Number of procedures      
    1   0.000   
    2 0.736 0.306 0.016 2.089 1.146–3.807    2
    3–4 1.882 0.489 0.000 6.567 2.516–17.139    7
Constant -6.779 0.567 0.000 0.001  
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Figure 12.  Receiver operating characteristics curves of additive and logistic EuroSCORE 
and modified score in predicting 30-day postoperative mortality after adult cardiac surgery.
 
Such marginal superiority of the modified score shown by ROC analysis became 
much more evident when we compared observed and predicted 30-day mortality 
along different additive scores. In fact, EuroSCORE was associated with a major 
difference between  predicted and observed mortality, whereas the modified score 
provided predicted mortality rates much closer to those observed  (Figure 13).
Outcome prediction after isolated major procedures
The modified risk score performed somewhat better than EuroSCORE in predict-
ing 30-day mortality after isolated coronary artery bypass surgery (area under the 
ROC curve: additive modified score 0.818, 95%C.I. 0.759–0.876; logistic modi-
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Figure 13.  Observed and predicted postoperative mortality according to the logistic 
EuroSCORE and the logistic modified score in different additive modified score classes 
and additive EuroSCORE classes.
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fied score 0.819, 95%C.I. 0.761–0.877; additive EuroSCORE 0.781, 95%C.I. 0.710–
0.853; logistic EuroSCORE 0.785, 95%C.I. 0.714–0.855).
The modified risk score as well as EuroSCORE performed extremely well in 
predicting 30-day mortality after isolated aortic valve surgery (area under the ROC 
curve: additive modified score 0.946, 95%C.I. 0.898–0.993; logistic modified score 
0.964, 95%C.I. 0.932–0.997; additive EuroSCORE 0.908, 95%C.I. 0.844–0.971; 
logistic EuroSCORE 0.936, 95%C.I. 0.893–0.980). When both additive scores were 
divided into quartiles, mortality occurred only in the last quartiles, i.e. additive 
scores ≥ 8 (EuroSCORE: observed 30-day mortality 8.2%, mean expected mortal-
ity 15.9±9.9%; modified score: observed 30-day mortality, 6.6%, mean predicted 
mortality 5.3±6.9%).
The modified risk score also performed well in predicting 30-day mortality 
after mitral valve surgery (area under the ROC curve: additive modified score 
0.877, 95%C.I. 0.805–0.950; logistic modified score 0.907, 95%C.I. 0.850–0.964). 
EuroSCORE tended likewise to be a valid predictor of postoperative mortality after 
isolated mitral valve surgery (area under the ROC curve: additive EuroSCORE 
0.801, 95%C.I. 0.505–1.096; logistic EuroSCORE 0.832, 95%C.I. 0.605–1.058). 
Severe postoperative complications
Combined adverse end-point (30-day mortality, intensive care unit stay ≥ 5 days, 
stroke, postoperative use of intra-aortic balloon pump, and need for postopera-
tive dialysis) was observed in 383 patients (10.6%). Both risk scoring methods 
were good predictors of combined end-point (area under the ROC curve: additive 
modified score 0.782, 95%C.I. 0.760–0.807; logistic modified score 0.786, 95%C.I. 
0.762–0.810; additive EuroSCORE 0.748, 95%C.I. 0.722–0.774; logistic Euro-
SCORE 0.752, 95%C.I. 0.726–0.778).
Long-term outcome
The modified score had a somewhat better area under the ROC curve (additive: 
0.841, 95%C.I. 0.810–0.872; logistic: 0.849, 95%C.I. 0.818–0.879) tan the Euro-
SCORE (additive: 0.807, 95%C.I. 0.771–0.844; logistic: 0.815, 95%C.I. 0.780–0.851) 
in predicting overall mortality at 1 year. 
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Figure 14.  Kaplan-Meier estimates of overall survival after adult cardiac surgery according 
to quintiles of logistic modified score (A) and logistic EuroSCORE (B).
 
 
0.88-1.54%
4.30-7.48%
1.55-2.63%
0.53-1.06%
0.25-0.52%
0.11-0.24%
B p<0.0001
A p<0.0001
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According to Cox’s survival analysis, both scoring methods were good predic-
tors of all-cause late mortality (when both scoring methods were included in the 
regression analysis: additive modified score, R.R. 1.132, 95%C.I. 1.099–1.167; addi-
tive EuroSCORE, R.R. 1.091, 95%C.I. 1.055–1.129). Similar results were obtained 
when only operative survivors were included in the analysis. Figure 14 shows the 
Kaplan-Meier estimates of overall survival according to logistic modified score 
and the logistic EuroSCORE quintiles. 
Study vI
In-hospital postoperative mortality rate was 3.2% (129/4014). Stroke occurred in 
1.9%, low cardiac output syndrome in 4.0% and renal complications in 2.3% of 
these patients. Both EuroSCORE (AUC for additive EuroSCORE 0.81, 95%C.I. 
0.78–0.85, AUC for logistic EuroSCORE 0.82, 95%C.I. 0.79–0.85) and modified 
score (AUC for additive modified score 0.79, 95%C.I. 0.75–0.83, AUC for logistic 
modified score 0.79, 95%C.I. 0.75–0.83) performed well in predicting in-hospital 
mortality in this series (Fig. 15). These scoring methods were also predictors of 
postoperative stroke (logistic EuroSCORE: AUC 0.72, 95%C.I 0.67–0.77; logistic 
modified score: AUC 0.71, 95%C.I. 0.66–0.77), renal complications (logistic Euro-
SCORE: AUC 0.79, 95%C.I 0.74–0.84; logistic modified score: AUC 0.78, 95%C.I. 
0.74–0.83), and low cardiac output syndrome (logistic EuroSCORE: AUC 0.81, 
95%C.I 0.77–0.84; logistic modified score: AUC 0.76, 95%C.I. 0.72–0.80). 
The mean logistic EuroSCORE was 8.0±11.5% and the mean logistic modified 
score was 2.2±6.1%. Thus the observed to expected ratio for in-hospital mortality 
was 0.4 for logistic EuroSCORE and 1.5 for logistic modified score. The expected 
mortality rates as estimated by the logistic EuroSCORE and the logistic modified 
EuroSCORE are presented in Figure 16 along with increasing classes of additive 
scores with their related observed in-hospital mortality rates.
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Figure 15.  Receiver operating characteristics curves of additive and logistic EuroSCORE 
and modified score in predicting in-hospital mortality after adult cardiac surgery in patients 
included in Study VI.
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Figure 16.  Observed and predicted postoperative mortality according to the logistic 
EuroSCORE and the logistic modified score in different additive modified score classes 
and additive EuroSCORE classes.
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The observed to predicted ratio in high-risk patients (within the 90th percen-
tile of each risk algorithm) was 0.36 (13.2%/36.2% in 402 patients) for logistic 
EuroSCORE, whereas it was 0.99 (14.7%/14.9% in 395 patients) for logistic modi-
fied score. This indicates that the latter score predicted the in-hospital mortality of 
these high risk patients almost perfectly.
Figure 17 shows the observed and predicted mortality rates in patients under-
going isolated coronary artery bypass grafting, isolated aortic valve replacement 
and isolated mitral valve surgery.
Figure 17. Observed and predicted in-hospital mortality according to the logistic 
EuroSCORE and the logistic modified score in patients undergoing isolated coronary artery 
bypass grafting (CABG), isolated aortic valve replacement (AVR) and isolated mitral valve 
replacement/repair (MVR).
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Among 345 patients who underwent isolated aortic valve procedure, logistic 
EuroSCORE (AUC 0.65, 95%C.I. 0.53–0.77) and logistic modified score (AUC 
0.64, 95%C.I. 0.51–0.76) had somewhat smaller areas under the ROC curve than 
those obtained in the overall study population. Seventy patients had a logistic Euro-
SCORE >10% and their observed in-hospital mortality rate was 5.7%. Their related 
mean logistic EuroSCORE was 20.8%, whereas their mean logistic modified score 
was 3.7%. The related observed to predicted ratios for logistic EuroSCORE were 
0.3 and 1.5 respectively.
The observed to predicted ratio in high-risk patients (within the 90th per-
centile of each risk algorithm) undergoing  isolated aortic valve replacement was 
0.11 (2.9%/27.6% in 34 patients) for logistic EuroSCORE, whereas it was 0.44 
(2.9%/6.6% in 34 patients) for logistic modified score. 
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7 DISCUSSION
Knowing, and controlling of risks by all means is an essential part of medical prac-
tice. Concerning surgery, recognizing the risks connected to the individual patient, 
his/her illness, the planned surgical procedures and postoperative circumstances is 
an essential part of the treatment process. Identifying the individual risks enables 
the best tailored treatment possible for each patient, to an accurate calculation of 
individualized prognosis and to plan and allocate treatment resources. Therefore it 
is of the utmost importance that the evaluation of risks is as accurate as possible. It 
is equally important to know which risks are increasing with regard to each patient 
in order to minimize their effects by appropriate pre-, intra- and postoperative 
treatment. This is rendered more difficult by rapidly evolving surgical technology 
and a steadily increasing proportion of ageing and sicker people in patient materi-
als.
Within heart surgery, several risk scoring methods have been developed in 
recent decades. The most used algorithms predicting in-hospital mortality are the 
STS score, used in USA and the EuroSCORE, launched in 1999 in Europe. Both 
of these coprehensively screen for risk factors connected to the patient and his/
her heart condition and give an estimate of the in-hospital mortality risk for a 
planned procedure. Where the STS score is a continuously developing risk profile, 
updated by several centres and a steadily growing patient database, the additional 
EuroSCORE is essentially based on the original material of 19.000 patients oper-
ated on over ten years ago. Later on a more powerful tool, the logistic EuroSCORE 
was developed to predict  30-day mortality more accurately. Especially the additive 
EuroSCORE but also the logistic EuroSCORE have long been known to overesti-
mate  mortality in low-risk patients and to underestimate  mortality in very high- 
risk patients (Choong,C.K. 2009). Around the world, wide variations between 
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different institutions have been reported (Nashef,S.A. 2009). A more accurate 
risk evaluation would therefore necessitate a validation of each institute. Time is 
also already passing the original EuroSCORE. The most complex surgical proce-
dures and the growing significance of extracardiac diseases are underestimated. 
A planned procedure to update the EuroSCORE is ongoing in 2010 ( Nashef,S.A. 
2010).
7.1   Pulmonary function and outcome after cardiac surgery
Cardiac surgery by its very nature alters pulmonary and cardiac mechanics (Weiss-
man 1999). The effects related to median sternotomy, use of CPB, impaired  post-
operative cardiac function, and manipulation of the thoracic contents contribute 
to postoperative derangements of the pulmonary function with deterioration of 
the ventilatory capacity in the immediate postoperative period. Pulmonary com-
plications are believed to be mainly related to depressed postoperative cardiac 
function (Weissman 1999). In fact, postoperative low cardiac output leads to car-
diogenic pulmonary oedema as well as to severe muscle fatigue with secondary 
poor chest mobility, ineffective coughing and lack of deep breathing. These events 
are further complicated by the systemic inflammatory response related to surgery 
and the use of cardiopulmonary bypass (Paparella et al. 2002a), the lungs being the 
main target of this inflammatory response. Thus, it is not unexpected that patients 
with poor preoperative pulmonary function could experience adverse postopera-
tive outcome. It is therefore important to establish the impact of COPD on the 
postoperative outcome and to identify patients at highest risk of adverse events.
Clinically, COPD represents a broad spectrum of lung diseases often difficult 
to define, including emphysema, combined with various degrees of fibrosis, cystic 
fibrosis, bronchiectasia and components of asthma. It has both an obstructive and 
restrictive nature revealed with spirometry (The definition of emphysema, the 
report of a national heart, lung, and blood institute, division of lung diseases work-
shop, 1985). There is currently a proof on the systemic effects of COPD, which 
contribute to the poor prognosis of these patients (Agusti 2007). Several studies 
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have established that COPD is associated with low-grade systemic inflammation, 
which is partly independent of smoking (Sin et al. 2004). Such a systemic inflam-
mation is likely to be a major contributor in the pathogenesis of adverse effects of 
COPD including weight loss, skeletal muscle dysfunction, cardiovascular disease, 
depression and osteoporosis (Agusti 2007). Importantly, contrary to most of the 
risk factors contributing to adverse immediate and late outcome of patients under-
going adult cardiac surgery, COPD is to some extent a treatable disease. Sin and 
colleagues (Sin et al. 2004, Huiart et al. 2005) showed that corticosteroids signifi-
cantly reduced plasma levels of C-reactive protein in these patients. Interestingly, 
very low dose of inhaled steroids has been shown to reduce the risk of myocardial 
infarction in COPD patients ( Huiart,L. 2005). In the TORCH study (Towards a 
Revolution in COPD Health), the combined treatment with salmeterol and fluti-
casone reduced the risk of death by 17.5% in patients with moderate and severe 
COPD (Calverley et al. 2007). Furthermore, potential beneficial effects in terms of 
early and late survival with the use of angiotensin-converting enzyme inhibitors 
and statins have been reported in patients with COPD (Mancini et al. 2006, van 
Gestel et al. 2008). Other studies showed that preoperative pulmonary rehabilita-
tion improves outcome after CABG ( Rajendran et al. 1998, Hulzebos et al. 2006).
COPD has been considered generally by most of the operative risk scores, but 
its functional nature and severity have not been addressed by these models. Euro-
SCORE gives COPD a value of 1 point, the Cleveland score two points, taking no 
further consideration to the severity of this illness (Higgins et al. 1992b, Roques 
et al. 1999). Both evaluations are based on continuous medication, not grading of 
the disease. Our pulmonary function study on CABG patients (II) showed that 
GOLD classes of predicted FEV1 were associated with increased in-hospital mor-
tality rates (I: 1.2%, II: 1.8%, III: 6.5%, IV: 0% respectively, p=0,010) when total in-
hospital mortality in this material was 1.6%. Garcia Fuster et al. showed a similar 
tendency in a CABG material from Spain, where in-hospital mortality was corre-
spondingly: I: 0.9%, II: 0.4%, III: 10.8%, IV: 54%, total in-hospital mortality being 
3.1% (Fuster et al. 2006).  Depending on the severity of the pulmonary dysfunc-
tion, mortality can be very high. Therefore, a correct diagnosis of COPD and its 
severity (by paying attention to the continuous nature of COPD) are indispensable 
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in order to take better preoperative care of patients having diminished lung capac-
ity (Samuels et al 1998b, Medalion et al. 2004).
Patients undergoing cardiac surgery are changing to an increasingly higher 
risk profile: they are older and have several comorbidities. Traditional cardiac-
related risk variables such as left main stenosis and angina class are losing their 
predictive value in favour of extracardiac factors such as universal arteriosclerosis, 
chronic renal failure or COPD (Abramov et al. 2000, Grover et al. 1996, Garcia 
Fuster et al. 2005). Our modified EuroSCORE (V) increased the relative weight 
of both pulmonary and renal disorders by giving COPD 3 points (vs. 1 in Euro-
SCORE), and by classifying chronic renal failure as a continuous phenomenon 
much as COPD above.
Interestingly, in our AVR study (I) FVC, FEV1 or a history of pulmonary dis-
ease were not associated with postoperative pneumonia. On the other hand our 
CABG study (II) showed a clear association of FVC<70% (11.4%) and FEV1<70% 
(9.2%) with postoperative pneumonia. Garcia Fuster et al. had the same finding in 
their CABG series, where pneumonia and sepsis were particularly more frequent 
in moderate-severe COPD patients (18% and 11% respectively) (Garcia Fuster et 
al. 2005). The vulnerability of CABG patients could be associated with more vig-
orous manipulation of thoracic cage and increased prevalence of universal ASO 
(Ross 1999).
In our AVR study (I), only FVC was an independent predictor of stroke. 
FVC<80% was associated with a 6.9% risk of postoperative stroke vs. 1.9% among 
those patients with better FVC. Stroke rates for decreasing quartiles of FVC were 
1.6%, 1.7%, 3.9% and 7.1% (P=0.10) respectively. In the CABG study, FEV1 had 
also a certain association with postoperative stroke (Gold I: 1.7%, II: 3.4%, III: 
3.2%, IV: 0%, respectively, p=0.059). It has been observed that spirometric param-
eters could be a surrogate of extrapulmonary conditions associated with postop-
erative stroke. In fact, current evidence suggests that COPD itself has systemic 
effects which contribute to the poor prognosis of these patients (Agusti 2007). In 
this sense, the FEV1 and FVC values evauated here had the merit of identifying 
those patients with poor general conditions along with poor lung function. It is 
worth noting that this was independent of smoking habit.
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Despite the fact that FEV1 is generally considered one of the most impor-
tant parameters in the identification and staging of COPD, we observed in our 
CABG study (II) that FVC had a somewhat better prognostic value than FEV1. It 
is possible that heart failure related to coronary artery disease may have resulted 
in restrictive pulmonary changes (Johnson et al. 2001). This finding is supported 
by our AVR study (I), where we showed that low left ventricular ejection fraction 
correlates with FVC values more than with FEV1 values. 
In our CABG patients (II) ten year overall survival was 72.9%.  COPD had a 
significant impact on the long-term survival after isolated CABG. Patients with 
FVC<70% as well as those with pulmonary disease according to EuroSCORE cri-
teria had a significant reduction of overall survival rate at 10-year of 10% to 18% 
respectively. This effect seems to be independent of smoking habit.
The role of OPCAB in the treatment of COPD patients has not been deter-
mined. Cox et al. in 2000 showed that myocardial revascularization with or with-
out cardiopulmonary bypass caused a similar degree of pulmonary dysfunction, 
as assessed by alveolar-arterial oxygen gradient (Cox et al. 2000). They postulated 
that the deterioration in pulmonary gas exchange associated with cardiac sur-
gery is due to other factors than the use of CPB. On the other hand, Güler et al., 
while comparing conventional cardiopulmonary bypass to OPCAB or minibypass, 
observed that FEV1 acquired in the second postoperative month was significantly 
lower than the preoperative values only in the conventional perfusion group (Güler 
et al. 2001). Manipulation of the beating heart and twisting into the right chest to 
perform posterolateral anastomosis may be a key factor for diminished lung func-
tion after OPCAB surgery. As also shown by Staton et al., compared to CABG/
CPB, OPCAB was associated with a greater reduction in postoperative respiratory 
compliance (Staton et al. 2005). This may be in conjunction with the concomitant 
increased fluid requirements necessary to maintain haemodynamic stability.
Actually, mild COPD is well tolerated by both CABG and AVR patients. Mod-
erate to severe COPD, on the contrary,  is associated with several serious post-
operative complications including increased in-hospital mortality rates, stroke, 
need for intra-aortic balloon pump, need for postoperative de novo dialysis, neu-
ropsychological disturbances, atrial fibrillation, pneumonia, combined adverse 
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end point and length of stay in the intensive care unit (I–II). The results of Stud-
ies I–II suggest that preoperative pulmonary function testing could be beneficial 
in preoperatively identifying high-risk patients. The optimization of management 
in the preoperative, perioperative and postoperative periods may be the key to 
reduce the negative outcomes in the high-risk group (Samuels et al. 1998). This 
is of importance in light of recent studies showing improved outcome in patients 
undergoing pulmonary rehabilitation before CABG (Rajendran et al., 1998Hulze-
bos et al. 2006). The use of thoracic epidural anaesthesia may decrease post-oper-
ative morbidity after cardiac surgery, particularly in patients with compromised 
pulmonary function. However, reports are contradictionary and hence the use of 
TEA in high-risk cardiac patients remains controversial (Royse et al. 2003, Tenen-
bein et al. 2008, Popping et al. 2008).
7.2 Coronary artery bypass surgery in octogenarians
In Finland the number of individuals aged 80 years or over has increased 3-fold 
during the past 30 years and will increase even more in future decades. There is a 
growing demand for health care for this aged population. Fast developing technol-
ogy, including catheter-based techniques, has widened the limits of invasive care 
to fields where the risks and benefits so far are not established. Minimally inva-
sive surgery has enabledt treatment options for patients who earlier were beyond 
known surgical care. This has happened especially to aged people with several 
comorbidities. Age is an important but, at the same time, a most confusing risk 
factor as the ’biological’ variation within the same age group is greater than in 
younger people. On the one hand there is an octogenarian without any medica-
tion or known comorbidities, taking care of him/herself. On the other hand there 
is a geriatric patient with several illnesses, poor cardiac condition among them, 
requiring care on the ward. Selection criteria for invasive care in octogenarians 
have approached those in younger people, as seen in our material. Yet a number of 
old people are not referred to cardiac care because of lack of evidence-based crite-
ria for invasive care (Zingone et al. 2009). This introduces a referral and selection 
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bias among invasively treated octogenarians confusing the weight of age as a risk 
factor still further. Clearly, advanced age increases the operative risk.
 In our evaluation of the performance of EuroSCORE (IV), we increased the 
weight of aged people by categorizing age classes and giving six modified points 
beginning from the age of 80 years. Nevertheless, the performance of patients over 
80 years in our CABG study (III) is quite acceptable, also compared to other studies 
(30-day mortality 4.7%, 5-year survival 77%) (Alexander et al. 2000, Suojaranta-
Ylinen et al. 2006, Zingone et al. 2009). The 5-year survival  especially is surpris-
ingly good, 77%, among Finnish population where life expectancy for an 80-year 
old man is 7.6 years and for an 80-year old woman 9.4 years. (Tilastokeskus/Statis-
tics Finland). Contemporary literature shows an operative mortality between 2.7% 
and 6.4% for isolated CABG and a five-year life expectancy of 65% (Tugtekin et al. 
2007, Zingone et al. 2009, Maganti et al. 2009).
 A greater share of octogenarians was operated on urgently (because of recent 
myocardial infarction, unstable angina and critical preoperative status) compared 
to the younger patient group (III). This may influence the inferior primary out-
come after CABG compared to the propensity score-matched younger pairs. It 
is proposed that earlier referral and intervention is essential to improve results 
in this patient population (Kirsch et al. 1998). Despite the large and expanding 
elderly population presenting for ACS care, available evidence is limited and insuf-
ficient to guide management in this subgroup to the same degree of certainty as in 
younger populations (Alexander et al. 2007).
On the other hand, in elective patients we always considered the possibilities 
for preoperative rehabilitation in order to diminish the risk of perioperative com-
plications. We believe that this has a positive influence on the parallel long-term 
survival over five years compared to the propensity score-matched younger pairs. 
Also, intraoperative ultrasound was used to detect calcified aortas. Zingone et al. 
showed that postoperative complications were stronger risk factors for hospital 
deaths than preoperative comorbidities and procedural variables. Their impact 
on long-term survival was also significant (Zingone et al. 2009). As stated by 
David B. Ross in the invited commentary of this article: ”These patients will do 
well if the operation is meticulously performed and they can avoid complications. 
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Conversely, they do not recover as well as younger patients from misadventures”. 
Therefore, especially in this subgroup of older patients, avoiding complications is 
the main key factor both for immediate and for long term good outcome.
The most appropriate method of revascularization for this group of patients has 
not been determined. McKellar et al. performed a systematic review and a meta-
analysis of 66 studies of coronary revascularization in patients aged over 80 years 
comparing PCI vs. CABG. Thirty-day mortality and one year survival were similar 
(7.3% for CABG vs. 5.4% for PCI and 86% for CABG vs. 87% for PCI respectively) 
(McKellar et al. 2008). IMA grafting has been shown to improve primary and mid-
term survival, angina and the functional class of octogenarians. Operative mortal-
ity with or without IMA grafting (5% versus 10%, p = 0.11) and midterm survival 
with or without IMA grafting (70% versus 56% at 4 years, p=0.21), however, was 
not statistically significant (Moon et al. 2001). IMA was used in 65% of cases. In 
our series, at least one mammary graft was used in 80.3% of cases, which also may 
have positively influenced long term survival.
In terms of Health Related Quality of Life (HRQoL) octogenarians are also 
doing well. In Fruitman’s material 127 patients over 80 years old were operated 
on. SF-36 scores were equal to or better than those for the general population of 
age greater than 65 years. Of the survivors, 83.7% were living in their own homes, 
74.8% rated their health as good or excellent (Fruitman et al. 1999). Jensen made 
a sub-study of the randomized Best Bypass Surgery Trial comparing off-pump to 
on-pump treatment, with respect to peri- and postoperative mortality and mor-
bidity in patients with moderate to high-predicted preoperative risk. Both on-
pump and off-pump patients improved in health-related quality of life scores after 
CABG surgery. No clinically relevant difference between the groups could be dem-
onstrated (Jensen et al. 2006).
Atrial fibrillation, decline of neurocognitive functions, delirium, stroke, 
increased length of stay, and renal failure are common complications among eld-
erly people. In terms of these illnesses these people could benefit from OPCAB 
surgery. Avoiding CPB may reduce complications and diminish mortality related 
to CABG in older people.(Al-Ruzzeh et al. 2006, Guru et al. 2007, Ricci et al. 2001, 
Angelini et al. 2009, Athanasiou et al. 2004). Seniors are known to be very sensitive 
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to the side effects of the CPB and require increased resource utilization compared 
with younger patients (Scott et al. 2005). Recent literature comparing on- and off-
pump techniques in elderly is scarce and reflects the difficulty of enrolling these 
very fragile patients in prospective randomized studies of sufficient power (Cartier 
2009). Nevertheless, a few of them demonstrate the potential benefit of avoiding 
CPB in elderly population (Athanasiou et al. 2004, Panesar et al. 2006, Kerendi et 
al. 2008).
The elderly with ACS have a high risk of death and adverse events. Thereby 
they often have greater absolute treatment benefits than do younger patients. If 
cardiac surgery is increasingly carried out safely on aged people with acceptable 
results, the effect of cardiac intervention on subjectively experienced health related 
quality of life will perhaps be more important than its effect on longevity alone 
(Jokinen et al. 2010). The greatest improvement in HRQoL occurs in patients with 
the poorest preoperative cardiac-symptoms-related HRQoL, whereas patients with 
relatively good HRQoL derive less benefit (Rumsfeld et al. 2004). Despite the large 
and expanding elderly population presenting for ACS care, existing evidence is 
limited and insufficient to guide management in this subgroup to the same degree 
of certainty as in younger populations (Alexander et al. 2007). 
7.3   Duration of aortic cross-clamping and cardiopulmonary bypass
Cardiopulmonary bypass time (CPBT) has been shown to be associated with 
enhanced systemic inflammatory response (Khabar et al. 1997, Whitten et al. 1998, 
Paparella et al. 2002b) and increased morbidity and mortality after pediatric and 
adult cardiac surgery (Kang et al. 2004, Salis et al. 2008). Our study (IV) confirms 
that the longer the aortic cross clamp time (XCT) and CPBT the worse their detri-
mental effects will be. Naturally, long XCT and CPBT reflect the complexity of the 
procedure and  hence also the preoperative condition of the patient and the heart. 
When categorizing the procedures as isolated, double or a combination of three to 
four procedures, we saw  mortality increase from 1.7 % – 5.4 % – 25 %. Accord-
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ingly, both XCT and CPBT increased 2.5-fold from simple to the most complex 
procedures.
 Myocardial protection is of paramount importance when XCT increases. 
During warm blood cardioplegia, Onorati et al. found that 6.9% of their CABG 
patients had Troponin I  greater than 3.1 μg/L at 12 hours which correlated with 
lower in-hospital and follow-up survival after one year and lower freedom from 
cardiac events. Aortic cross-clamp time greater than 90 minutes and cardiopul-
monary bypass time greater than 180 minutes were independent predictors of 
myocardial damage in multivariate analysis (Onorati et al. 2005). The negative 
impact of myocardial ischaemia, long duration of cardiopulmonary bypass, tech-
nical demands of the operation and the patients individual characteristics are an 
entity where individual co-factors are difficult to discern.  Myocardial protection 
has unequivocally been the same throughout our whole series, though perfusion 
techniques have varied somewhat within our material. With these limitations in 
mind we attempted to estimate the adverse effects of prolonged XCT and CPBT 
and observed in our material that if cardiopulmonary perfusion time is kept under 
240 minutes and aortic cross clamp time under 150 minutes, cardiac surgery can 
be performed with a fairly low risk of postoperative mortality and morbidity, inde-
pendent of the patients’ operative risk and the complexity of the procedure. 
Also, when adjusted for additive EuroSCORE, XCT and CPBT were independ-
ent predictors of 30-day mortality among patients who underwent complex proce-
dures. CPBT was a much stronger predictor of 30-day mortality than XCT, which 
may reflect the critical condition of the patient, technical difficulties during the 
operation or suboptimal myocardial protection.
Our study also confirms the impact of XCT and CPBT on postoperative mor-
bidity as shown in Figure 10. The strong correlation between postoperative stroke 
and XCT, and especially CPBT, is particularly interesting. CPBT has been shown 
by other authors to increase the risk of stroke (Hogue et al. 1999, Bucerius et al. 
2003b). Bucerius, in a material of over 16,000 patients from Leipzig, showed that 
CPBT>2 hours was an independent risk factor for stroke. Further, Hogue in a 
material of nearly 3,000 patients showed that duration of cardiopulmonary bypass 
was independently associated with early stroke.
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Both XCT and CPBT correlated significantly with the number of transfused 
red blood cell units, the number of transfused homologous blood products, time 
to extubation and length of stay in intensive care unit.
While short XCT and CPBT are associated with very low risk of postoperative 
adverse events, prolonged XCT and CPBT on the other hand do not automatically 
indicate a poor prognosis. Markedly long XCT and CPBT did not univocally result 
in postoperative mortality. Even in complex procedures, where XCT was >150 
min, but CPBT still <240 min, the mortality rate was not higher than 6.2%. Only 
when XCT was >150 min and  CPBT exceeded 240 minutes, did mortality rise to 
30%. Noteworthy still, 70% of these high-risk patients survived. Thus although 
these cutoff values (XCT>150 min, CPBT>240 min) have a high accuracy (over 
90%), they have a rather low sensitivity and very low predictive value in identify-
ing poor outcomes.
7.4   Application of risk adjustment models
Outcomes frequently considered include mortality, morbidity, critical events, 
resource utilization, costs, functional status postoperatively, and patient satisfac-
tion (e.g. in terms of quality of life). There are variable practices on which data 
should be routinely collected, how individual variables should be defined and how 
defined outcomes should be risk-stratified. Individual variables can be either natu-
rally complex, poorly defined or both, such as the complexity of the operation, 
unstable angina, extracardiac arteriopathy and pulmonary disease (V). By accu-
rately identifying the high-risk patient, it may be possible cost-effectively to alter 
and focus therapy on selected patients or patient groups and thereby reduce risk.
7.4.1   Mortality
Mortality is an outcome measure that is universally reported. The advantages of 
mortality as an outcome measure include lack of ambiguity and availability of 
mortality data from a variety of sources, including national databases. The limita-
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tions of mortality as a sole outcome measure are particularly evident in cardiac 
surgery, where unadjusted mortality figures can vary in a range from 2.0% to 4.5% 
(Higgins et al. 1992c, Edwards et al. 1994a). Mortality also does not accurately 
reflect costs, because early death results in a lower cost than prolonged hospitaliza-
tion and treatment of various complications. Short-term mortality is thus probably 
not by itself an adequate indicator of resource use or quality of care.
Caution must be exercised when applying scoring systems to individual 
patients, because the score produces a probability of death, but the fate of an indi-
vidual is binary: the patient either survives or dies. Probabilities are not predic-
tions and scoring systems alone cannot be used to define operability because there 
is no level of preoperative risk that always is associated with poor outcome (Hig-
gins 1998).
Long-term mortality, probably the most useful outcome, is rarely assessed, 
essentially because of the difficulty of following up patients over a long period of 
time. It certainly should be a priority for future research in risk modelling. (Kolh 
2006). In this regard, the findings by Nilsson et al. that some risk stratification 
models, such as EuroSCORE, can predict 1-year mortality, are potentially impor-
tant, but require further validation.(Nilsson et al. 2006)
7.4.2   Morbidity
Morbidity is a more attractive endpoint for analysis, because it constitutes the 
major determinant of hospital cost and quality of life after surgery. Being more 
frequent than mortality, it could provide more information and be measured in 
terms of postoperative complications and length of hospital stay. However, for 
most scoring models, predictive values for morbidity are considerably lower than 
predictive values for mortality. Various algorithms have been developed to predict 
postoperative renal insufficiency or failure, delayed extubation and length of stay 
in the ICU (Wong et al. 1999, Suematsu et al. 2000,  Nilsson et al. 2004a, Mehta et 
al. 2006).  There would also be interest in using these models for resource planning 
and prediction of costs.
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Earlier studies have implied that preoperative risk factors may be used to pre-
dict costs of cardiac surgery (Smith et al. 1997, MaWhinney et al. 2000). The addi-
tive EuroSCORE model has good discriminatory power and accuracy for an ICU 
stay longer than 2 days (Nilsson et al. 2004a). It appears that patients requiring 
prolonged ICU stay tend to have more unstable angina, left ventricular dysfunc-
tion, pulmonary hypertension and extracardiac arteriopathy. Previous cardiac sur-
gery and emergency operations also contribute to extended ICU stays (Messaoudi 
et al. 2009). Other risk factors not included in the EuroSCORE have also recently 
been investigated. Hypertension, atrial fibrillation, smoking, increased body mass 
index, diabetes and hypercholesterolemia have been shown to be strong predictors 
for prolonged ICU stay following cardiac surgery (Ghotkar et al. 2006, Bucerius 
et al. 2004). Intraoperative factors like prolonged operation and perfusion times, 
IABP-support and intraoperative hemofiltration are also independent predictors 
of prolonged ICU stay, while OPCAB and MIDCAB procedures seem to be asso-
ciated with lower prevalence of prolonged ICU stay (Bucerius et al. 2004). A pro-
longed ICU stay is much more dependent on patient’s preoperatvive characteristics 
and intraoperative events than a prolonged preoperative stay on the ward. Besides 
the costs of the operation itself, the costs of the ICU care are most dominant and 
a specific risk algorithm for the prediction of ICU stay would be useful, both from 
an economic standpoint and for rational planning of weekly resources.
Continuous development of specific morbidity risk scores could improve out-
come and hospital cost prediction. Furthermore, because of the heterogeneity of 
morbidity events, future scoring systems should probably generate separate pre-
dictions for mortality and morbidity events.
Patient satisfaction is another outcome measure that requires substantial effort 
to collect, but should be highly valued by health care professionals.
7.5   Evaluation of risk scoring
Several risk scoring methods have been developed and employed during the last 
two decades to stratify the risk of cardiac surgical patients. Among these, the Euro-
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pean system for cardiac operative risk evaluation (EuroSCORE) has been shown to 
be a fairly reliable and simple method to predict both immediate and late mortality 
(Biancari et al. 2006, Toumpoulis et al. 2005, Nilsson et al. 2006). 
The additive EuroSCORE model has been shown to work satisfactorily to pre-
dict 30-day mortality in many European countries (Roques et al. 2000) and in the 
United States (Nashef et al. 2002) and compares favourably with the Society of 
Thoracic Surgeons’ (STS) risk score (Nilsson et al. 2004b). Nilsson in 2006 com-
pared 19 commonly used cardiac surgical risk scores with regard to their validity 
in a single institution patient population (Nilsson et al. 2006). The results showed 
that four of the algorithms had superior performance and accuracy to the other 
15 algorithms in predicting 30-day and 1-year mortality. The logistic and additive 
EuroSCORE outperformed the rest of the algorithms, Cleveland and Magovern 
scales following next. 
However, at least the original additive EuroSCORE model constructed in 1999 
tends to overpredict the mortality risk in lower risk groups (Geissler et al. 2000, 
Asimakopoulos et al. 2003, Gogbashian et al. 2004b, D’Errigo et al. 2008, Brown et 
al. 2008). On the other hand, the additive model seems to underestimate mortality 
in high-risk patient groups (Roques et al. 2003a, Michel et al. 2003a, Gogbashian 
et al. 2004a).  The later (2003) constructed logistic EuroSCORE is more accurate in 
predicting mortality, especially in high-risk patients (Roques et al. 2003a, Michel 
et al. 2003a) but requires computerized analysis. In high-performing centres and 
countries even the logistic EuroSCORE has a tendency to overpredict the mortal-
ity (Bhatti et al. 2006, D’Errigo et al. 2008, Yap et al. 2006, Zheng et al. 2009). In the 
United Kingdom cardiac surgical mortality is currently running at approximately 
0.6 of EuroSCORE prediction, the Italian CABG outcome project generated a 
coefficient of 0.4. The same finding was made in our study (V) where, especially in 
high-risk groups, the logistic EuroSCORE tended to overestimate mortality. Esti-
mation of the individual risk of patients undergoing cardiac surgery is difficult also 
due to the complex nature of surgical, anaesthesiologic and any related periopera-
tive treatment. Individual comorbidities (possibly not included in risk stratifica-
tion models), variations in case mixes and development of new techniques in car-
diac surgery (such as catheter-based and minimally invasive techniques) further 
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complicate precise risk analysis. Comparison between institutions is also difficult 
because of different case mix and various risk profiles between materials (Zheng et 
al. 2009, Choong et al. 2009). An institutionally corrected estimate can be made by 
quoting a predicted mortality = patient logistic EuroSCORE x hospital mortality / 
hospital logistic EuroSCORE. This coefficient gives a more realistic picture of the 
performance of a particular institute, also where strict universal restrictions are in 
place for certain operations. For example, if the criterion for including a patient for 
a transcatheter aortic valve operation is a calculated logistic EuroSCORE of 20%, 
the true limit of performance of the institute is 20% divided by the coefficient of 
the particular institute. However, reliance on a risk stratification model that over-
predicts mortality may have serious consequences, because it leads to a false sense 
of confidence, underperformance may go undetected, and patient welfare may be 
compromised. 
The environment in which cardiac surgery is performed is changing drastically. 
This evolution has been driven by continuously evolving surgical and anaesthetic 
skills, development and spread of interventional cardiology, off-pump coronary 
bypass surgery, catheter-based interventions and minimally invasive, robotically 
assisted and hybrid cardiac procedures for cardiac disease. Thus, the majority of 
data used to generate the existing risk stratification systems for cardiac surgery 
predates many of the newer surgical techniques. Patients referred for cardiac sur-
gery nowadays have extensive coronary disease, associated valvular diseases, are 
older, and have a greater burden of both cardiac and non-cardiac comorbidities. 
What this has done and will continue to do to the outcomes of cardiac surgery is a 
matter of great debate and has escaped the frames of conventional risk models. At 
the present time it is possible to operate on patients with very poor left ventricles 
with EF 20%–25%. However, existing models give no extra weight for left ventricu-
lar performance <30%–40%, depending on the individual algorithm. EuroSCORE 
gives the same risk for an individual coming for an aortic valve operation com-
pared to a patient scheduled for a combination of CABG and mitral valve opera-
tion, not to mention an operation including double-valve surgery combined with 
a CABG, which still has the same risk estimate. 
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7.6   Modified EuroSCORE
We attempted to modify the EuroSCORE in order to preserve all the positive 
aspects inherent in it. The accuracy was increased by more precise classification of 
some heavy risk factors such as renal and pulmonary insufficiency, and complex-
ity of the procedure. Our study (V) confirmed that even the simplified version of 
the modified EuroSCORE could estimate the operative risk for cardiac surgical 
patients fairly accurately. This was accordingly successfully validated with cardiac 
surgical material from Tampere (VI). The accuracy of the modified score was par-
ticularly obvious in high-risk patients defined as those included in the 90th per-
centile of this algorithm. In our regression model, some EuroSCORE variables 
such as emergency surgery, recent myocardial infarction and nitrate-infusion on 
arrival in the operating theatre were not predictive of adverse outcome. This can be 
explained by the subjective nature and the influence of logistic factors in defining 
these variables. On the other hand, it reflects the diminishing weight of these con-
ditions as risk factors, and the increasing weight of risk being loaded on various 
extracardiac comorbidities of the individual patient.
7.7   Future aspects of risk calculation
Of all the risk algorhitms available to day, only the STS database is continuously 
developing with material collected. Among other older models, EuroSCORE, 
developed more than 10 years ago, begins now to be out of date. Changes in 
patient characteristics, medical care, and the surgical and anaesthetic spectrum 
have exceeded the limits set by the initial EuroSCORE. This year, several units 
within and beyond Europe are participating in data collection aiming to derive an 
updated risk stratification model.
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7.8   Limitations of the study
The present patient material was collected prospectively. Only EuroSCORE values 
were retrospectively calculated for those patients operated on before the launch of 
the EuroSCORE in 1999. However, the analysis of this material is retrospective. 
This is also a single institution database having, however, the power of homogene-
ity in terms of anaesthesia, surgical techniques and protection of the heart.
Another limitation of the study is the long time period of data collection and 
analysis (14 years); changes especially in patient population are quite evident dur-
ing the study period.
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8 SUMMARY AND CONCLUSIONS
These studies suggest that pulmonary disease is an important risk factor leading 
to markedly increased in-hospital and long-term mortality after adult cardiac sur-
gery. Despite the fact that FEV1 is generally considered one of the most important 
parameters in the identification and staging of COPD, we have observed here that 
FVC had a somewhat greater prognostic significance than FEV1.
Immediate and five-year survival of octogenarians undergoing CABG can be 
better than previously expected. Survival of octogenarians may be lower during 
the first months after cardiac surgery, after which, during the following five years, 
the life expectancy may not differ much from that of younger patients with other-
wise similar operative risks.
With current methods in adult cardiac surgery, cardiac procedures with aortic 
cross-clamp time less than 150 minutes and cardiopulmonary bypass time less 
than 240 minutes are associated with a fairly low risk of immediate postoperative 
events. It seems that long cardiopulmonary bypass time is a more important pre-
dictive factor than long aortic cross-clamp time.
Modified EuroSCORE derived from adult cardiac surgical material from Vaasa 
Central Hospital and validated with a material from Tampere University Hospital, 
proved to be a more accurate risk scoring method in the immediate postoperative 
period than the traditional EuroSCORE. This improvement could be achieved by 
modifying a few of EuroSCORE variables and distributing more weight on param-
eters which in the light of current knowledge are of increasing importance.
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Pulmonary Function and Immediate Outcome of
Patients Undergoing Aortic Valve Replacement
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Patients with severe chronic obstructive pulmonary
disease (COPD) are known to be at increased risk of
mortality and morbidity (1), and this is particularly
true when they undergo major surgery (2).
Although, several risk-scoring methods include pul-
monary disease as a major determinant of mortality
after adult cardiac surgery (3-5), the adverse role of this
condition has not been recognized in many other major
risk-scoring methods (6-9). Whilst COPD has been
shown to predict the immediate outcome after coro-
nary artery bypass surgery (CABG) (10,11), in patients
undergoing aortic valve replacement (AVR) there is less
evidence of any impact of pulmonary disease on the
immediate postoperative outcome. A recent extensive
systematic review of the prognostic factors in patients
undergoing AVR failed to identify pulmonary disease
as a risk factor for early mortality (12).
The aim of the present study was to evaluate
whether pulmonary disease, as assessed by spirome-
try, had any impact on the immediate outcome after
AVR, with or without CABG.
Clinical material and methods
Patients
A total of 453 patients who underwent spirometry
immediately before AVR surgery, with or without
CABG, at the Vaasa Central Hospital, Vaasa, Finland,
between January 1996 and June 2008, was included in
the study. Patients who underwent any other concomi-
tant heart valve operation, as well as surgery on the
ascending aorta, were excluded from the analysis.
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Background and aim of the study: The study aim was
to evaluate whether pulmonary function, as assessed
by spirometry, affects immediate outcome after aortic
valve replacement (AVR).
Methods: Data relating to the preoperative percent-
ages of predicted forced vital capacity (FVC) and
forced expiratory volume in 1 s (FEV1) were retrieved
from a series of 453 patients who underwent AVR,
with or without coronary artery bypass surgery.
Results: The percentage of predictive FVC (odds ratio
(OR) 0.952; 95% CI 0.914-0.990; AUC 0.749; p = 0.019),
but not of predicted FEV1, nor any history of pul-
monary disease, proved to be independent predictors
of in-hospital mortality, even when adjusted for the
logistic EuroSCORE. A percentage predictive FVC of
<80% proved to be the best cut-off (in-hospital mor-
tality 6.3% versus 1.3%; p = 0.005; OR 5.100; 95% CI
1.544-16.849; specificity 69%, sensitivity 69%). The
percentage of predictive FVC was found to be an
independent predictor of stroke (OR 0.956; 95% CI
0.923-0.989; p = 0.009). Patients with a percentage of
predictive FVC <80% had a risk of postoperative
stroke of 6.9% versus 1.9% among those patients with
better FVC values (OR 3.769; 95% CI 1.342-10.581; p =
0.012). Patients with a percentage of predictive FVC
<80% (10.4% versus 4.2%; OR 2.648; 95% CI 1.225-
5.724; p = 0.011) and a history of pulmonary disease
(13.1% versus 5.1%; OR 2.808; 95% CI 1.117-6.694; p =
0.016) had a significantly higher risk of an intensive
care unit stay of five or more days. Postoperative
pneumonia was not associated with either spiromet-
ric parameters, nor with any history of pulmonary
disease.
Conclusion: Pulmonary disease, as indicated by
decreased preoperative values of FVC and FEV1, is an
important comorbidity factor in patients undergoing
AVR surgery. Further studies are required to demon-
strate whether the identification and treatment of
these patients could improve their outcome after AVR.
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The patient data were collected prospectively into an
institutional cardiac surgery database. Spirometry was
performed preoperatively in all patients; the percent-
ages of predicted forced vital capacity (FVC) and of
predicted forced expiratory volume in 1 s (FEV1) were
calculated according to normal values of the Finnish
population, as reported by Viljanen and colleagues (13).
As spirometry is performed routinely before cardiac
surgery at the authors’ institution, none of the patients
was asked to consent to participate in the study; nei-
ther was approval sought from the Institutional ethics
committee to conduct the study, as it represents a
review of the authors’ clinical experience.
Anesthesia
In the majority of patients a combined general anes-
thesia was utilized, but thoracic epidural anesthesia
was used (at the discretion of the anesthesiologist) in
patients with anticipated pulmonary or other signifi-
cant risks. Fentanyl (3-3.5 μg/kg) and propofol (0.8-2
mg/kg) were administered intravenously to induce
anesthesia, followed by a continuous infusion of
propofol (1-2 mg/kg/h). Pancuronium (0.10 mg/kg)
was administered as a muscle relaxant. Clonidine (1.5-
2 μg/kg) was given as a slow intravenous bolus dose
to induce anesthesia in patients without thoracic
epidural anesthesia. All patients were ventilated with
oxygen in air (FiO2 = 0.4-0.5), supplemented with
isoflurane or sevoflurane.
For cardiopulmonary bypass (CPB), a membrane
oxygenator (Dideco Compactflo; Dideco S.p.A.,
Mirandola, Italy) fitted with a non-pulsatile pump flow
by means of a Stöckert roller pump (CAPS or SIII;
Stöckert GMBH, Munich, Germany) was used, with a
systemic temperature drift down to 32-34°C. A 40 μm
arterial line filter (D734; Dideco S.p.A.) was included in
the CPB circuit. Although, between 1996 and 2002, con-
ventional non-coated PVC tubing was used, since 2002
a phosphorylcholine-coated bypass circuit (Ph.I.S.I.O.;
Dideco S.p.A.) has been used routinely by the present
authors. Blood cardioplegia was utilized for cardiac
protection in all cases. Cardiac arrest was initiated with
a bolus dose of K/Mg-cardioplegia concentrate solu-
tion, administered via a warm (35-37°C) mixture of a
moderately hyperkalemic 5% glucose solution and oxy-
genated blood infused into the aortic root, at a ratio of
1:8. The mixture was cooled to approximately 30°C
after cardiac arrest, and administered thereafter as a
continuous antegrade/retrograde infusion directly into
the coronary ostia and/or through the coronary sinus,
and into the venous grafts. Before declamping the aorta
the blood cardioplegia was warmed to 35-37°C and
infused for 4-5 min. The target activated clotting time
was ≥600 s, due to the use of a moderate dose of apro-
tinin (2.5-4×106 units per patient).
Surgical technique
Surgery was undertaken via a median sternotomy.
All procedures were prosthetic valve implantations,
with the valve type being selected in consensus with
the patient. The normal ‘dividing point’ between
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Table I: Preoperativea and operative data for patients who
underwent aortic valve replacement with or without
coronary artery bypass surgery.
Variable Value
Age (years) 69 ± 11
Female gender (n) 186 (41)
Body mass index (kg/m2) 28±5
Percentage of predicted FEV1 88 ± 17**
Percentage of predicted FVC 82 ± 18**
History of smoking (n)b 115 (23)
Current smoker (n)b 36 (8)
Pulmonary disease (n)c 61 (14)**
Diabetes (n) 70 (16)
Serum creatinine (mol/l) 90 ± 41
Cerebrovascular disease (n) 37 (8)*
Neurological dysfunction (n) 3 (1)
Myocardial infarction <3 months (n) 17 (4)
Extracardiac arteriopathy (n) 23 (5)
Previous vascular/endovascular surgery (n) 11 (2)
Previous cardiac surgery (n) 18 (4)
LVEF (%) 54 ± 11
Unstable angina pectoris (n) 6 (1)*
Critical preoperative status (n) 6 (1)
Active endocarditis (n) 7 (2)
PASP >60 mmHg (n) 14 (3)
Emergency operation (n) 3 (1)
Indication for surgery (n)
Aortic valve stenosis 281 (62)
Aortic valve regurgitation 64 (14)
Combined aortic valve disease 98 (22)
Other 10 (2)
Additive EuroSCORE 6 ± 3**
Logistic EuroSCORE (%) 7 ± 8**
Coronary artery bypass surgery (n) 224 (49)
No. of distal anastomoses 2.8 ± 1.4
No. of proximal anastomoses 1.7 ± 0.9
Aortic cross-clamp time (min) 111 ± 37
Cardiopulmonary bypass time (min) 144 ± 51*
___________________________________________________
Continuous variables are reported as mean ± SD (unless
otherwise indicated).
Values in parentheses are percentages.
aDefinition criteria for preoperative variables are according
to EuroSCORE.
bData missing from 18 patients.
cClassified as use of bronchodilators or steroids for
COPD/asthma.
*p <0.05; **p <0.01; p-values refer to univariate analysis for
prediction of in-hospital mortality.
LVEF: Left ventricular ejection fraction; PASP: Pulmonary
artery systolic pressure.
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employing a mechanical or a biological valve was a
patient age of 70 years.
The clinical and operative data are summarized in
Table I; variables were categorized according to the
EuroSCORE criteria (5). The operative risk has been
estimated according to the EuroSCORE scoring
method criteria (5), while pulmonary disease was clas-
sified according to the use of bronchodilators or
steroids for the treatment of COPD/asthma.
The in-hospital mortality was considered to be the
main outcome measure; other outcome end-points are
listed in Table II.
Statistical analysis
All statistical analyses were performed using SPSS
statistical software (v. 14.0.1; SPSS Inc., Chicago, IL,
USA). Continuous variables were reported as mean ±
SD. Pearson’s chi-square test, Fisher’s exact test and
the Mann-Whitney U-test were each used for the uni-
variate analysis. A receiver operating characteristics
(ROC) curve was used to estimate the predictive value
of the continuous variables. Spearman’s test was used
to estimate the correlation of continuous variables.
Logistic regression with backward selection was used
for multivariate analysis. Variables with a p-value
<0.05 at univariate analysis were included into the
regression model. A p-value <0.05 was considered to
be statistically significant.
Results
Spirometry parameters
Patients undergoing AVR with CABG had similar
spirometry parameters as those undergoing isolated
AVR. The percentage predicted FVC (rho = 0.125, p =
0.009) and percentage predicted FEV1 (rho = 0.113, p =
0.012) correlated with the preoperative left ventricular
ejection fraction (LVEF). Similarly, these parameters
were associated with EuroSCORE LVEF classes (p =
0.005 and p = 0.05, respectively). Interestingly, a LVEF
<50% was significantly associated with the percentage
predicted FVC <80% (30.6% versus 15.5%, p <0.0001),
but not the percentage of predicted FEV1 <75% (24.7%
versus 18.1%, p = 0.11).
As expected, the percentages of predicted FEV1, but
not of predicted FVC (p = 0.11 and p = 0.097, respec-
tively), were significantly lower among patients with
history of smoking (74.7 ± 16.8% versus 84.3 ± 18.1%, p
<0.0001) and current smokers (69.9 ± 13.6% versus 82.8
± 18.3%, p <0.0001).
The percentages of predicted FVC and FEV1 did not
correlate with the CPB time.
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Figure 1: Observed in-hospital mortality rates according to
quartiles of percentages of the predicted FVC and of the
predicted FEV1.
Table II: Postoperative outcome.
Clinical end-point Value
In-hospital mortality (n) 13 (3)
30-day mortality (n) 12 (3)
Resternotomy (n) 48 (10)
Mediastinitis (n) 3 (1)
Stroke (n) 16 (4)
Stroke or TIA 20 (4)
Intra-aortic balloon pump (n) 7 (2)
Acute renal failure requiring 2 (1)
dialysis (n)
Delirium (n) 47 (10)
Atrial fibrillation (n) 245 (54)
Extubation time (h)* 8 ± 17
Reintubation (n) 21 (5)
Pneumonia (n) 35 (8)
Intensive care unit stay (days)* 2 ± 3
Intensive care unit stay ≥5 days (n) 28 (6)
*Continuous variables are reported as mean ± SD.
Values in parentheses are percentages.
TIA: Transient ischemic attack.
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Pulmonary disease and in-hospital mortality
The immediate outcome end-points are summarized
in Table II. When all variables listed in Table I which
had a p-value <0.05 at univariate analysis were includ-
ed into the regression analysis, the percentages of pre-
dicted FVC (OR 0.952; 95% CI 0.914-0.990; p = 0.019),
unstable angina pectoris (OR 12.981; 95% CI 1.618-
104.126; p = 0.016) and CPB duration (OR 1.010; 95% CI
1.004-1.102; p = 0.001) were independent predictors of
in-hospital mortality. These variables remained inde-
pendent predictors even when the logistic EuroSCORE
was included into the logistic regression analysis. The
percentages of predicted FVC (AUC 0.749; 95% CI
0.632-0.866; p = 0.002) and of the predicted FEV1 (AUC
0.723; 95% CI 0.591-0.854; p = 0.003) had satisfactory
areas under the ROC curve. The best cut-off value for
the percentage of predicted FVC was 80% (in-hospital
mortality 6.3% versus 1.3%; p = 0.005; OR 5.100; 95%
CI 1.544-16.849; specificity 69%, sensitivity 69%) and
for the percentage of predicted FEV1 was 75% (in-hos-
pital mortality 5.2% versus 1.7%; p = 0.04; OR 3.233;
95% CI 1.039-10.056; specificity 67%, sensitivity 62%).
A history of pulmonary disease was also associated
with an increased risk of in-hospital mortality (9.7%
versus 1.8%; OR 5.893; 95% CI 1.911-18.167; p = 0.004).
However, even when the percentage of predicted FVC
<80% and of predicted FEV1 <75% were included into
the regression analysis, only the percentage of predict-
ed FVC was, again, an independent predictor of
adverse outcome. The mortality rates of different quar-
tiles of percentages of the predicted FVC and FEV1 are
shown in Figure 1.
Impact of pulmonary disease on the other outcome
end-points
The percentage of predicted FVC was significantly
associated with postoperative stroke (p = 0.008), but
neither the percentage of predicted FEV1 (p = 0.21) nor
any history of pulmonary disease (p = 0.25) were asso-
ciated with this complication. When adjusted for cere-
brovascular disease, neurological dysfunction,
redo-surgery, CPB time and aortic cross-clamp time
(which were significantly associated with postopera-
tive stroke at univariate analysis), only the percentage
of predicted FVC was found to be an independent pre-
dictor of stroke (OR 0.956; 95% CI 0.923-0.989; p =
0.009). A percentage of the predicted FVC <80% was
associated with a risk of postoperative stroke of 6.9%
versus 1.9% among those patients with better FVC val-
ues (OR 3.769; 95% CI 1.342-10.581; p = 0.012). Stroke
rates for decreasing quartiles of percentage of the pre-
dicted FVC were 1.6%, 1.7%. 3.9% and 7.1% (p=0.10),
respectively. Similarly, the percentage of predicted
FVC was significantly associated with stroke and/or
transient ischemic attack (Mann-Whitney U-test: p =
0.008; for 80% cut-off value: 8.3% versus 2.6%, p =
0.006, OR 3.420, 95% CI 1.366-8.536, p = 0.006).
Interestingly, the percentages of predicted FVC and
of predicted FEV1, and a history of pulmonary disease,
were not associated with postoperative pneumonia,
which otherwise was significantly associated with
extracardiac arteriopathy (p = 0.025), CPB time (p =
0.004) and aortic cross-clamp time (p <0.0001).
The percentages of predicted FVC (rho: -0.139, p =
0.003) and of predicted FEV1 (rho: -0.093, p = 0.050)
were negatively correlated with extubation time,
although the correlation coefficients were rather small.
Only the percentage of predicted FVC correlated with
the length of stay in the intensive care unit (rho: -0.127,
p = 0.007). The percentage of predicted FVC <80%
(10.4% versus 4.2%, OR 2.648, 95% CI 1.225-5.724, p =
0.011) and a history of pulmonary disease (13.1% ver-
sus 5.1%, OR 2.808, 95% CI 1.117-6.694, p = 0.016) were
significantly associated with a higher risk of intensive
care unit stay of five or more days.
Discussion
Cardiac surgery, by its very nature, alters both pul-
monary and cardiac mechanics (14). The effects related
to median sternotomy, the use of CPB, depressed post-
operative cardiac function, and manipulation of the
thoracic contents, each contribute to postoperative
derangements of pulmonary function. Pulmonary
complications are believed to be mainly related to
depressed postoperative cardiac function (14). In fact,
a postoperative low cardiac output leads to cardio-
genic pulmonary edema, as well as to severe muscle
fatigue with secondary poor chest mobility, ineffective
coughing and lack of deep breathing. These events are
further complicated by the systemic inflammatory
response related to surgery and the use of CPB (15), the
lungs being the main target of this inflammatory
response. Thus, it is not unexpected that patients with
a poor preoperative pulmonary function would expe-
rience an adverse postoperative outcome.
The results of the present study suggest that preop-
erative pulmonary function testing could be of benefit
in identifying high-risk patients. These findings are
especially important in view of recent studies which
have shown an improved outcome in patients under-
going pulmonary rehabilitation before CABG (16,17).
However, the present study results did not show any
association between preoperative poor lung function
and pneumonia, but rather identified those patients
who were at risk of dying from non-pulmonary com-
plications. In this sense, the percentages of predicted
FEV1 and FVC that were evaluated had the merit to
identify those patients who were in poor general con-
dition, along with poor lung function. It is worth not-
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ing that this was independent of any smoking habits. It
has been observed that spirometric parameters could
be a surrogate of extrapulmonary conditions associat-
ed with postoperative stroke. In fact, current evidence
suggests that COPD per se has systemic effects, which
contribute to the poor prognosis of these patients (18).
Several studies have established that COPD is associ-
ated with low-grade systemic inflammation, which is
partly independent of smoking (19). Such a systemic
inflammation is likely to be a major contributor in the
pathogenesis of adverse effects of COPD, including
weight loss, skeletal muscle dysfunction, cardiovascu-
lar disease, depression and osteoporosis (18).
Importantly - and in contrast to most of the risk factors
that contribute to adverse immediate and late out-
comes of patients undergoing cardiac surgery - COPD
is to some extent a treatable disease. Sin and Man (20)
have shown that corticosteroids significantly reduced
the plasma levels of C-reactive protein in these
patients. Interestingly, a very low dose of inhaled
steroids has been shown to reduce the risk of myocar-
dial infarction in COPD patients (21). In the TORCH
study, a combined treatment with salmeterol and fluti-
casone reduced the risk of death by 17.5% in patients
with moderate and severe COPD (22). Furthermore,
potential beneficial effects in terms of early and late
survival with the use of angiotensin-converting
enzyme inhibitors and statins have been reported in
patients with COPD (23,24).
The question remains, therefore, as to whether the
identification and treatment of this condition could
improve the immediate postoperative outcome after
AVR. The present study was not planned to answer
this issue, and the results suggest only the prognostic
importance of pulmonary disease in these patients.
Deaths secondary to cardiovascular and pulmonary
complications, as well as to multiorgan failure, are
potentially preventable by improving pulmonary
function, as well as the oxyhemodynamics. A short-
term treatment with corticosteroids has been shown to
improve pulmonary function and the immediate out-
come of patients undergoing CABG (25,26). Other
studies (16,17) have shown that preoperative pul-
monary rehabilitation improves the outcome after
CABG. Unfortunately, however, there is as yet insuffi-
cient evidence regarding the potential benefits of pre-
operative pulmonary rehabilitation/medical treatment
before cardiac surgery. It is likely that patients with
COPD undergoing cardiac surgery would, in any case,
benefit from these therapeutic measures to the same
extent as would non-surgical COPD patients (27).
The present findings suggest that that the percentage
of predicted FVC has a somewhat better prognostic
importance than the percentage of predicted FEV1.
Whilst this seems to contradict the findings in patients
undergoing CABG (10,11), it is likely that hemodynam-
ic changes associated with severe aortic valve disease
may result in lung changes. This could contribute to a
different pattern of pulmonary disease among patients
undergoing isolated CABG compared to those under-
going AVR. Recently, chronic heart failure has been
shown to be associated with restrictive lung changes
(28). The present findings confirm that a low LVEF cor-
relates more with values of FVC than with FEV1.
In conclusion, the study results suggest that pulmonary
disease, as indicated by decreased FVC and FEV1, is an
important comorbidity factor in patients undergoing
AVR surgery. Further studies are required to demon-
strate whether the identification and treatment of these
patients could improve their outcome after AVR.
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ctogenarians undergoing coronary artery bypass grafting.
Methods. A consecutive series of 274 patients age 80
ears or greater out of 3,474 patients who underwent
solated coronary artery bypass grafting. We have as-
essed the intrinsic risk aged 80 years or greater by
omparing them with a propensity score-matched cohort
f younger patients with similar operative risk (other
han age).
Results. Thirty-day mortality (4.7% vs 1.3%, p < 0.0001),
ombined adverse event rates (13.1% vs 6.6%, p < 0.0001),
nd five-year survival (76.6% vs 90.4%, p < 0.0001) were
ignificantly poorer among patients aged 80 years or
reater as compared with younger patients. These figures
ere, however, better than estimates of a recent system-
tic review by McKellar and colleagues (McKellar SH,
rown ML, Frye RL, Schaff HV, Sundt TM III. Compar-
son of coronary revascularization procedures in octoge-
arians: a systematic review and meta-analysis. Nat Clin
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ublished by Elsevier Incere compared with 273 propensity score-matched pa-
ients aged less than 80 years, the 30-day mortality (4.8%
s 2.6%, p  0.17) and combined adverse event rates
13.2% vs 10.6%, p  0.36) did not significantly differ.
ive-year survival, despite statistical significance, was
ot remarkably lower than that of propensity-matched
atients aged less than 80 years (77.0% vs 81.3%, p 
.009). The decrease in survival of octogenarians was
vident only during the first few months after surgery,
ut not later on.
Conclusions. The results of this study suggest that
mmediate and five-year survival of octogenarians under-
oing coronary artery bypass grafting may be even better
han previously estimated. Survival of octogenarians
ay be suboptimal only during the first fewmonths after
urgery, whereas at five years may not differ remarkably
rom younger patients with otherwise similar operative
isk.
(Ann Thorac Surg 2010;89:1119–24)
© 2010 by The Society of Thoracic Surgeonsn Finland, from 1980 to 2008 the prevalence of persons
aged 80 years or greater has increased from 1.8% to
.5% [1]. This introduces an increase in the burden of
ealth care for this continuously growing greying popu-
ation. In particular, revascularization procedures for
oronary artery disease are becoming more common. In
he United States, the prevalence of coronary revascular-
zation among patients aged 75 to 84 years increased from
9.1 per 10,000 population in 1990 to 140.0 per 10,000
opulation in 2006, and in patients aged 85 years or
reater increased during the same period from 14.0 to
9.9 per 10, 000 population [2]. This, in part, is due to a
ore confident approach toward coronary revasculariza-
ion in this high-risk patient population.
ccepted for publication Dec 30, 2009.
ddress correspondence to Dr Biancari, Department of Surgery, DivisionMcKellar and colleagues [3] have exhaustively summa-
ized the rather good immediate and five-year outcome
f octogenarians after coronary artery bypass surgery
CABG) and percutaneous coronary intervention (PCI).
lthough the latter can intuitively be associated with
ower immediate postoperative mortality rates (estimates
ccording to McKellar and colleagues: PCI 5.4% vs CABG
.2%), CABG is very often the only feasible treatment for
hese patients who have diffuse coronary artery disease.
ndeed, cardiac surgeons not infrequently are called
pon to care for octogenarians with unstable angina
ectoris and (or) acute heart failure unresponsive to
edical treatment and (or) PCI. The latter introduce a
ias which prevents any comparative analysis between
ABG and PCI in octogenarians.
Age is a remarkably important risk factor in cardiac
urgery, but it is not easy to discern the impact of age
rom the comorbidities accompanying the elderly.
erein, we have reviewed our experience with octoge-
arians undergoing CABG and we attempted to assess
he intrinsic risk of age 80 years or greater by comparing
he latter patients with a propensity score-matched co-
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Cort of younger patients with similar operative risk (other
han age).
aterial and Methods
his study included a consecutive series of 274 patients
ged 80 years or greater (only one patient was 90-years
ld) who underwent isolated CABG from 1994 to 2008 at
aasa Central Hospital, Vaasa, Finland. The study pro-
ocol was approved by the Ethics Committee of Vaasa
entral Hospital and a waiver of the requirement of
ritten informed consent was obtained.
These patients belong to a series of 3,474 patients who
nderwent isolated CABG during the study period. All of
hem had complete data regarding the European system
or cardiac operative risk evaluation (EuroSCORE) vari-
able 1. Clinical and Operative Data of Patients Aged 80 Yea
solated Coronary Artery Bypass Surgery
ariable
Overall Series
Octogenarian
Patients
(n  274)
(%)
Youn
Patie
(n  3
(%
ge (years) 82.5  1.9 66.6 
emales 110 (40.1) 761 (
ulmonary disease 24 (8.8) 356 (
iabetes 63 (23.0) 618 (
enal failure 3 (1.1) 28 (
erebrovascular disease 42 (15.3) 373 (
eurologic dysfunction 5 (1.8) 34 (
yocardial infarction3 months 106 (38.7) 628 (
xtracardiac arteriopathy 30 (10.9) 270 (
revious cardiac surgery 0 (0) 126 (
VEF  0.50 89 (0.325) 10 (
nstable angina pectoris 53 (19.3) 417 (
ritical preoperative status 6 (2.2) 33 (
ystolic pulmonary a. pressure
60 mm Hg
2 (0.7) 18 (
mergency operation 21 (7.7) 180 (
dditive EuroSCORE 7.6  2.4 3.9 
ogistic EuroSCORE (%) 10.6  9.3 4.3 
iggins score 3.8  2.2 2.4 
t least one mammary artery
graft
220 (80.3) 2986 (
ilateral mammary artery graft 3 (1.1) 515 (
o. of distal anastomosis 4.1  1.1 4.1 
eating heart surgery 54 (19.7) 288 (
ortic cross-clamping
time (minutes)
71  30 80 
ardiopulmonary bypass
time (minutes)
101  24 103 
efinition criteria for preoperative variables are according to EuroSCOR
ontinuous variables are reported as mean  standard deviation.
alues in parentheses are percentages.
uroSCORE  European system for cardiac operative risk evaluation;bles [4]. No attempt to replace missing values has been eone. Clinical variables have been classified according to
uroSCORE criteria. Data on these patients were entered
rospectively into an institutional database and are sum-
arized in Table 1. The operative risk was assessed by
uroSCORE and Higgins score [5].
The anesthesia method consisted of combined general
nesthesia. Thoracic epidural anesthesia was used at the
iscretion of the anesthesiologist for patients with antic-
pated pulmonary or other significant risk. When con-
entional CABG was carried out, a blood cardioplegia
echnique was employed for cardiac protection and it
as given as a continuous anterograde-retrograde
nfusion.
Epiaortic ultrasound was performed in most of these
atients. The decision to avoid aortic cross- or side-
lamping was based on intraoperative findings of dis-
Greater and Less Than 80 Years, and Who Underwent
Propensity Score-Matched Pairs
p Value
Octogenarian
Patients
(n  273)
(%)
Younger
Patients
(n  273)
(%) p Value
0.0001 82.5  1.9 70.5  6.8 0.0001
0.0001 109 (39.9) 109 (39.9) 1.00
0.23 24 (8.8) 37 (13.6) 0.08
0.14 63 (23.1) 69 (25.3) 0.55
0.73 3 (1.1) 4 (1.5) 0.73
0.07 41 (15.0) 43 (15.8) 0.81
0.25 5 (1.8) 3 (1.1) 0.73
0.0001 105 (38.5) 105 (38.5) 1.00
0.16 30 (11.0) 26 (9.5) 0.57
0.0001 0 (0) 17 (6.2) 0.0001
) 0.56 89 (0.326) 98 (0.359) 0.42
0.003 53 (19.4) 58 (21.2) 0.60
0.08 6 (2.2) 11 (4.0) 0.22
0.67 2 (0.7) 3 (1.1) 0.69
0.17 21 (7.7) 29 (10.6) 0.24
0.0001 7.6  2.4 5.6  3.0 0.0001
0.0001 10.6  9.6 7.0  8.2 0.0001
0.0001 3.8  2.2 3.5  2.8 0.002
0.0001 219 (80.2) 219 (80.2) 1.00
0.0001 2 (0.2) 2 (0.2) 1.00
0.61 4.1  1.1 3.9  1.2 0.13
0.0001 53 (19.4) 53 (19.4) 1.00
0.0001 71  30 73  31 0.50
0.44 101  24 105  34 0.45
F  left ventricular ejection fraction.rs or
ger
nts
,200)
)
8.8
23.8)
11.1)
19.3)
0.9)
11.7)
1.1)
19.6)
8.4)
3.9)
0.342
13.0)
1.0)
0.6)
5.6)
2.7
5.6
2.4
93.3)
16.1)
1.3
9.0)
28
31
E.ased ascending aorta and individual operative risk.
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Ceartstring anastomosis seal device (Guidant Corpo-
ation, San Jose, CA) was used whenever severely
alcified ascending aorta prevented its safe cross-
lamping and side-clamping. Data on late death were
etrieved from the National Registry of Statistics Fin-
and (Tilastokeskus).
tatistical Analysis
tatistical analysis was performed using SPSS statistical
oftware (SPSS v. 16.0.1; SPSS Inc, Chicago, IL). Contin-
ous variables are reported as the mean  standard
eviation. The Pearson test, the Fisher exact test (with or
ithout the Monte Carlo method), the Mann-Whitney
est, and the Kruskall-Wallis test were used for univariate
nalysis. Because patients aged 80 years or greater had an
perative risk markedly higher (as indicated by EuroSCORE
nd Higgins score) than younger patients, which can be
artly explained by the age, we have calculated a pro-
ensity score to get one-to-one match pairs with similar
linical and operative characteristics (other than age).
ndeed, elderly patients also have been operated on
mploying, less frequently, one or two bilateral mam-
ary artery grafts. Logistic regression with backward
election was performed to calculate the propensity
core. All variables but age, EuroSCORE, and Higgins
core (listed in Table 1) with a p less than 0.20 have been
ncluded into the regression model. Receiver operating
haracteristic curve analysis was used to estimate the
rea under the curve of the calculated propensity score.
he latter was employed for one-to-one matching ac-
ording to a difference in the propensity score less than
.005. Long-term outcome has been assessed by the
aplan-Meier test and Cox regression analysis. Only
ariables with a p less than 0.20 have been included into
he regression model for prediction of immediate and
ate mortality. A p value of less than 0.05 was considered
tatistically significant.
esults
he prevalence of octogenarians has significantly in-
reased over the years (p  0.0001; Fig 1), reaching a rate
f about 15% during the last years of our experience. The
ncreasing prevalence of octogenarians was anyway as-
ociated also with a trend for increased 30-day mortality
1994 to 1998: 0%, 0 of 23 patients; 1999 to 2003: 4.5%, 4 of
8 patients; 2004 to 2008: 5.5%, 9 of 163, p  0.75).
owever, this was likely due to a certain increase in the
perative risk observed during the last decade (mean
ogistic EuroSCORE: 8.0%, 10.8%, and 10.9%, respec-
ively, Kruskall-Wallis’ test: p  0.48) as well as a more
onfident and aggressive revascularization policy in this
atient population.
Table 2 summarizes the postoperative complications as
ell as the immediate and long-term outcome. Octoge-
arians have a significantly poorer immediate and long-
erm outcome compared with younger patients. How-
ver, when compared with pooled survival estimates
ccording to the study by McKellar and colleagues [3],
he overall survival of octogenarians of the present series as much better than the estimated one (Fig 2). This
omparison could be affected by the inclusion into this
ystematic review of patients operated in the eighties.
redictors of Immediate and Late Mortality Among
ctogenarians
nivariate analysis showed that diabetes (9.5% vs 3.3%,
 0.04) and critical preoperative status (50.0% vs 3.7%, p
.002) were the only preoperative variables predicting
0-day postoperative mortality. Logistic regression anal-
sis showed that only critical preoperative status was
ndependently associated with 30-day postoperative
ortality (p  0.0001, odds ratio 26.03, 95% confidence
nterval (CI) 4.38 to 154.65).
Univariate analysis showed that diabetes (p  0.0001),
xtracardiac arteriopathy (p 0.006), neurologic dysfunc-
ion (p  0.005), renal failure (p  0.02), critical preoper-
tive status (p  0.0001), unstable angina pectoris (p 
.004), and recent myocardial infarction (p  0.001) were
ssociated with poorer long-term outcome. Cox regres-
ion analysis showed that recent myocardial infarction
p  0.04, risk ratio (RR) 1.70, 95% CI 1.04 to 2.79), extracar-
iac arteriopathy (p  0.001, RR 2.78, 95% CI 1.50 to 5.15),
eurologic dysfunction (p  0.03, RR 3.83, 95% CI 1.15 to
2.68), diabetes (p 0.0001, RR 2.63, 95% CI 1.61 to 4.30), and
ritical preoperative status (p 0.0001, RR 11.78, 95% CI 4.30
o 32.21) were independent predictors of late mortality.
ropensity Score Analysis
ropensity score analysis provided a model with a Hosmer-
emeshow p  0.32 and showed that the prevalence of
emale gender, recent myocardial infarction, at least one
nternal mammary artery graft used, bilateral mammary
rtery grafting, and beating heart surgery significantly
iffered between patients aged 80 years or greater and
ounger patients. The obtained propensity score had an
ig 1. Increasing prevalence along the study period of patients aged
0 years or greater who underwent isolated coronary artery bypass
urgery at Vaasa Central Hospital, Finland (Fisher exact test, Monte
arlo method: p  0.0001).rea under the receiver operating characteristic curve of
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C.71 (95% CI 0.69 to 0.75, p  0.0001). This propensity
core provided 273 matched pairs with similar risk factors
ther than age (Table 1).
The immediate outcome of propensity score-matched
airs is summarized in Table 2. These findings demon-
trate that, despite the evident negative prognostic im-
able 2. Immediate Outcome After Isolated Coronary Artery B
ariable
Overall
Octogenarian
Patients
(n  274)
(%)
Yo
P
(n 
mmediate postoperative outcome:
30-day mortality 13 (4.7) 4
Reoperation 18 (6.6) 16
Reoperation for bleeding 9 (3.3) 10
Stroke 7 (2.4)
Intraaortic balloon pump 6 (2.2) 2
Acute renal failure requiring
dialysis
7 (2.6) 2
ICU stay (days) 2.0  2.7 1.
ICU stay  5 days 24 (8.8) 12
Delirium 52 (19.0) 25
Pneumonia 21 (7.7) 17
Atrial fibrillation 143 (55.4) 114
Combined adverse endpointa 36 (13.1) 21
ate postoperative outcome:
1-year overall survival 90.8% 9
3-year overall survival 86.3% 9
5-year overall survival 76.6% 9
10-year overall survival 34.9% 7
In-hospital mortality, stroke, length of stay in ICU  5 days, acute rena
alues in parentheses are percentages.
ate survival has been estimated by the Kaplan-Meier method with the
CU  intensive care unit.
ig 2. Overall survival rates of patients aged 80 years or greater
ho underwent isolated coronary artery bypass surgery in the
resent series (black circles) and according to pooled estimatespgrey circles) reported by McKellar and colleagues [3].act of increased age, the immediate outcome of octoge-
arians does not significantly differ from that of younger
atients with otherwise similar baseline risk factors and
perated on with the same technical approach (ie, beat-
ng heart surgery and use of internal mammary artery
rafts). Figure 3 shows the five-year overall survival
hich, despite the statistical significance, is not remark-
bly lower than that of propensity-matched patients aged
ess than 80 years (77.0% vs 81.3%, p  0.009). The
ecrease in survival of octogenarians seems to be evident
uring the first few months after surgery, but not later on
Fig 3). Ten-year survival was, by the finite nature of life,
ather poor (Table 2). Propensity score analysis, despite a
ather good matching of patients, has not eliminated
hose patients who had prior cardiac surgery. When the
atter were excluded, five-year overall survival rates were
7.0% among octogenarians versus 80.5% among patients
ged less than 80 years (p  0.019).
omment
number of octogenarians are not referred to cardiac
urgery because of lack of evidence-based criteria for
eferral, an age-related fading interest on neutralizing
premature death,” skepticism among physicians and
urgeons about any expected gain in quality of life in the
ss Surgery in Octogenarians and Younger Patients
s Propensity Score-Matched Pairs
er
ts
00)
p Value
Octogenarian
Patients
(n  273)
(%)
Younger
Patients
(n  273)
(%)
p
Value
) 0.0001 13 (4.8) 7 (2.6) 0.17
) 0.27 18 (6.6) 20 (7.3) 0.74
) 0.99 9 (3.3) 16 (5.9) 0.22
) 0.88 7 (2.6) 6 (2.2) 0.78
) 0.02 6 (2.2) 5 (1.8) 0.76
) 0.008 7 (2.6) 3 (1.1) 0.34
.5 0.0001 2.0  2.7 1.9  3.2 0.21
) 0.0001 24 (8.8) 19 (7.0) 0.43
) 0.0001 52 (19.1) 30 (11.1) 0.009
) 0.14 21 (7.7) 18 (6.6) 0.62
.5) 0.0001 142 (55.3) 113 (43.6) 0.008
) 0.0001 36 (13.2) 29 (10.6) 0.36
0.0001 0.009
90.8% 96.7%
86.7% 90.5%
77.0% 81.3%
35.0% 55.3%
re requiring dialysis.
nk test.ypa
Serie
ung
atien
3,2
(%)
0 (1.3
1 (5.0
6 (3.3
7 (2.6
6 (0.8
8 (0.9
6  3
1 (3.8
4 (8.0
7 (5.5
2 (36
1 (6.6
7.3%
3.9%
0.4%
6.1%
l failu
log-raresence of rather high operative risk, cost considerations,
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Cnd finally, the patients themselves facing a difficult deci-
ion with limited, if any, emotional support from their
elatives [6]. This introduces a remarkable bias in esti-
ating the real risk and benefits associated with CABG
s many patients are denied (or deny) a myocardial
evascularization procedure. With these limitations in
ind, the present study confirmed that the overall sur-
ival of these patients can be even better than that
stimated by a recent systematic review [3] (Fig 2). This
omparison could be affected by the inclusion into this
ystematic review of patients operated in the eighties,
ven if at that time a more conservative approach in
reating octogenarians is likely to have been adopted. How-
ver, univariate analysis showed that more recent enroll-
ent was associated with improved 30-day and one-year
urvival, but it did not affect long-term survival [3].
Furthermore, of particular importance is the gain in
uality of life which octogenarians experience after car-
iac surgery when compared with the age-adjusted and
ender-adjusted general population [7–9], particularly
hen arterial grafts are used in these older patients.
omen seem to receive the most benefit from cardiac
perations in terms of quality of life [7]. However, even
en, who are expecting to gain a quality of life similar to
he age-adjusted and gender-adjusted general popula-
ion, seem to receive an important benefit from CABG.
We have herein observed that CABG can be performed
ith results markedly better than expected. This encour-
ged us toward an even more aggressive policy over the
ears. However, we believe that the most important
nding in this study is the fact that the risk of immediate
ostoperative complications was similar to that of a
ropensity-matched cohort of patients aged less than 80
ears. This means that surgeons and cardiologists should
ecide to operate more on the basis of relevant risk mactors rather than age itself. The most evident proof of
his are the similar rates of combined adverse events that
ccurred in the propensity-matched pairs (octogenari-
ns: 13.2% versus younger patients: 10.6%, p  0.36).
urthermore, Figure 3 shows that the survival curve of
ctogenarians differed from that of the propensity score-
atched group only during the first few months after
urgery and later on was similar to the latter group. This
uggests that it may be of paramount importance to
mprove the early outcome of these elderly patients as
hey are expected to experience a significant benefit in
erms of five-year survival. Indeed, there is still room also
or improving late survival; for example, by complete
evascularization [10] using arterial grafts [9], and a
olicy of aggressive secondary prevention [11].
Worth noting is the rather low rate of postoperative
troke herein observed. This is a major finding of this
tudy which likely is the result of our policy of intraop-
rative screening for diseased ascending aorta along with
voidance of aortic manipulation when indicated.
Although retrospective in nature, this study shows that
ABG is a highly effective treatment also in octogenari-
ns with acceptable short-term risks and excellent five-
ear survival rates. Ten-year survival rate is not brilliant
nd simply reflects the finite nature of our lives. Together
ith findings of other studies demonstrating improved
uality of life after CABG in octogenarians, it is impor-
ant to make such results public among patients and
eferrers. The message to them is clear; age alone cannot
e accepted as a sufficient criterion for not considering
ABG surgery seriously as a treatment option.
In conclusion, the results of this study suggest that
mmediate and five-year survival of octogenarians un-
ergoing CABG can be even better that previously esti-
Fig 3. Overall survival rates of 273 propensity
score-matched pairs of patients aged 80 years or
greater and less than 80 years who underwent iso-
lated coronary artery bypass surgery (log-rank:
p  0.009).ated. Survival of octogenarians may be lower only
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Curing the first few months after surgery, whereas at five
ears may not differ remarkably from younger patients
ith otherwise similar operative risk.
his work was supported by The Medical Research Fund of Vasa
ospital District.
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1417–24.NVITED COMMENTARYhe more we read or write regarding surgical outcomes in
ctogenarians, the greater we miss specific measurements
hat might better describe the accumulation of somatic and
unctional damage associated with aging. Would it not be
seful that whatever information is currently vehicled by
age” itself or summarized by a “fit for surgery” dummy
ariable could be broken down into a number of socioeco-
omic, physical, and mental functioning factors? Is there
ny other alternative to improve the accuracy of risk pro-
ling of the elderly, along with our understanding of
imilarities and differences among different studies?
It is the lack of this kind of information that makes it
ifficult to put into perspective the outstanding 77%
-year survival rate, as achieved by Nissinen and col-
eagues [1] in their octogenarians who underwent coro-
ary artery bypass grafting. In order to do so, the authors
1] used for reference a series with an inadequately
haracterized risk profile pooled from different units,
ifferent geographic sources, and different eras. They
lso warned us that such an unadjusted comparison
annot be overly relied upon. On the other hand, balanc-
ng scores are not ideally suited for resuscitating similar-
ties already buried, did they ever exist, by a strict
election process upstream. Nor do balancing scores
djust, by definition, for the unmeasured and unmeasur-
ble confounding so prevalent when selecting very old
atients for surgery.
In addition, a landmark analysis would have shown the
urvival curves of Nissinen and colleagues’ [1] matched
roups to be superimposed from month 6 through the
-year term. Unfortunately, the authors did not provide
ackground information from life tables of an age- andhown quite separate and diverging survival curves due
o age differences between groups. Therefore, it is not
nown whether in this study [1] octogenarians fared
etter or if the control group fared worse than expected,
lthough both of these conclusions may be true.
Finally, the authors state that the low rate of immediate
ostoperative complications was the most important
nding in this study, and I definitely concur with this
onclusion because the complications may indepen-
ently affect both early and late survival. In fact, we have
ound that early complications may be independent
redictors of death in the late hazard phase, although
hether this is a consequence of an ongoing “toxic,”
acro-apoptotic effect or rather expresses a propensity
or both early and late adverse events remains to be seen.
Although excellent surgery is a key factor to success, as
n Nissinen and colleagues’ [1] series, we should appre-
iate that heterogeneity increases with advancing age
nd that further progress will require us to better under-
tand that and fully account for it.
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Safe time limits of aortic cross-clamping 
and cardiopulmonary bypass in adult cardiac 
surgery
Juha Nissinen,1,4 Fausto Biancari,2 Jan-Ola Wistbacka,3 
Timo Peltola,1 Pertti Loponen,1,4 Pekka Tarkiainen,3 
Markku Virkkilä,3 Matti Tarkka4
Abstract
Objectives: We evaluated the impact of aortic cross-clamping time (XCT) and cardiopulmonary bypass time (CPBT) on 
the immediate and late outcome after adult cardiac surgery and attempted to identify their safe time limits.
Methods: This study includes 3280 patients who underwent adult cardiac surgery of various complexities. Myocardial 
protection was achieved with tepid continuous antegrade/retrograde blood cardioplegia. 
Results: Receiver operating characteristics (ROC) curve analysis showed that XCT (area under the curve, AUC: 0.66), 
CPBT (AUC: 0.73) and CPBT with unclamped aorta (AUC: 0.77) were significantly associated with 30-day postoperative 
mortality. XCT of increasing 30-minute intervals (Odds Ratio (OR) 1.21, 95%C.I. 1.01-1.52) and CPBT of increasing 
30-minute intervals (OR 1.47, 95%C.I. 1.27-1.71) were independent predictors of 30-day mortality. The best cutoff value 
for XCT was 150 min (30-day death: 1.8% vs. 12.2%, adjusted OR 3.07, 95%C.I. 1.48-6.39, accuracy 91.5%) and for CPBT 
240 min (30-day death: 1.9% vs. 31.5%, adjusted OR 8.78, 95%C.I. 4.64-16.61, accuracy 96.0%). These parameters were 
significantly associated also with postoperative morbidity, particularly with postoperative stroke.
Conclusions: XCT and CPBT are predictors of immediate postoperative morbidity and mortality. In our experience, 
cardiac procedures with CPBT<240 min and XCT<150 min were associated with a rather low risk of immediate 
postoperative adverse events independently of the complexity of surgery patient’s operative risk.
Keywords
cardiopulmonary bypass; aortic cross-clamping; perfusion; duration; safe limit
Introduction
During the last decades, many methods have been devel-
oped to provide optimal myocardial and non-cardiac 
organ protection during cardiac surgery. Myocardial 
protection can be achieved in different ways and recent 
systematic reviews seem to favour blood cardioplegia.1,2 
Whether cardioplegia should be administered in an 
antegrade or an antegrade/retrograde way and the opti-
mal cardioplegia temperature are still matters of debate. 
The recent introduction of new perfusion systems is 
thought also to improve the safety of cardiopulmonary 
bypass and non-cardiac organ protection, but, so far, evi-
dence of such benefits is still lacking.3 In view of the lim-
its of current methods, minimizing aortic cross-clamping 
time (XCT) and cardiopulmonary bypass time (CPBT) 
is certainly one of the most important issues in cardiac 
surgery. Indeed, CPBT has been shown to be associated 
with enhanced inflammatory response4,5 and increased 
morbidity and mortality after pediatric and adult cardiac 
surgery.6,7 In this study, we evaluated the impact of XCT 
and CPBT on the immediate outcome after adult cardiac 
surgery and attempted to identify their safe time limits.
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Material and methods
This study includes a series of 3280 patients who under-
went adult cardiac surgery at Vaasa Central Hospital, 
Vaasa, Finland, from January 1994 to June 2008. Data on 
these patients were collected prospectively into an insti-
tutional cardiac surgery database. Only the first proce-
dure for each patient was entered into the registry. Any 
other operation performed during the same in-hospital 
stay was not coded as a further procedure, but rather as 
a complication. 
These patients belong to a series of 4563 patients who 
underwent cardiac surgery during the study period. 
Patients who underwent a cardiac procedure with the 
beating heart technique and those without data on pre-
operative serum creatinine and left ventricular ejection 
fraction were excluded from this analysis. Patients who 
underwent isolated minor procedures, such as pericar-
diectomy or for arrhythmias, have been excluded as well. 
No attempt to replace missing values has been done. 
Data on late death were retrieved from the National 
Registry of Statistics Finland (Tilastokeskus).
Risk factor and definition criteria
Variables have been classified according to EuroSCORE 
criteria8 and additive and logistic EuroSCOREs were
calculated according to the proposed formulas.8,9 
Preoperative glomerular filtration rate was estimated 
according to the modified Modification of Diet in Renal 
Disease study equation.10
In order to estimate the impact of complex surgery on 
the immediate and late outcome, we have categorized 
major cardiac procedures as isolated, double or a combi-
nation of three to four procedures. This may reflect a 
longer XCT and CPBT and, probably, more technically 
demanding procedures. Herein, we refer to isolated or 
multiple procedures according to the number of proce-
dures on each major anatomical structure (coronary 
arteries, heart valves, ascending aorta/aortic arch, atrial 
or ventricular septum). Surgery for cardiac tumors was 
considered as a major cardiac procedure. 
Anesthesia and cardiopulmonary bypass
The anesthesia method consisted of combined general 
anesthesia. Thoracic epidural anesthesia was used at the 
discretion of the anesthesiologist for patients with antici-
pated pulmonary or other significant risk. Fentanyl 
3-3.5ug/kg and propofol 0.8-2mg/kg were given intrave-
nously for anesthesia induction, followed by continuous 
infusion of propofol 1-2mg/kg/h. Pancuronium 0.10mg/
kg was given for muscle relaxation. Clonidine 1.5-2ug/kg 
was given as a slow intravenous bolus dose at induction of 
anesthesia to patients without thoracic epidural anesthesia. 
Patients were ventilated with oxygen in air, FiO
2
 0.4-0.5, 
supplemented with isoflurane or sevoflurane.
For CPB, we used a membrane oxygenator (Dideco 
Compactflo; Dideco S.p.A., Mirandola, Italy) with a 
 non-pulsatile pump flow by means of a Stöckert roller 
pump (CAPS or SIII, Stöckert GmbH, Munich, Germany) 
or, from 2005 on, a centrifugal pump (Stöckert SCP, 
Sorin Group Deutschland GmbH, Munich, Germany). 
Generally, we have used a systemic temperature drift 
down to 32-34oC. A 40mm arterial line filter (D734, 
Dideco S.p.A.) was included in the CPB circuit. From 
1994 to 2002, we used conventional non-coated PVC-
tubing, but, from 2002, we have routinely used a 
phosphorylcholine-coated bypass circuit (Ph.I.S.I.O., 
Dideco S.p.A.) and, from 2005 on, we have used a modi-
fied ECC.O mini-bypass circuit (Dideco S.p.A.) in part 
of the cases. A blood cardioplegia technique was employed 
for cardiac protection in all cases. Cardiac arrest was initi-
ated with a bolus dose of K/Mg-cardioplegia concentrate 
solution given into a 35 to 37°C warm mixture of a mod-
erately hyperkalemic 5% glucose solution and oxygenated 
blood infused into the aortic root in a ratio of 1:8. The 
mixture was cooled to 28-30oC after cardiac arrest and 
thereafter given as a continuous ante/retrograde infusion 
directly into the coronary ostia and/or through the coro-
nary sinus and into the venous grafts. Before declamping 
of the aorta, the blood cardioplegia was warmed to 35 to 
37oC and infused for 4 to 5 minutes. The target activated 
clotting time was ≥ 600 sec due to use of a moderate dose 
of aprotinin (2.5-4 million units).
Graft anastomoses to the ascending aorta were carried 
out with a single cross-clamp technique.
Outcome measures
The main outcome end-point of this study is 30-day post-
operative mortality. The other outcome end-points are 
severe complications, such as intensive care unit stay ≥ 5 
days, stroke, postoperative use of intra-aortic balloon 
pump (IABP), and de novo postoperative dialysis, and 
combined severe complications (any of 30-day postoper-
ative death, intensive care unit stay ≥ 5 days, stroke, post-
operative use of IABP, and de novo postoperative dialysis). 
Statistical analysis
Statistical analysis was performed using SPSS statistical 
software (SPSS v. 14.0.1, SPSS Inc., Chicago, IL., USA). 
Continuous variables are reported as the mean ± stan-
dard deviation. The Pearson’s Chi-square test, Fisher’s 
exact test, the Kruskal-Wallis test and the Mann-Whitney 
test were used for univariate analysis. Correlation between 
continuous variables was estimated by the Spearman test. 
Receiver operating characteristics (ROC) curve was used 
to estimate the predictive value of continuous variables. 
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The best cutoff values have been chosen according to the 
best sensitivity, specificity, accuracy and adjusted Odds 
Ratio. Logistic regression with the help of backward 
selection was used for multivariate analysis by including 
all the variables with a p<0.05 at univariate analysis. A 
p<0.05 was considered statistically significant.
Results
Aortic cross-clamping and cardiopulmonary 
bypass time 
Cross-clamp time, as expected, strongly correlated with 
CPBT (rho: 0.94, p<0.0001). However, the correlation 
between XCT and CPBT with an unclamped aorta was 
somewhat weaker (rho: 0.44, p<0.0001). Figure 1 shows 
a scattered correlation, indicating that a prolonged XCT 
was not necessarily associated with prolonged CPBT 
with unclamped aorta. 
30-day postoperative mortality
Thirty-day postoperative mortality rate was 2.5% 
(83/3280). Additive EuroSCORE (p<0.0001, AUC 0.837, 
95%C.I. 0.791-0.882) and logistic EuroSCORE (p<0.0001, 
AUC 0.84, 95%C.I. 0.80-0.89) performed well in predict-
ing 30-day postoperative mortality. 
Thirty-day mortality rate was not significantly differ-
ent after isolated coronary artery bypass surgery (1.6%), 
isolated aortic valve surgery (1.7%) and isolated mitral 
valve surgery (1.7%) (p=0.75). On the other hand, 
30-day mortality rates after isolated procedure, double 
procedure and three-to-four procedures were 1.7% 
(47/2820), 5.4% (22/404) and 25% (14/56), respectively 
(p<0.0001). Accordingly, the XCTs of (83±26 min, 
134±36 min and 191±56 min, respectively, p<0.0001) 
and the CPBT of (106±34 min, 173±52 min and 262±98 
min, respectively, p<0.0001) correlated with the com-
plexity of the operation.
ROC curve analysis showed that XCT (p<0.0001, 
AUC: 0.66, 95%C.I. 0.60-0.73), CPBT (p<0.0001, AUC: 
0.73, 95%C.I. 0.67-0.78), and CPBT with unclamped 
aorta (p<0.0001, AUC: 0.77, 95%C.I. 0.71-0.83) were 
associated with 30-day postoperative mortality. The 
increasing risk of 30-day mortality along with increased 
XCT and CPBT is depicted in Figure 2.
The results of logistic regression for predicting 30-day 
mortality are summarized in Tables 1 and 2 (Hosmer-
Lemeshow’s test: p=0.244). This regression model 
showed that both XCT and CPBT were independent pre-
dictors of immediate postoperative death. It is worth 
noting that, in the correlation matrix, XCT and CPBT 
were negatively correlated. Thus, XCT and CPBT were 
included into the regression model separately and the 
results where similar. XCT of increasing 30-minute inter-
vals (p=0.04, OR 1.24, 95%C.I. 1.01-1.52, Hosmer-
Lemeshow’s test: p=0.43, change in -2 Log likelihood: 
4.45) and CPBT of increasing 30-minute intervals 
(p<0.0001, OR 1.47, 95%C.I. 1.270-1.71, Hosmer-
Lemeshow’s test: p=0.49, change in -2 Log likelihood: 
24.28) were also independent predictors of 30-day post-
operative mortality when included separately into the 
regression model. 
The best cutoff value for XCT was 150 min (1.8% vs. 
12.2%, p<0.0001, OR 3.07, 95%C.I. 1.48 -6.39 as adjusted 
for additive EuroSCORE and complexity of the opera-
tion; sensitivity 33.7%, specificity 93%, accuracy 91.5%) 
and for CPBT was 240 min (1.9% vs. 31.5%, p<0.0001, 
OR 8.78, 95%C.I. 4.64-16.61 as adjusted for additive 
EuroSCORE and complexity of the operation; sensitivity 
27.8%, specificity 97.8%, accuracy 96.0%).
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Figure 1. Aortic cross-clamping time strongly correlated 
with cardiopulmonary bypass duration (rho: 0.941, p<0.0001). 
The correlation between aortic cross-clamping time and 
cardiopulmonary bypass time with unclamped aorta was 
somewhat weaker (rho: 0.439, p<0.0001). Black circles indicate 
patients who died during 30-day postoperative period.
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Figure 2. 30-day mortality rates for increasing duration of aortic cross-clamping (p<0.0001, O.R. 1.41, 95%C.I. 1.23-1.62 adjusted 
for additive EuroSCORE) and cardiopulmonary bypass (p<0.0001, O.R. 1.45, 95%C.I. 1.30-1.61 adjusted for additive EuroSCORE).
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Table 1. Preoperative clinical characteristics and their impact on 30-day mortality according to univariate analysis and logistic regression
Clinical variables  No. (%) Univariate analysis p-value Logistic regression O.R. 95%C.I.
Age (years)  67.4±10.4 <0.0001 <0.0001, 1.076, 1.037–1.116
Females  944 (28.8) 0.001
Pulmonary disease  352 (10.7) <0.0001 0.001, 2.711, 1.485–4.948
Diabetes  618 (18.8) 0.001
Cerebrovascular disease 348 (10.6) 0.001
Neurological dysfunction 41 (1.3) 0.08 0.021, 4.631, 1.266–16.938
Extracardiac arteriopathy  251 (7.7) 0.005
Serum creatinine (mmol/L) 94.0±49.4 <0.0001
Renal failure  35 (1.1) 0.002
Estimated glomerular filtration rate ml/min/1.73 m2 74.5±19.5 <0.0001 0.003, 1.798, 1.044–3.096
Chronic kidney disease classification  <0.0001
  Classes 1–2 2573 (78.4)
  Class 3 668 (20.4)
  Classes 4–5 39 (1.2)
Active endocarditis  19 (0.6) 0.001
Myocardial infarction <3 months  626 (19.1) <0.0001
Previous cardiac surgery  120 (3.7) <0.0001
LVEF >50% 2180 (66.5) <0.0001
  30–50% 967 (29.5)  0.34, 1.798, 1.044–3.096
  <30% 133 (4.1)  0.071, 2.437, 0.927–6.407
Nitrates infusion at OR arrival 359 (10.9) <0.0001
Critical preoperative status 62 (1.9) <0.0001 <0.0001, 8.274, 3.971–17.240
Systolic pulmonary a. pressure>60 mmHg  82 (2.5) <0.0001
Emergency operation 171 (5.2) <0.0001
Postinfarct ventricular septal rupture 9 (0.3) <0.0001
Additive EuroSCORE 4.8±3.1 <0.0001
Logistic EuroSCORE (%) 5.9±8.7 <0.0001
Continuous variables are reported as the mean±standard deviation; LVEF: left ventricular ejection fraction; OR: operating room O.R.: odds ratio.
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Figure 3. 30-day mortality rates after complex cardiac surgery 
according to different combination of cutoff values of aortic 
cross-clamping and cardiopulmonary bypass duration. P-value 
adjusted for additive EuroSCORE. XCT: aortic cross-clamping 
time. CPBT: cardiopulmonary bypass time.
Outcome prediction after isolated procedures
According to logistic regression CPBT, but not XCT, was 
associated with 30-day mortality among patients who 
underwent isolated procedures. However, the area 
under the ROC curve of CPBT was rather small 
(p=0.001, AUC: 0.64, 95%C.I. 0.58-0.71) compared to 
that of the overall series and of patients undergoing 
complex procedures. 
Outcome prediction after complex procedures
Four hundred and twenty patients underwent two or 
more procedures on coronary arteries, heart valves, 
ascending aorta/aortic arch, and atrial or ventricular sep-
tum. ROC curve analysis showed that XCT (p<0.0001, 
AUC: 0.681, 95%C.I. 0.57-0.80), CPBT duration 
(p<0.0001, AUC: 0.74, 95%C.I. 0.64-0.85), and CPBT 
duration with unclamped aorta (p<0.0001, AUC: 0.79, 
95%C.I. 0.70-0.88) were associated with 30-day postop-
erative mortality.
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When adjusted for additive EuroSCORE, XCT 
(p<0.0001, O.R. 1.01, 95%C.I. 1.01-1.02) and CPBT 
(p<0.0001, OR 1.01, 95%C.I. 1.01-1.02) were independ-
ent predictors of 30-day mortality among patients who 
underwent complex procedures. XCT>150 min 
(p<0.0001, OR 4.24, 95%C.I. 2.03-8.85) and CPBT>240 
min (p<0.0001, OR 9.10, 95%C.I. 4.40-18.81) were 
associated with a highly increased risk of 30-day mor-
tality. When their best cutoff values were adjusted for 
additive EuroSCORE, XCT>150 min (p=0.001, OR 4.13, 
95%C.I. 1.82-9.37) and CPBT>240 min (p<0.0001, OR 
4.81, 95%C.I. 2.13-10.86) were also associated with 
30-day mortality in this high risk group. The effect of 
combining the cutoff values of these two risk factors is 
depicted in Figure 3 (p<0.0001 adjusted for additive 
EuroSCORE). 
Severe postoperative complications
The rate of combined severe complications end-point 
(30-mortality, intensive care unit stay ≥ 5 days, stroke, post-
operative use of IABP, and need of postoperative dialysis) 
was 10.9% (357/3280 patients). ROC curve analysis showed 
that XCT (p<0.0001, AUC: 0.644, 95%C.I. 0.61-0.68), 
CPBT duration (p<0.0001, AUC: 0.70, 95%C.I. 0.67-0.73), 
and CPBT duration with unclamped aorta (p<0.0001, 
AUC: 0.74, 95%C.I. 0.71-0.77) were associated with com-
bined severe complications end-point. Figure 4 shows the 
Table 2. Operative and perfusion data and their impact on 30-day mortality according to univariate and multivariate analysis
Operative/perfusion variables No. (%) Univariate analysis Logistic regression  
  p-value p-value, O.R. 95%C.I.
Type of operation
  Isolated CABG 2422 (73.8)
  CABG + ventriculoplasty 15 (0.5)
  CABG + AVR 245 (7.5)
  CABG + MV surgery 72 (2.2)
  CABG + double valve surgery 20 (0.6)
  CABG + triple valve surgery 3 (0.1)
  CABG + other major cardiac procedures 9 (0.3)
  CABG + other non cardiac procedures 11 (0.3)
  Isolated AVR 236 (7.2)
  Isolated MV surgery ± ASD closure 124 (3.8)
  Double valve surgery 24 (0.7)
  Triple valve surgery 7 (0.2)
  Bentall-DeBono procedure ± CABG 50 (1.5)
  Other aortic procedures 2 (0.1)
  Tricuspid valve surgery + other procedures 3 (0.1)
  Isolated ASD closure 20 (0.6)
  Isolated VSD closure 4 (0.1)
  Other major cardiac procedures 13 (0.4)
No. major cardiac procedures*  <0.0001 0.001, 2.43, 1.41–4.19
  1 2820 (86.0)
  2 404 (12.3)
  3–4 56 (1.7)
Surgery on the thoracic aorta 56 (1.7) <0.0001
Procedures other than isolated CABG 854 (26.0) <0.0001
Aortic cross-clamping time (min) 91±36 <0.0001 <0.0001, 0.97, 0.96–0.99**
Cardiopulmonary bypass duration (min) 117±48 <0.0001 <0.0001, 1.03, 1.02–1.04
Total potassium/magnesium administered through  40.2±21.2 0.067
cardioplegia (ml); K+ 1mmol/ml, Mg2+ 0.25mmol/ml
Lowest cardioplegia temperature (°C) 28.3±2.1 0.18
Maintenance cardioplegia temperature (°C) 28.9±1.9 0.19
Crystalloid component of cardioplegia (ml) 493±253 0.006
Lowest systemic temperature during CPB (°C) 32.9±1.5 <0.0001
Highest plasma level of K+ during CPB (mmol/l) 5.7±0.8 0.31
Lowest hematocrit during CPB (%) 22±0.0 <0.0001  0.03, 0.92, 0.85–0.99
Continuous variables are reported as the mean±standard deviation; CPB: cardiopulmonary bypass; CABG: coronary artery bypass grafting; AVR: aortic 
valve replacement; MV: mitral valve; ASD: atrial septal defect; VSD: ventricular septal defect: *: We refer to isolated or multiple procedure according 
to the number of procedures on each major anatomical structure (coronary arteries, heart valves, ascending aorta/aortic arch, atrial or ventricular 
septum); **: Both cardiopulmonary bypass time and aortic cross-clamping time entered the regression model and correlation matrix showed their 
strong and negative correlation. For separate analysis refer to the results section.
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Figure 4. Rates of postoperative complications for increasing duration of aortic cross-clamping and cardiopulmonary bypass. 
P-values are adjusted for additive EuroSCORE.
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rates of severe complications according to different XCTs 
and CPBTs as adjusted for additive EuroSCORE.
XCT correlated significantly with the amount of 
transfused red blood cell units (rho: 0.26, p<0.0001),
the number of transfused homologous blood products 
(rho: 0.27, p<0.0001), time to extubation (rho: 0.136, 
p<0.0001) and length of stay in intensive care unit (rho: 
0.19, p<0.0001). Likewise, CPBT correlated significantly 
with amount of transfused red blood cell units (rho: 
0.31, p<0.0001), the number of transfused homologous 
blood products (rho: 0.32, p<0.0001), time to extubation 
(rho: 0.16, p<0.0001) and length of stay in intensive care 
unit (rho: 0.25, p<0.0001). 
Discussion
The present findings confirm that the longer the XCT 
and CPBT the worse their detrimental effects will be.7 
This is mostly related to the well established systemic 
inflammatory response syndrome occurring after CPB11 
and myocardial ischemia occurring during cross-clamp.12 
However, the correlation between these parameters and 
adverse outcome is not straightforward. Indeed, it is 
rather difficult to discern the isolated, negative impact of 
myocardial ischemia and use of cardiopulmonary bypass 
from the patient’s individual operative risk, intraopera-
tive technical difficulties, as well as the surgeon’s and 
anesthesist’s skills and experience, and, last but not the 
least, the quality of postoperative care. Herein, we 
attempted to estimate the adverse effect of prolonged 
XCT and CPBT by multivariate analysis and by perform-
ing subanalyses in a series of patients who underwent 
cardiac surgery employing, contrary to other reports,7 
rather similar myocardial and non-cardiac organ protec-
tion strategies. We have observed that, with these meth-
ods and within safe CPBT and XCT intervals, i.e. 
CPBT<240 minutes and XCT<150 minutes, cardiac sur-
gery can be performed with a rather low risk of postop-
erative mortality and morbidity independently of the 
patient’s operative risk and the complexity of the proce-
dure. It is worth noting that these time cutoff values, 
despite having a high accuracy (over 90%), have a rather 
low sensitivity. In such a large, complex and heteroge-
nous patient population, we could not expect to have a 
sensitivity of 100% and a specificity of 100%. Since a sig-
nificant number of patients having prolonged perfusion 
times will survive the operation, we could expect to have 
a large number of “true negatives”, patients who do not 
experience such adverse end-points. In this sense, the 
herein reported cut-off values are predictive of true neg-
atives under those threshold time limits, namely, pro-
longed CPBT and XCT do not automatically indicate a 
poor prognosis after the operation, rather that short 
CPBT and XCT are associated with very low risk of post-
operative adverse events. Indeed, markedly long XCT 
and CPBT not univocally resulted in postoperative 
mortality. 
This study also confirmed the marked impact of XCT 
and CPBT on postoperative morbidity, as is clearly 
shown in Figure 4. The strong association between post-
operative stroke and XCT as well as CPBT is of particu-
lar interest. This is not a new finding as other authors13,14 
have shown that CPBT is an independent predictor of 
stroke, a severe complication which, by itself, has a sig-
nificant impact on immediate and late mortality.14 
Brucerius and colleagues13 have identified CPBT>2 
hours as an independent predictor of postoperative 
stroke. This finding is rather similar to ours (Fig. 3). It 
seems that the safe CPBT for preventing postoperative 
stroke is much shorter than to prevent 30-day death. 
Not surprisingly, prolonged XCT also was significantly 
associated with an increased risk of postoperative stroke 
as it indicates more complex procedures, resulting in a 
prolonged CPBT. 
Does CPBT have a more significant impact on the 
immediate outcome than XCT? There is a very strong 
correlation between these two parameters as shown by 
the correlation matrix of logistic regression. Because of 
this, we included these two variables separately into the 
final regression models. However, likelihood ratios 
showed that, in this series, CPBT was a much stronger 
predictor of 30-day mortality. Figure 1 shows that the 
correlation between XCT and CBPT with unclamped 
aorta was weaker than XCT and CPBT. ROC curve analy-
sis confirmed these findings as CBPT with unclamped 
aorta had a larger area under the curve than XCT and 
CPBT in predicting 30-day postoperative death. Prolonged 
CPBT with unclamped aorta is a combination of per-
fusion time before cross-clamp and the reperfusion time 
after releasing the cross-clamp. A number of patients had 
prolonged CPBTs with unclamped aorta despite rather 
short XCTs. This may rather be related to critical preop-
erative condition of the patient or to technical difficulties 
than to ischemia and poor myocardial protection result-
ing in prolonged weaning from the CPB, particularly as 
there were many patients with long XCTs and relatively 
short CPBTs with unclamped aorta. 
In conclusion, this study has shown that, in a series of 
patients who underwent adult cardiac surgery employ-
ing similar myocardial and non-cardiac organ protec-
tion techniques, XCT and CPBT were independent 
predictors of immediate postoperative morbidity and 
mortality. Based on our experience, cardiac procedures 
with CPBT<240 min and XCT<150 min were associated 
with a rather low risk of immediate postoperative 
adverse events. 
Nissinen J et al. 305
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Abstract
Objective: We derived a new risk-scoring method by modifying some of the risk factors included in the EuroSCORE algorithm. Methods: This
study includes 3613 patients who underwent cardiac surgery at the Vaasa Central Hospital, Finland. The EuroSCORE variables, alongwithmodified
age classes (<60 years, 60—69.9 years, 70—79.9 years and80 years), eGFR-based chronic kidney disease classes (classes 1—2, class 3 and classes
4—5) and the number of cardiac procedures, were entered into the regression analysis. Results: An additive risk scorewas calculated according to
the results of logistic regression by adding the risk of the following variables: patients’ age classes (0, 2, 4 and 6 points), female (2 points),
pulmonary disease (3 points), extracardiac arteriopathy (2 points), neurological dysfunction (4 points), redo surgery (3 points), critical
preoperative status (8 points), left ventricular ejection fraction (>50%: 0; 30—50%: 2 and <30%: 3 points), thoracic aortic surgery (8 points),
postinfarct septal rupture (9 points), chronic kidney disease classes (0, 3 and 6 points), number of procedures (1: 0; 2: 2 and 3 or more: 7 points).
The modified score had a better area under the receiver operating characteristic curve (additive: 0.867; logistic: 0.873) than the EuroSCORE
(additive: 0.835; logistic: 0.840) in predicting 30-day postoperative mortality. The modified score, but not EuroSCORE, correctly estimated the
30-day postoperative mortality. Conclusion: EuroSCORE still performs well in identifying high-risk patients, but significantly overestimates the
immediate postoperativemortality. This study shows that the score’s accuracy and clinical relevance can be significantly improved bymodifying a
few of its variables. This institutionally derived risk-scoring method represents a modification and simplification of the EuroSCORE and, likely, it
would provide a more realistic estimation of the mortality risk after adult cardiac surgery.
# 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Thepredictionof the riskof adversepostoperativeoutcome
is of paramount importance in cardiac surgery as it may guide
thedecision-makingprocesswhether toopt for cardiac surgery
or for other currently available treatments. Furthermore, risk
prediction allows for planning of resource utilisation,
comparison between different institutions or surgeons and,
least but not last, an estimate of the patient’s individual risk.
During the last decades, several risk-scoring methods have
been derived and validated with variable success [1]. Among
these, the European system for cardiac operative risk
evaluation (EuroSCORE) [2,3] is recognised as one of the most
reliable risk-scoring method for prediction of immediate
postoperative mortality [1]. It also seems to perform ratherPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069
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doi:10.1016/j.ejcts.2009.03.069well in predicting late mortality [1,4,5]. Importantly, Euro-
SCORE is a simple, easy-to-use tool in the clinical field. Because
of this, during the last few years, EuroSCORE has been
extensively used for scientific and clinical purposes. However,
the use of EuroSCORE as well as that of other risk-scoring
methods is flawed by a significant overprediction of the
mortality risk [1,6,7]. This may lead to a false sense of
reassurance, underperformance may go undetected and
patient welfare may be compromised [8]. Thus, any risk-
scoring method in cardiac surgery should be both accurate and
have a good predictive power.
In the present study, we evaluated the performance of
EuroSCORE at our institution and derived a new risk-scoring
method by modifying some of the risk factors originally
included in the EuroSCORE algorithm.
2. Material and methods
This study includes a series of 3613 patients who
underwent adult cardiac surgery at the Vaasa Centralve the accuracy of EuroSCORE?. Eur J Cardiothorac Surg (2009),
Surgery. Published by Elsevier B.V. All rights reserved.
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EJCTS-7072; No of Pages 6Hospital, Vaasa, Finland, from January 1994 to June 2008.
The data on these patients were collected prospectively into
an institutional cardiac surgery database. Only the first
procedure for each patient was entered into the registry. Any
other operation performed during the same in-hospital stay
was not coded as a further procedure, but rather as a
complication.
These patients belong to a series of 4563 patients who
underwent cardiac surgery during the study period. The only
exclusion criterion was the lack of preoperative data on
creatinine and left ventricular ejection fraction. Patients
who underwent isolated minor procedures such as pericar-
diectomy or for arrhythmias have been excluded as well. No
attempt to replace missing values has been done.
The data on late death were retrieved from the National
Registry of Statistics, Finland (Tilastokeskus).
2.1. Risk factor and definition criteria
Variables have been classified according to the EuroSCORE
criteria [2].
The preoperative glomerular filtration rate was estimated
according to the modified Modification of Diet in Renal
Disease study equation [9,10]: eGFR (ml/min/1.73 m2) = 186
 (serum creatinine (mg/dl))1.154  (age)0.203  0.742 (if
the subject is female) or1.212 (if the subject is black). The
severity of renal failurewas classified according to the chronic
kidney disease (CKD) classification [9]: Class 1 (normal):
eGFR > 90 ml/min/1.73 m2; Class 2 (mild): eGFR—60—89 ml/
min/1.73 m2; Class 3 (moderate): eGFR — 30—59 ml/min/
1.73 m2; Class 4 (severe): eGFR — 15—29 ml/min/1.73 m2 and
Class 5 (kidney failure): eGFR < 15 ml/min/1.73 m2. We have
entered three groups of patients into the regression analysis:
Classes 1—2, Class 3 and Classes 4—5.
We have classified patients’ age in four classes (<60 years,
60—69.9 years, 70—79.9 years and 80 years), as this
classification was associated with a more evident increase in
operative risk than the additive EuroSCORE age classes.
Indeed, octogenarians and nonagenarians represent a
relatively small number of high-risk patients whose age-
related risk can be represented in only one class.
In the original EuroSCORE, non-coronary surgery was
considered as a predictor of adverse outcome, despite the
fact that patients with few or no co-morbidities may undergo
any other isolated, major cardiac procedure without sig-
nificantly highermortality risk. In order to better estimate the
impact of complex surgery on the immediate outcome, we
have categorised major cardiac procedure as isolated, double
or a combination of three ormore procedures. Thismay reflect
a longer cardiopulmonary bypass (CPB) duration and, not
infrequently, more technically demanding procedures.
Herein, we refer to isolated or multiple procedure according
to the number of procedures for each major area (coronary
arteries, heart valves, ascending aorta/aortic arch and atrial
and ventricular septal defect). Surgery for cardiac tumours
was considered as a type of major cardiac procedure. On the
contrary, operations for arrhythmias or pericardial diseases
were not classified as major cardiac procedures.
The method adopted for anaesthesia was combined
general anaesthesia. Thoracic epidural anaesthesia (TEA)
was used at the discretion of the anaesthesiologist forPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069patients with anticipated pulmonary or other significant
risks. Fentanyl 3—3.5 mg/kg, and propofol 0.8—2 mg/kg,
were given intravenously for anaesthesia induction, followed
by continuous infusion of propofol 1—2 mg/kg/h. Pancur-
onium 0.10 mg/kg was given for muscle relaxation. Clonidine
1.5—2 mg/kg was given as a slow intravenous bolus dose at
the induction of anaesthesia to patients without TEA. The
patients were ventilated with oxygen in air, fractional
inspired oxygen (FiO2) 0.4—0.5, supplemented with isoflur-
ane or sevoflurane.
For CPB, we used a membrane oxygenator (Dideco
Compactflo; Dideco S.p.A., Mirandola, Italy) with a non-
pulsatile pump flow bymeans of a Sto¨ckert roller pump (CAPS
or SIII, Sto¨ckert GMBH, Munich, Germany) or, from 2005, on a
centrifugal pump (Sto¨ckert SCP, Sorin Group Deutschland
GMBH, Mu¨nchen, Germany). Generally we have used a
systemic temperature drift down to 32—34 8C. A 40-mm
arterial line filter (D734, Dideco S.p.A.) was included in the
CPB circuit. From 1994 to 2002, we used conventional non-
coated PVC-tubings, but from 2002 we have routinely used a
phosphorylcholine-coated bypass circuit (Ph.I.S.I.O., Dideco
S.p.A.), and from 2005 on we have used a modified ECC.O
mini-bypass circuit (Dideco S.p.A., Mirandola, Italy) in some
of the cases. A blood cardioplegia technique was employed
for cardiac protection in all cases. Cardiac arrest was
initiated with a bolus dose of K/mg-cardioplegia concentrate
solution given into a 35—37 8C warm mixture of a moderately
hyperkalaemic 5% glucose solution and oxygenated blood was
infused into the aortic root in a ratio of 1:8. The mixture was
cooled to about 30 8C after cardiac arrest, and thereafter
given as a continuous ante/retrograde infusion directly into
the coronary ostia and/or through the coronary sinus and into
the venous grafts. Before declamping of the aorta, the blood
cardioplegia was warmed to 35—37 8C and infused for
4—5 min. The target activated clotting time was 600 s
due to the use of a moderate dose of aprotinin (2.5—4 million
units per patient).
2.2. Statistical analysis
Statistical analysis was performed using a SPSS statistical
software (SPSS, version 14.0.1, SPSS Inc., Chicago, IL, USA).
Continuous variables are reported as the mean  standard
deviation. The Pearson’s chi-square, Fisher’s exact, Kruskal—
Wallis’ and the Mann—Whitney’s tests were used for
univariate analysis. The receiver operating characteristics
(ROC) curve was used to estimate the predictive value of
continuous variables. The best cut-off values have been
chosen according to the best sensitivity, specificity, accuracy
and odds ratio. The Spearman’s test was used to estimate the
correlation of continuous variables. Logistic regression with
the help of backward selection was used for multivariate
analysis. The variables listed in Table 1 with a p < 0.2 at
univariate analysis were included into the logistic regression
model along with the year of operation. Additive and logistic
scoring systems were then developed, the former having
been calculated by adding rounded odds ratios. Additive and
logistic EuroSCOREs were calculated according to the
proposed formulas [2,3]. The Kaplan—Meier test and Cox’s
regression analysis were used to evaluate late survival. A
p < 0.05 was considered statistically significant.ve the accuracy of EuroSCORE?. Eur J Cardiothorac Surg (2009),
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Table 1
Clinical characteristics and operative data.
No. (%) Univariate
analysis
p-value
Age (years) 67.7  10.3 <0.0001
Age 70 years 1705 (47.2) <0.0001
Females 1028 (28.5) <0.0001
Pulmonary disease 404 (11.2) <0.0001
Diabetes 695 (19.2) 0.004
Cerebrovascular disease 396 (11.0) <0.0001
Extracardiac arteriopathy 304 (8.4) <0.0001
Serum creatinine (mmol/l) 94.8  49.4 <0.0001
Renal failure 41 (4.4) 0.003
Estimated glomerular filtration
rate (ml/min/1.73 m2)
74.3  19.7 <0.0001
Chronic kidney disease classification <0.0001
Classes 1—2 2815 (77.9)
Class 3 753 (20.8)
Classes 4—5 45 (1.2)
Active endocarditis 19 (0.5) 0.001
Neurological dysfunction 47 (1.3) 0.028
Myocardial infarction <3 months 698 (19.3) <0.0001
Previous cardiac surgery 158 (4.4) <0.0001
LVEF >50% 2430 (67.3) <0.0001
30—50% 1043 (28.9)
<30% 140 (3.9)
Nitrates infusion at OR arrival 397 (11.0) <0.0001
Critical preoperative status 65 (1.8) <0.0001
Systolic pulmonary a. pressure >60 mmHg 83 (2.3) <0.0001
Emergency operation 186 (5.1) <0.0001
Postinfarct ventricular septal rupture 9 (0.2) <0.0001
Surgery on the thoracic aorta 56 (1.5) <0.0001
Additive EuroSCORE 4.8  3.1 <0.0001
Logistic EuroSCORE (%) 5.9  8.4 <0.0001
Type of operation
Isolated CABG 2750 (76.1)
CABG + ventriculoplasty 15 (0.4)
CABG + AVR 245 (6.8)
CABG + MV surgery 72 (2.0)
CABG + double valve surgery 20 (0.6)
CABG + triple valve surgery 3 (0.1)
CABG + other major cardiac procedures 9 (0.2)
CABG + other non-cardiac procedures 13 (0.4)
Isolated AVR 235 (6.5)
Isolated MV surgery  ASD closure 127 (3.5)
Double valve surgery 24 (0.7)
Triple valve surgery 7 (0.2)
Bentall—DeBono procedure  CABG 50 (1.4)
Other aortic procedures 2 (0.1)
Tricuspid valve surgery + other procedures 3 (0.1)
Isolated ASD closure 20 (0.6)
Isolated VSD closure 4 (0.2)
Other major cardiac procedures 8 (0.2)
Isolated major cardiac procedures 3152 (87.2) <0.0001
Procedures other than isolated CABG 850 (23.5) <0.0001
Continuous variables are reported as the mean  standard deviation; CABG:
coronary artery bypass grafting; AVR: aortic valve replacement; MV: mitral
valve; ASD: atrial septal defect; and VSD: ventricular septal defect.3. Results
3.1. 30-day postoperative mortality
The overall 30-day postoperative mortality rate was 2.5%
(90 of the 3613). The 30-day postoperative mortality was notPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069significantly different after isolated coronary artery bypass
surgery (1.6%), isolated aortic valve surgery (1.7%) and
isolated mitral valve surgery (2.5%) ( p = 0.75). On the other
hand, 30-day mortality rates after isolated procedure,
double procedure and three to four procedures were 1.7%
(54 of the 3152), 5.4% (22 of the 405) and 25% (14 of the 56),
respectively ( p < 0.0001). Accordingly, the CPB duration also
correlated with the amount of procedures (106  34 min,
172  52 min and 262  98 min, respectively, p < 0.0001).
The area under the ROC curve for predicting the 30-day
mortality was much larger for the estimated preoperative
glomerular filtration rate (0.716; 95% confidence interval
(CI): 0.656—0.776; p < 0.0001) than for preoperative serum
creatinine (0.660; 95%CI: 0.594—0.727; p < 0.0001). The 30-
day mortality rate for CKD Classes 1—2 was 1.3%, for Class 3 it
was 6.1% and for Classes 4—5 it was 13.3%, respectively
( p < 0.0001), whereas it was 12.2% and 2.4% for patients
with and without renal failure according to EuroSCORE
criteria ( p = 0.003). The estimated glomerular filtration
rate, but not the preoperative serum creatinine, was an
independent predictor of the 30-day mortality.
The patients’ age, in all regression models, was an
independent predictor of the 30-day mortality. When we
evaluate age according to additive EuroSCORE criteria,
marked difference in mortality was detected for patients
aged 70 or older. However, a further increase was observed
among octogenarians. Because of this factor, we have divided
patient’s age into four classes (30-day mortality rates: <60
years, 0.6%; 60—69.9 years, 1.8%; 70—79.9 years, 3.6%; 80
years, 4.6%, p < 0.0001).
Risk factors associated with the 30-day postoperative
mortality at univariate, and at the final, regression analysis
are listed in Tables 1 and 2. The Hosmer—Lemeshow chi-
square of the final regression model was 4.952, p = 0.763.
The ROC analysis showed that the modified score had a
slightly better area under the curve (additive: 0.867, 95%CI:
0.830—0.904; logistic: 0.873, 95%CI: 0.837—0.909) than the
EuroSCORE (additive: 0.835, 95%CI: 0.790—0.879; logistic:
0.840, 95%CI: 0.796—0.883) (Fig. 1) for prediction of the 30-
day postoperative mortality. Similar areas under the ROC
curve were observed in predicting in-hospital mortality (area
under the ROC curve: additive modified score 0.867, 95%CI:
0.832—0.902; logistic modified score 0.872, 95%CI: 0.838—
0.907; additive EuroSCORE 0.831, 95%CI: 0.788—0.873;
logistic EuroSCORE 0.836, 95%CI: 0.794—0.878).
Such marginal superiority of the modified score shown by
ROC analysis became much more significant when we
compared the observed and predicted 30-day mortality
along different additive scores. In fact, EuroSCORE was
associated with a large difference between the predicted and
observed mortality, whereas the modified score provided
predicted mortality rates much closer to the observed ones
(Fig. 2).
3.2. Outcome prediction after isolated major procedures
The modified risk score performed somewhat better than
EuroSCORE in predicting the 30-day mortality after isolated
coronary artery bypass surgery (area under the ROC curve:
additivemodified score — 0.818, 95%CI: 0.759—0.876; logistic
modified score — 0.819, 95%CI: 0.761—0.877; additiveve the accuracy of EuroSCORE?. Eur J Cardiothorac Surg (2009),
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Table 2
Results of logistic regression in predicting 30-day postoperative mortality.
Beta-coefficient Standard
error
p-value Odds ratio 95% confidence
interval
Additive score
points
Patients’ age
<60 years 0.005
60—69 years 0.779 0.571 0.173 2.178 0.711—6.674 2
70—79 years 1.371 0.550 0.013 3.940 1.340—11.588 4
80 years 1.853 0.606 0.002 6.377 1.944—20.923 6
Female 0.536 0.263 0.042 1.709 1.020—2.863 2
Pulmonary disease 1.080 0.280 0.000 2.945 1.700—5.101 3
Extracardiac arteriopathy 0.778 0.320 0.015 2.178 1.164—4.075 2
Neurological dysfunction 1.461 0.615 0.018 4.309 1.290—14.398 4
Redo surgery 1.049 0.385 0.006 2.855 1.343—6.070 3
Critical preoperative status 2.079 0.371 0.000 7.993 3.860—16.552 8
Left ventricular ejection fraction
>50% 0.001
30—50% 0.870 0.262 0.001 2.387 1.429—3.986 2
<30% 1.102 0.461 0.017 3.010 1.218—7.436 3
Surgery of the thoracic aorta 2.115 0.549 0.000 8.287 2.825—24.305 8
Ventricular septal defect secondary
to myocardial infarction
2.219 0.777 0.004 9.197 2.005—42.192 9
Chronic kidney disease classification
Classes 1—2 0.000
Class 3 0.995 0.263 0.000 2.704 1.615—4.527 3
Classes 4—5 1.858 0.586 0.002 6.413 2.035—20.211 6
Number of procedures
1 0.000
2 0.736 0.306 0.016 2.089 1.146—3.807 2
3—4 1.882 0.489 0.000 6.567 2.516—17.139 7
Constant 6.779 0.567 0.000 0.001EuroSCORE — 0.781, 95%CI: 0.710—0.853; logistic EuroSCORE
— 0.785, 95%CI: 0.714—0.855).
The modified risk score as well as EuroSCORE performed
extremely well in predicting the 30-day mortality after
isolated aortic valve surgery (area under the ROC curve:
additivemodified score — 0.946, 95%CI: 0.898—0.993; logistic
modified score — 0.964, 95%CI: 0.932—0.997; additive
EuroSCORE — 0.908, 95%CI: 0.844—0.971; logistic EuroSCORE
— 0.936, 95%CI: 0.893—0.980). When both additive scores
were divided in quartiles, mortality occurred only in the last
quartiles, that is, additive scores 8 (EuroSCORE: observedPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069
Fig. 1. Receiver operating characteristics curves of additive and logistic
EuroSCORE and modified score in predicting 30-day postoperative mortality
after adult cardiac surgery.30-day mortality 8.2%, mean expected mortality
15.9  9.9%; modified score: observed 30-day mortality
6.6%, mean predicted mortality 5.3  6.9%).
The modified risk score performed well also in predicting
the 30-day mortality after mitral valve surgery (area under
the ROC curve: additive modified score 0.877, 95%CI: 0.805—
0.950; logistic modified score: 0.907, 95%CI: 0.850—0.964).
The EuroSCORE tended, likewise, to be a valid predictor of
postoperative mortality after isolated mitral valve surgery
(area under the ROC curve: additive EuroSCORE 0.801, 95%CI:
0.505—1.096; logistic EuroSCORE: 0.832, 95%CI: 0.605—
1.058).
3.3. Severe postoperative complications
The combined adverse end-point (30-day mortality,
intensive care unit stay 5 days, stroke, postoperative use
of intra-aortic balloon pump and the need of postoperative
dialysis) was observed in 383 patients (10.6%). Both risk-
scoring methods were good predictors of combined end-point
(area under the ROC curve: additive modified score — 0.782,
95%CI: 0.760—0.807; logistic modified score — 0.786, 95%CI:
0.762—0.810; additive EuroSCORE — 0.748, 95%CI: 0.722—
0.774; logistic EuroSCORE — 0.752, 95%CI: 0.726—0.778).
3.4. Long-term outcome
The modified score had a somewhat better area under the
ROC curve (additive: 0.841, 95%CI: 0.810—0.872; logistic:
0.849, 95%CI: 0.818—0.879) compared to the EuroSCOREve the accuracy of EuroSCORE?. Eur J Cardiothorac Surg (2009),
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Fig. 2. Observed and predicted postoperative mortality according to the
logistic EuroSCORE and the logistic modified score in different additive mod-
ified score classes and additive EuroSCORE classes.
Fig. 3. Kaplan—Meier’s estimates of overall survival after adult cardiac surgery
according to quintiles of logistic modified score (A) and logistic EuroSCORE (B).(additive: 0.807, 95%CI: 0.771—0.844; logistic: 0.815, 95%CI:
0.780—0.851) in predicting overall mortality at 1 year.
According to Cox’s survival analysis, both scoring methods
were good predictors of all-cause late mortality (when both
scoring methods were included into the regression analysis:
additive modified score — relative risk (RR): 1.132, 95%CI:
1.099—1.167; additive EuroSCORE — RR: 1.091, 95%CI: 1.055—
1.129). Similar results were achieved when only operative
survivors were included in the analysis. Fig. 3 shows the
Kaplan—Meier’s estimates of overall survival according to
logistic modified score and the logistic EuroSCORE quintiles.
4. Discussion
The evaluation of EuroSCORE in our institutional database
showed that it is a rather accurate tool for risk stratification of
30-day and long-term mortality after adult cardiac surgery.
However, this study confirms its previously observed pitfalls in
estimating immediate postoperative mortality rate of these
patients [1]. This issue is of great clinical importanceatpresent
as new, less invasive surgical procedures as well as percuta-
neous and medical treatments can be offered as alternative
therapies in high-risk patients. However, an overestimation of
the operative risk would lead to an indication of less invasive
treatment methods in patients who could have better
immediate and/or late results with traditional surgicalPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069procedures. This applies particularly to treatment methods
such as transcatheter aortic valve implantation [7] and
percutaneous coronary interventions [11], whose durability,
so far, is inferior to traditional surgical treatments.
The risk-scoring method developed for the present study
demonstrates that the modification of a few risk factors
included in the EuroSCORE may markedly improve its
predictive power. In particular, the introduction of estimated
glomerular filtration rate and a better classification of the
complexity of surgery seem to provide a better estimation of
the operative risk.
Renal failure is recognised as one of the most powerful
predictors of outcome after cardiovascular surgery, and
estimated glomerular filtration rate seems to be superior to
serum creatinine for operative risk estimation [12,13].
Importantly, estimated glomerular filtration rate may be
useful to identify those patients with subclinical renal failure
whomay benefit from early referral to a nephrologist [14]. Its
use in cardiac surgery would lead to a better identification
and prompt treatment of patients who are at risk of
developing late renal failure.ve the accuracy of EuroSCORE?. Eur J Cardiothorac Surg (2009),
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determinant of adverse outcome. This is related not only to a
longer operative time and CPB duration, but also to technical
aspects and their related complications. However, it is
difficult to quantify the complexity of the procedure as it can
be multifactorial, with the results, possibly, being related to
the surgeon’s experience and skills. We believe that the
variable ‘other than isolated coronary artery bypass surgery’
as defined by EuroSCORE is likely to consider several isolated
procedures as complex cardiac surgery though not having a
significantly higher mortality risk than isolated coronary
surgery. We attempted to redefine this variable including
three classes of procedures which should correlate better
with the complexity of cardiac surgery. Indeed, when both
variables were included into the regression analysis, only the
amount of procedures/areas of intervention was an inde-
pendent predictor of the 30-day mortality. It is worth noting
that performing three or more interventions (e.g., double
valve surgery plus coronary surgery, replacement of the
ascending aorta and aortic valve plus coronary surgery) is
associated with a rather high odds ratio. Interestingly,
despite such findings, aortic surgery was still an important,
independent predictor of postoperative mortality.
In our regressionmodel, some EuroSCORE variables such as
emergency surgery and nitrates infusion at operating-room
arrival were not predictive of adverse outcome. This can be
explained by the subjective nature and the influence of
logistic factors in defining these two variables. Undoubtedly,
most of patients requiring emergency surgery and/or nitrates
infusion have an increased operative risk, but certainly not
all of them. Similarly, recent myocardial infarction was also
not an independent predictor of postoperative mortality.
This could be due to the large heterogeneity of patients
having a myocardial infarction within the 3 months prior to
the surgery. The transmural and subclinical myocardial
infarctions lie within this group. Furthermore, it is not
unusual to detect a small increase of troponin levels just prior
to elective surgery in asymptomatic patients without history
of myocardial infarction. Other risk factors such as left
ventricular ejection fraction and critical preoperative state
are probably more representative for the most clinically
relevant myocardial infarctions.
This study has several limitations. The first is that the
study subjects have been operated across a long period of
time, during which changes in treatment methods and in
patients’ operative risk have certainly occurred. We
attempted to control for such a possible bias by including
the year of operation into the logistic regression analysis. The
second limitation is the small size of the study which, we
believe, does not allow division into sufficiently large
derivation and validation datasets. The third is the possibility
of errors in defining clinical variables in the pre-EuroSCORE
era. However, such a risk should be minimal as all variables
were originally and prospectively classified according the
Higgins’ risk-scoring method [15].
In conclusion, EuroSCORE still performs very well in
identifying high-risk patients. Its main pitfall is the over-
estimation of immediate postoperative mortality. This studyPlease cite this article in press as: Nissinen J, et al. Is it possible to impro
doi:10.1016/j.ejcts.2009.03.069shows that its accuracy and clinical relevance can be
significantly improved by modifying a few of its variables
in the light of current knowledge on predictors of poor
outcome after cardiac surgery. The institutionally derived
risk-scoring method presented in this article represents a
modification and simplification of the EuroSCORE which could
provide a more realistic estimation of the mortality risk after
adult cardiac surgery during the immediate postoperative
period.
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